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RESEARCH SUMMARY 
 
Sphingolipids play crucial roles in eukaryotic cells both as membrane components and as 
mediators of signalling events. Sphingosine and ceramide promote apoptosis while 
sphingosine-1-phosphate (S1P) is involved in the regulation of cell growth, survival, 
proliferation and migration as well as in inflammation and angiogenesis. The relative balance 
between sphingosine and ceramide on one side and S1P on the other side has been found to 
play a key role in the determination of cell fate. The metabolism of S1P is often deregulated 
in pathologies like cancer, allergic response, diabetes and multiple sclerosis. The intracellular 
concentration of S1P is tightly regulated by a set of three enzymes, sphingosine kinase, S1P 
phosphatase and S1P lyase (SPL), the biochemistry of which is at present poorly understood. 
SPL carries out the irreversible degradation of S1P into hexadecenal and 
phosphoethanolamine (PE). Eukaryotic SPL is a single-pass membrane protein located in the 
endoplasmic reticulum (ER) with the active site situated in the cytosol. The enzyme requires 
pyridoxal 5’-phosphate (PLP) as a cofactor. Yeast SPL is involved in the response to heat 
stress and nutrient deprivation, in calcium homeostasis and in endocytosis. In mammals, SPL 
plays a crucial role in the maintenance of the immune system, in cell turnover and 
development. 
In this thesis work, a thorough structural characterization of eukaryotic SPL and of a 
prokaryotic orthologue was successfully carried out, together with a detailed functional 
analysis. The prokaryotic enzyme, originating from the thermophilic bacterium 
Symbiobacterium thermophilum exhibited a dimer-tetramer equilibrium on size-exclusion 
chromatography. We solved the structure of a homodimer at 1.8 Å and of a homotetramer 
at 3.4 Å. The tetramer interface was analysed and categorized as a crystal contact. The 
protein was active in a preliminary spectrophotometric activity assay validated using mass 
spectrometry. The structure of the protein inactivated with semicarbazide, a “classical” 
inhibitor of PLP-dependent enzymes, was solved at 2.1 Å resolution and provided a clear 
insight into the mode of SPL inhibition. Additionally we solved the structure of a homodimer 
with conformational heterogeneities at a resolution of 3 Å: one active site lacked PLP and 
several surrounding loops were conformationally disordered. This active site was assumed to 
represent an inactive state of the enzyme. The structure of an inactive mutant of the protein 
in complex with the reaction product PE was solved at 2.9 Å. This and the previous 
structures served as a basis for the design of active site mutants, which allowed the 
identification of key residues for activity. 
Importantly, the structure of a truncated variant of yeast SPL was solved at 3.1 Å. Despite 
the striking similarity between the active sites of bacterial and yeast SPLs, truncated yeast 
SPL turned out to be inactive in vitro. Thus, the missing residues appear to be needed for 
activity, possibly for recruiting the substrate. 
An in vivo activity assay was carried out on mutants of full-length yeast SPL in collaboration 
with Prof. Howard Riezman, University of Geneva. The results of the in vitro activity tests on 
bacterial SPL and of the in vivo activity test on yeast SPL are in good agreement with each 
other and provide a solid basis for the proposed reaction mechanism of the enzyme. 
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ZUSAMMENFASSUNG 
 
Sphingolipide haben in Eukaryoten nicht nur als Membrankomponente eine zentrale Funktion, 
sondern auch als Mediatoren innerhalb des Signalübertragungsweges der Zelle. Während 
Sphingosin und Ceramid den programmierten Zelltod auslösen, reguliert Sphingosin-1-phosphat 
(S1P) nicht nur das Zellwachstum sondern steuert auch die Zelllebensdauer, sowie die Zellteilung 
und spielt bei Entzündungen und beim Gefässwachstum eine wichtige Rolle. Es hat sich 
herausgestellt, dass das relative Konzentrationsverhältnis von Sphingosin-Ceramid zu S1P für die 
Überlebenschance einer Zelle bestimmend ist. Zum Beispiel bei Krebs, Allergie, Diabetes und 
Multiple Sklerosis ist der S1P Metabolismus sehr oft aus dem Gleichgewicht geraten. Die 
intrazelluläre Konzentration von S1P wird von den drei Enzymen Sphingosin-Kinase, S1P-
Phosphatase und S1P-Lyase (SPL) reguliert. Die damit verbundenen biochemischen Abläufe 
dieser Regulierung sind jedoch nur zum Teil bekannt. SPL ist für den irreversiblen Abbau von S1P 
zu Hexadecenal und Phosphoethanolamin (PE) verantwortlich. Eukaryotisches SPL ist ein 
singlepass Transmembranprotein welches im endoplasmatischen Reticulum (ER) positioniert ist. 
Das aktive Zentrum liegt im Cytosol. Dieses Enzym benötigt Pyridoxal-5’-Phosphat (PLP) als 
Enzym-Cofaktor. SPL aus Hefe ist mitverantwortlich für die Reaktion der Zelle auf Wärmestress 
und Nährstoffmangel, und spielt eine Rolle in der Aufrechterhaltung des zellulären 
Calciumspiegels sowie in der Endozytose. SPL in Säugetieren spielt eine zentrale Rolle in der 
Aufrechterhaltung des Immunsystems, im Zellumsatz und in der Entwicklung des Gewebes. 
In dieser Dissertation wird eine umfassende strukturelle Charakterisierung und detaillierte 
funktionelle Analyse des eukariotischen SPL-Enzyms sowie eines prokaryotischen Orthologs 
präsentiert. Das prokaryotische Enzym des thermophilen Bakteriums Symbiobacterium 
thermophilum zeigte in Gelfiltrations Experimenten ein Equilibrium zwischen dem Dimer und 
dem Tetramer. Es ist uns gelungen die Struktur des Homodimers auf 1.8Å und die des 
Homotetramers auf 3.4Å zu lösen. Das Interface der tetrameren Form wurde analysiert und als 
Kristallkontakt klassiert. Die zuvor gemessene Aktivität in einem spektophotometrischen Assay 
konnte in der anschliessenden massenspektrometrischen Analyse bestätigt werden. Die Struktur 
des mit N-Aminoharnstoff (Semicarbazid) inhibierten Proteins konnte bis auf 2.1Å gelöst werden. 
Die hohe Auflösung erlaubte einen vertieften Einblick in die Funktionsweise der SPL-Inhibition. 
Zusätzlich konnten wir die homodimere Struktur mit konformationellen Heterogenität bis auf 
eine Auflösung von 3Å bestimmen. Bei dieser Struktur fehlte im aktiven Zentrum das PLP und 
mehrere Stellen zeigten eine veränderte konformationelle Anordnung. Es ist naheliegend, dass 
das aktive Zentrum in dieser Form den inaktiven Zustand des Enzymes darstellt. Die 
Proteinstruktur einer inaktiven Mutante im Komplex mit dem Reaktionsprodukt PE konnte bis 
auf 2.9Å gelöst werden. Diese und alle vorhergehenden Proteinstrukturen dienten als Basis für 
den Entwurf von Varianten mit Mutationen im aktiven Zentrum. Dies sollte die präzise 
Lokalisierung der für die Aktivität verantwortlichen Aminosäureresten ermöglichen.  
Wichtig für das Projekt war auch die Strukturbestimmung auf 3.1Å einer gekürzten Variante von 
SPL aus Hefe. Trotz der verblüffenden Ähnlichkeit des aktiven Zentrums zum bakteriellen SPL, 
zeigte die gekürzte Variante aus Hefe keine Aktivität in vitro. Das ist ein Hinweis dafür, dass die 
fehlenden Aminosäuren eine Funktion haben müssen, welche sich auf die Aktivität des Proteins 
auswirkt. Es wird vermutet, dass diese Aminosäurenresten eine wichtige Rolle bei der 
Rekrutierung des Substrates übernehmen. 
Ein in vivo Aktivitätstest an Mutanten mit komplettem SPL aus Hefe wurde in Kollaboration mit 
Prof. Howard Riezman von der Universität in Genf durchgeführt. Die sehr gut 
übereinstimmenden Resultate des in vitro Aktivitätstests mit bakteriellem SPL und dem in vivo 
Aktivitätstest mit SPL aus Hefezellen bilden eine solide Basis für mögliche Erklärungen des 
Reaktionsmechanismus dieses Enzyms. 
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ABBREVIATIONS 
 
ABC, ATP-binding cassette 
AC, adenylyl cyclase-cyclic AMP 
ADP, adenosine 5'-diphosphate 
AET, S-(2-aminoethyl)isothiouronium bromide hydrobromide 
AMP, adenosine 5'-monophosphate 
ATP, adenosine 5'-triphosphate 
a.u., asymmetric unit 
AU, absorbance unit 
AUC, analytical ultracentrifugation 
 
BSA, bovine serum albumin 
 
CAPS, 3-(cyclohexylamino)-1-propanesulfonic acid 
CD, circular dichroism 
CER, ceramide 
CER'ase, ceramidase 
CERT, ceramide transport protein 
CFTR, cystic fibrosis transmembrane regulator 
CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate 
CHES, 2-(cyclohexylamino)ethanesulfonic acid 
CHOL, cholesterol 
CMC, critical micelle concentration 
COS7, CV-1 (cell line derived from kidney cells of the African green monkey) in Origin carrying SV40 
(Simian-Virus 40) genetic material 
C1P, ceramide-1-phosphate 
CPT2, carnitine palmitoyl-transferase 2 
 
Da, dalton (g/mol) 
DAG, diacylglycerol 
DDM, dodecylmaltoside 
DHS1P, dihydrosphingosine-1-phosphate 
DMSO, dimethyl sulfoxide 
DNA, deoxyribonucleic acid 
DNPH, dinitrophenylhydrazine 
Dpl1p, dihydrosphingosine-1-phosphate lyase 1 
DTT, dithiothreitol 
 
EDG, endothelial differentiation gene 
EDTA, ethylenediaminetetraacetic acid 
EG, ethylene glycol 
ER, endoplasmic reticulum 
ERK, extracellular signal-regulated kinase 
ESI, electrospray 
 
FL, full-length 
FTY720 (fingolimod), 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol 
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GABA, γ-amino butyric acid 
Gad/GAD, glutamate decarboxylase 
GLTP, glycolipid transfer protein 
GSL, glycosphingolipids 
GTP, guanosine 5'-triphosphate 
 
HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPLC, high performance (or high-pressure) liquid chromatography 
Hs, Homo sapiens 
 
IGF, insulin-like growth factor 
IL, interleukin 
IMAC, immobilized metal affinity chromatography 
IPTG, isopropyl β-D-1-thiogalactopyranoside 
ITC, isothermal titration calorimetry 
 
JNK, Jun amino-terminal kinase 
 
L, litre 
LB, Luria broth 
LCB, long-chain base 
LDAO, lauryldimethylamine-oxide 
LL-DAP-AT, LL-diaminopimelate aminotransferase 
LPA, lysophosphatidic acid 
 
MAMs, mitochondria-associated membranes 
MME, monomethyl ether (PEG) 
MPD, 2-methyl-2,4-pentanediol 
MS, mass spectrometry 
MW, molecular weight 
MWCO, molecular weight cut-off 
 
NDA, naphthalene-2,3-dicarboxaldehyde 
NEM, N-ethylmaleimide 
NF-κB, nuclear factor κB 
Ni-NTA, nickel-nitriloacetic acid 
 
OD, optical density 
 
PA, phosphatidic acid 
PARP, poly-ADP-ribose polymerase 
PC, phosphatidylcholine 
PCR, polymerase chain reaction 
PDB, protein data bank 
PDGF, platelet-derived growth factor 
PE, phosphoethanolamine 
PEG, polyethylene glycol 
PG, phosphatidylglycerol 
PH, pleckstrin homology 
PI, phosphatidylinositol 
PIDD, p53-inducible death domain protein 
PI3K, phosphatidylinositol-3 kinase 
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PIP / PIP2 / PIP3, phosphatidylinositol phosphate / biphosphate / triphosphate 
PI4P, phosphatidylinositol 4-monophosphate 
PKC, protein kinase C 
PLC, phospholipase C 
PLP, pyridoxal 5'-phosphate 
PM, plasma membrane 
PRR, proline-rich repeat (or region) 
PS, phosphatidylserine 
PS1P, phytosphingosine-1-phosphate 
PtE, phosphatidylethanolamine 
PVDF, polyvinylidene fluoride 
 
rmsd, root mean square deviation 
 
SAXS, small-angle X-ray scattering 
Sc, Saccharomyces cerevisiæ 
SDS-PAGE, sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEC, size-exclusion chromatography 
SK, sphingosine kinase 
SM, sphingomyelin 
SM'ase, sphingomyelinase 
S1P, sphingosine-1-phosphate 
SPH, sphingosine 
SPL, sphingosine-1-phosphate lyase 
SPP, sphingosine-1-phosphate phosphatase 
SPR, surface plasmon resonance 
SPT, serine palmitoyl-transferase 
SQR, sulphide:quinine oxidoreductase 
SREBP, sterol regulatory element binding protein 
St, Symbiobacterium thermophilum 
START, steroidogenic acute regulatory protein-related lipid transfer 
 
TAPS, N-[tris(hydroxymethyl)methyl]-3-aminopropanesulfonic acid 
TB, terrific broth 
TCEP, tris(2-carboxyethyl)phosphine 
THI, 2-acetyl-4-tetrahydroxybutyl-imidazole 
TLC, thin-layer chromatography 
TM, transmembrane 
TNF, tumour-necrosis factor 
TOF, time-of-flight 
Tris, tris(hydroxymethyl)aminomethane 
 
VEGF, vascular endothelial growth factor 
 
WT, wild-type 
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1. INTRODUCTION 
 
1.1. MEMBRANE LIPIDS 
 
Lipids perform three main functions in living organisms: they are an energy source, they 
form cellular membranes and they act as signalling molecules (1). Approximately 5% of a 
eukaryotic genome encodes lipid-related proteins, tuned by evolution to generate, degrade 
and transport more than a thousand different lipids. The lipid repertoire of an organism is 
highly conserved across evolution. Failure in lipid metabolism or transport is associated with 
severe dysfunctions. Moreover, specific lipids are connected to viral and bacterial infection 
(2). In spite of the importance of this class of molecules, biochemical investigations are 
hindered by the difficulty of handling these hydrophobic compounds in aqueous solutions. 
 
1.1.1. METABOLISM AND LOCALISATION 
 
Cellular membranes are composed by amphipathic lipids, molecules exhibiting both a 
hydrophobic and a hydrophilic portion. The formation of a lipid bilayer is spontaneous. The 
hydrophobic moiety of the lipid self-associates and the hydrophilic part interacts with an 
aqueous environment. This enables cells to segregate their internal constituents from the 
external environment and to create specialized compartments where specific chemical or 
enzymatic reactions take place. 
Importantly, the lipid composition of membranes exerts an influence on the activity of 
integral and peripheral membrane proteins. Some lipids, by arranging into defined 
membrane domains, are able to recruit proteins that mediate signalling events, transport of 
solutes and nutrients or provide enzymatic activity. The major structural lipids in eukaryotic 
membranes are glycerophospholipids: phosphatidic acid (PA), phosphatidylethanolamine 
(PtE), phosphatidylserine (PS), phosphatidylinositol (PI), and phosphatidylcholine (PC), the 
most abundant phospholipid in eukaryotic cells (figure 1-1). Their hydrophobic portion, 
diacylglycerol (DAG), features a variable length and degree of insaturation. This allows a 
further degree of specialization in addition to the polar head group. Due to its relatively 
small polar head, PtE does not spontaneously associate into a bilayer, but rather interacts 
with membrane proteins and modulates their activity. Additionally, PtE allows for membrane 
curvature, a property required for membrane budding, fission, and fusion (3). Another class 
of structural lipids is that of sphingolipids (figure 1-2). They possess saturated or trans-
insaturated hydrophobic tails and pack together more tightly than PC does. 
Glycosphingolipids are located at the cell surface and are involved in cell-to-cell recognition 
and cellular communication. The hydrolysis (or phosphorylation) of glycerophospholipids 
and sphingolipids produces bioactive lipids: PA, DAG, sphingosine (SPH), sphingosine-1-
phosphate (S1P), ceramide (CER) and ceramide-1-phophate (C1P) (figures 1-1 & 1-2). Since 
SPH and S1P contain only one aliphatic chain and are thus presumably less tightly bound to 
the membrane than CER and C1P, they might be involved in signalling events through 
interaction with cognate membrane receptors (4). Sterols are non-polar membrane lipids 
(figure 1-3). These molecules are able to intercalate between sphingolipid tails, thus 
increasing the fluidity of sphingolipid-rich domains. In yeast cell membranes the 
predominant sterol is ergosterol, while cholesterol predominates in mammals. 
The various kinds of lipids specifically distribute into given organelles. The enzymes involved 
in the synthesis of lipids are distributed in several cellular compartments. The endoplasmic 
reticulum (ER) is the major site of synthesis of cholesterol, phospholipids and ceramides. The 
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enzymes of lipid metabolism are subcompartmentalized in defined regions of the ER called 
mitochondria-associated membranes (MAMs). The newly synthesized lipids are quickly 
transported to other organelles. The Golgi apparatus is specialized in sphingolipid synthesis. 
It produces phosphosphingolipids like sphingomyelin, glycosphingolipids like 
glucosylceramide and lactosylceramide, as well as gangliosides, which are glycosphingolipids 
with a terminal sialic acid. Most of the lipids synthesized in the Golgi will be further 
transported to the plasma membrane (PM). The PM is enriched in sphingolipids and sterols, 
which are densely packed and make it resistant to mechanical stress. Numerous reactions of 
lipid metabolism take place in this part of the cell, for example the degradation of 
sphingomyelin to ceramide by sphingomyelinase. The synthesis of phosphoinositides occurs 
in the PM as well as in early and late endosomes (figure 1-1). Phosphoinositides are 
signalling molecules specialized in membrane recognition and sorting of membrane proteins 
to organelles. Late endosomes are specialized in lipid catabolism. For example, one isoform 
of sphingomyelinase located in late endosomes and possessing an acidic pH optimum, is 
responsible for the turnover of plasma membrane sphingomyelin. Sterols and PS are also 
degraded in late endosomes. The mitochondrion synthesizes phosphatidylglycerol (PG), the 
building block for cardiolipin, a lipid unique to the inner membrane of mitochondria and to 
bacterial membranes (5) (figure 1-4). This organelle also synthesizes lysophosphatidic acid 
(LPA), PA, and PtE. Moreover, mitochondria are involved in the metabolism of cholesterol 
together with the ER (6). 
 
Figure 1-1. Glycerophospholipids 
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Figure 1-2. Sphingolipids 
 
 
 
Figure 1-3. Sterols 
 
 
 
Figure 1-4. Mitochondrion lipids 
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1.1.2. TRANSMEMBRANE DISTRIBUTION 
 
The lipid composition of the two leaflets of the ER membrane and the inner membrane of 
Gram-negative bacteria is symmetric. This is not true for the two leaflets of the Golgi, 
endosomal and plasma membranes. Sphingomyelin and glycosphingolipids are found in the 
external leaflet of the PM, whereas the cytosolic leaflet is enriched in PS and PtE (7). Lipid 
asymmetry has functional consequences. For example, phagocytosis is mediated by sensing 
of PS exposed to the cell surface. Furthermore, an imbalance in lipid quantity is required for 
vesicle budding (8). 
Lipid asymmetry results from three main phenomenona. First, some lipids are able to 
spontaneously cross the hydrophobic core of the membrane depending on the size, charge 
and polarity of the molecule (9). PS and PtE are known to equilibrate between the two 
leaflets of the ER membrane. Second, lipids can be retained in one leaflet via specific 
interactions with proteins or other lipids (10). This is presumably the case for cholesterol, 
which is assumed to be more abundant in the exoplasmic leaflet of the cell membrane due 
to its affinity with sphingolipids, despite controversial data on its orientation in the PM (11) 
(7). Third, the lipids can undergo membrane protein-mediated transport from one leaflet to 
the other (12). In the ER, ATP-independent transport occurs, resulting in the equilibration of 
lipids in the two leaflets. Specific or aspecific ATP-dependent transport involves members of 
the P4 family of lipid flippases and of ABC (ATP-binding cassette) transporters, known as 
floppases (figure 1-5). The flippases commonly carry out the import of lipids, whereas the 
export is achieved by the floppases. Other membrane proteins, the plasma membrane 
scramblases (also called lipid translocases) are involved in Ca2+-dependent and ATP-
independent randomization of lipid location between the two leaflets. 
 
Figure 1-5. The three major classes of lipid transporters (adapted from (12)) 
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1.1.3. TRANSPORT BETWEEN ORGANELLES 
 
Transport of specific lipids from organelles is mandatory for their metabolism and is most 
commonly mediated by budding and fusion of membrane vesicles. Specific lipid transport 
covers the ER, the Golgi, the PM, the endosomes, and the lysosomes. Some lipids are 
preferentially incorporated into anterograde vesicles (that is, the vesicles targeted to the 
PM) and are excluded from retrograde transport. This phenomenon contributes to enriching 
the PM in certain lipids, like sphingolipids and sterols. 
In contrast, the import and export of lipids from and to the mitochondria and the 
peroxisomes are not connected to the vesicular transport system. There, proteins are likely 
responsible for lipid transport, presumably through contact sites between organelles. Non-
vesicular transport of lipids between organelles has been demonstrated (13) (14) (15) (16) 
(17) (18) (figure 1-6). It involves specialized proteins such as CERT (ceramide transport 
protein). CERT is a protein harbouring a START lipid transfer domain and additional domains 
required for the identification of donor and acceptor membranes (19) (20) (see section 
1.5.3.). 
 
Figure 1-6. Cellular distribution of cholesterol, phospholipids and sphingolipids 
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1.2. SPHINGOLIPIDS 
 
Sphingolipids were first isolated in 1884 by J.L.W. Thudichum and named with the prefix 
sphingo- due to their enigmatic behaviour. In fact, they exhibited at the same time some 
features of hydrophilic and hydrophobic compounds, and their function was a riddle. They 
are strictly found in eukaryotes, with the exception of the Sphingomonas bacterial genus. 
 
1.2.1. CHEMICAL STRUCTURE 
 
Sphingolipids are composed of three modules: a sphingosine backbone called long-chain 
base (LCB), a polar head group, and an amine-linked fatty acid chain (figures 1-7 & 1-2). The 
common structure of the sphingosine backbone, 2-amino-1,3-diol-alkane, is unique in nature 
and possesses two optical centres at carbon atoms 2 and 3. The naturally occurring 
diastereoisomers of sphingolipids have the (2D,3D) [or D(+)-erythro-] configuration (21). The 
sphingosine backbone and the fatty acid chain are variable in length, degree of insaturation 
and substitution. The most common sphingosine backbone has 18 carbon atoms and one 4-
trans double bond (abbreviated d18:1) (table 1-1). The length of the fatty acid chain usually 
ranges from 14 to 30 carbon atoms and can also carry one single insaturation as well as 
hydroxyl groups. In mammals alone, there are a couple of dozen types of LCB and fatty acid 
chains and more than 400 polar head groups exist: they combine in tens of thousands of 
various sphingolipids (22). 
 
Figure 1-7. Chemical structure of sphingolipids  
 
 
NAME ABBREVIATION - R - X 
SPHINGOSINE SPH H H 
SPHINGOSINE-1-
PHOSPHATE S1P  Phosphate 
CERAMIDE CER Fatty acid H 
CERAMIDE-1-
PHOSPHATE C1P  Phosphate 
GLUCO- / GALACTO- 
CEREBROSIDE GlcCer / GalCer  Glucose / Galactose 
SPHINGOMYELIN SM  Phosphocholine 
GLOBOSIDE   
Several neutral sugars:
Glucose / Galactose / N-acetyl 
galactosamine 
GANGLIOSIDE   
Several Glucose / Galactose / N-acetyl 
galactosamine + 
1 to 4 N-acetyl neuraminic acid (NANA) 
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Table 1-1. Examples of sphingosine backbones 
 
NAME LENGTH INSATURATION ADDITIONAL HYDROXYL GROUP CODE
SPHINGOSINE  
(SPHINGENINE) 18 C 4-trans  d18:1
DIHYDOSPHINGOSINE 
(SPHINGANINE)    d18:0
PHYTOSPHINGOSINE 
(4-HYDROXYSPHINGANINE)   4-Hydroxy- t18:0 
SPHINGADIENE  4-trans 14-cis  d18:2
 
1.2.2. METABOLISM 
 
Sphingolipids can either be produced via the degradation of existing sphingolipids or de novo 
in a synthesis pathway initiated by serine palmitoyl-transferase (SPT) (figure 1-8) (23). SPT 
catalyzes the condensation of serine and palmitoyl-CoA to the first sphingolipid, 3-keto-
dihydrosphingosine (24). This reaction is the entry point of sphingolipid metabolism. 
Acylation of dihydrosphingosine generates dihydroceramide (25), which is subsequently 
desaturated to form ceramide (CER) (26), a sphingolipid metabolic hub. CER is the building 
block of glycosphingolipids (27), ceramide-1-phosphate (C1P) (28) and sphingomyelin (SM) 
(29). CER deacylation by various ceramidases produces sphingosine (SPH) (30) (31), a single-
chain sphingolipid. SPH is the substrate of sphingosine kinase (SK) (32), which produces 
sphingosine-1-phosphate (S1P). S1P can be reversibly dephosphorylated by S1P phosphatase 
(SPP) (33) or irreversibly degraded by S1P lyase (SPL) in one long-chain aldehyde and 
phosphoethanolamine (PE), a polar compound (34). The cleavage of S1P catalyzed by SPL is 
the exit point of the sphingolipid metabolism. PE can be reintroduced into the lipid 
metabolic pathway by phophoethanolamine transferase, which produces 
phosphatidylethanolamine (PtE) from PE and diacylglycerol (35). In fruit fly PtE, in addition 
to being a plasma membrane phospholipid, is required for the processing of SREBP (sterol 
regulatory element binding protein), a key regulator of lipid biosynthetic gene transcription 
(36). 
A second route for the generation of ceramide consists in the breakdown of complex 
sphingolipids by specific hydrolases (37) and of sphingomyelin by specific sphingomyelinases 
(30). 
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Figure 1-8. Sphingolipid metabolism (adapted from (23)) 
 
 
 
1.2.3. LOCALISATION 
 
The subcellular localisation of sphingolipids and of the proteins involved in their metabolism 
is an important parameter influencing the function and regulation of a given lipid or protein. 
Neutral hydrophobic sphingolipids such as ceramide may be able to flip-flop across 
membrane (10), while charged sphingolipids are most likely to be confined in their site of 
synthesis or transported by an active mechanism from one to the other leaflet or to their 
target organelle.  
CER is produced in the ER and transported to the Golgi and the PM where it serves to build 
SM and complex sphingolipids (figure 1-9) (38). The transport is carried out by vesicular 
transport and by CERT, a multi-domain protein able to specifically translocate a sphingolipid 
molecule from the ER to the Golgi (19) (see section 1.5.3.). The six known ceramide 
synthases show distinct affinities for different fatty acyl-CoA substrates and locate in 
different cell compartments (table 1-2) (25). CER is also produced from the breakdown of 
SM, by three types of sphingomyelinase (SM'ase) featuring different pH optima, primary 
sequence and localisation. Acid SM'ase is mainly found in the endolysosomal pathway, but 
can be primed to relocate to the outer leaflet of the PM, whereas the neutral isoform 
localizes to the inner leaflet of the PM (39). The third isoform, alkaline SM'ase, is a secreted 
enzyme responsible for the digestion of dietary sphingomyelin in the gut (40). 
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Sphingosine kinase 1 (SK1) translocates to the PM from the cytosol and interacts with 
anionic phospholipids (41). The nature of the second isoform (SK2) seems to be more 
elusive, as it was reported either sharing SK1 properties and localisation or being more 
tightly associated to membranes (42) (43). S1P is a pivotal cell signalling molecule, which is 
located in various cell compartments and cell types. S1P is transported into the blood stream 
by lipoproteins and albumin, a non-specific lipid adsorbent. Platelets and erythrocytes lack 
the S1P degrading enzymes and can release S1P in response to certain stimuli (44) (45). 
Within the cell, S1P is produced in the inner leaflet of the PM and can be transported to the 
outer leaflet by ABCC1, an ABC transporter (46). Cystic fibrosis transmembrane regulator 
(CFTR) is another ABC transporter that facilitates S1P transport from the outer to the inner 
leaflet of the membrane (47). 
 
Figure 1-9. Spatial organisation of the sphingolipid metabolism (adapted from (23)) 
 
 
Part 1: Introduction 
28 
Table 1-2. Human sphingolipid-related proteins locations and properties 
 
NAME ISOFORM TYPE LOCALISATION REFERENCE
SPHINGOMYELINASE 
(SM'ASE) Acid Soluble 
Lysosome
Secreted 
Outer PM 
(38) (48) 
 Neutral -2 Integral membrane protein 
Debated (Golgi, ER, 
nucleus, PM) (48) 
 Alkaline Soluble or membrane-anchored 
Secreted (Intestine) 
Outer PM (38) (40) 
SM SYNTHASE 1 Integral membrane protein Golgi (29) 
 2  Golgi PM (29) (49) 
 r  ER (29) (50) 
CERAMIDASE 
(CER'ASE) Acid Not determined Lysosome (51) (52) 
 Neutral Integral membrane protein 
Secreted (Intestine) 
Outer PM 
Mitochondria 
(38) (53) 
 Alkaline Integral membrane protein Golgi (31) 
CERAMIDE SYNTHASE 1-6 Integral membrane protein ER 
(25) (25, 
54) 
SERINE PALMITOYL- 
TRANSFERASE 
(SPT) 
(1) Debated (1-2 TMH) ER 
(55) (56) 
(57) 
S1P PHOSPHATASE 
(SPP) 1-2 
Integral membrane 
protein ER (58) 
SPH KINASE 
(SK) 1 
Soluble but recruited to 
the membrane 
Cytosol  
PM 
(41) (59) 
(60) 
 2 
Debated:
Similar to SK1 or Integral 
membrane protein 
Cytosol or 
ER and Nucleus (42) (43) 
S1P LYASE 
(SPL) (1) N-terminal TMH ER (61) 
CERAMIDE TRANSPORT
PROTEIN 
(CERT) 
 Soluble with membrane-interacting domains ER and Golgi (18) (19) 
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1.2.4. FUNCTIONS 
 
Sphingolipids play crucial roles in living cells. 
Together with cholesterol, sphingomyelin and glycosphingolipids form lipid detergent-
resistant membrane microdomains called "lipid rafts". Lipid rafts are involved in the 
clustering of membrane proteins, for example during signal transduction, in vesicular 
budding, and in the entry of pathogens. Sphingolipids can directly interact with domains of 
membrane proteins, thereby modifying their activity. An example is the inhibition of the EGF 
(epidermal growth factor) receptor tyrosine kinase by a ganglioside (62). Some pathogenic 
bacteria like Escherichia coli, Mycobacterium tuberculosis, Vibrio cholerae, Clostridium 
tetani, Salmonella typhimurium and some viruses like Influenzavirus, HIV, Ebolavirus use 
rafts as a gateway to the host cell. The same is true for various parasites like trypanosomes, 
Plasmodium falciparum, Leishmania, Toxoplasma and even for prions (63) (64). 
Some sphingolipids are “bioactive”, that is a change in their concentration brings about 
functional consequences (65). The enzymes of the sphingolipid metabolism are 
biochemically interconnected, meaning that an increase in synthesis of one compound is 
related to a decrease in the other. Such interconnectivity increases the complexity of the 
signalling pathway and allows the cell to modulate the levels of a signalling molecule and its 
antagonist. An example is the interconversion of sphingosine to S1P. Phosphorylation of 
sphingosine increases the level of S1P and decreases at the same time the level of 
sphingosine. Moreover, the relative levels of ceramide, sphingosine, and S1P differs 
tremendously (figure 1-10). As a consequence, phosphorylation of 1% of the sphingosine 
pool may lead to a doubled amount of S1P (65). In addition, the location and transport of 
metabolites and enzymes, allowing pathways to operate in parallel, add another level of 
complexity. The balance of the concentrations of ceramide and sphingosine on one side and 
of S1P on the other side has been proposed to form a "sphingolipid rheostat" that controls 
cell fate (figure 1-10) (66). The relative amounts of sphingolipids and imbalances in their 
metabolism have been univocally linked to allergic response, colon and breast cancer, 
diabetes mellitus type II and multiple sclerosis. In particular, glucosylceramide is involved in 
drug resistance (67). Sphingosine modulates the activity of various kinases involved in the 
regulation of the cytoskeleton, endocytosis, cell cycle, and apoptosis (68). Ceramide 
regulates stress-induced senescence (69) and apoptosis (70), whereas ceramide-1-
phosphate is involved in inflammation, vesicular trafficking and phagocytosis (71) (72). S1P 
mediates cell survival, cell migration and inflammation (73). 
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Figure 1-10. The sphingolipid rheostat (adapted from (65)) 
 
 
 
1.3. SPHINGOSINE-1-PHOSPHATE (S1P) 
 
S1P is a bioactive lipid involved in the regulation of proliferation, cell growth, cell survival, 
cell migration, inflammation, angiogenesis and resistance to apoptosis. It is a tumour-
promoting agent antagonist to the cellular response primed by ceramide and sphingosine 
(figure 1-10) (43). Elevated amounts of S1P are found in cancer cells (74). Inhibitors of the 
enzyme responsible for S1P synthesis, sphingosine kinase, are currently used as antitumor 
drugs (75) (76). S1P is a unique messenger in that it shows both an intracellular and 
extracellular mode of action. This latter is made possible through the binding to its five yet 
identified cognate receptors S1PR1-5 (77). 
 
1.3.1. INTRACELLULAR MESSENGER 
 
Consistently with its function in signalling, S1P is present in nanomolar amounts in cells (78) 
and its concentration is tightly regulated by a set of three enzymes: sphingosine kinase (SK), 
sphingosine-1-phophate phosphatase (SPP) and sphingosine-1-phosphate lyase (SPL) (see 
1.2.2. and 1.4.) (figure 1-11). 
Two isoforms of sphingosine kinase are known in mammals, SK1 and SK2. SK1 is the main 
enzyme responsible for the synthesis of S1P at the PM (79). SK1 is activated subsequently to 
PDGF (platelet-derived growth factor) (80) and VEGF (vascular endothelial growth factor) 
receptors activation (81), by cytokines like tumour necrosis factor-α (TNF- α), and by 
numerous other growth and survival factors (66). One known activation scheme involves the 
phosphorylation of SK1 on a critical serine residue by protein kinase C (PKC), promoting the 
interaction of SK1 with phosphatidylserine located in the cytoplasmic leaflet of the PM (60). 
Other studies highlight the role of Ca2+ and calmodulin in the translocation of SK1 to the PM 
(59) (82). The fate of the newly synthesized S1P is unclear: it might interact with a specific 
carrier, might undergo vesicular transport or might associate to a yet unknown specific 
target. An increase in S1P concentration correlates with the activation of nuclear factor κB 
(NF-κB) (83) and of GTPases of the Ras family (81), with the inactivation of the Jun amino-
terminal kinase (JNK) (84), and with an increase in intracellular calcium concentration (85). 
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Figure 1-11. S1P modes of action (adapted from (86)) 
 
 
 
1.3.2. EXTRACELLULAR MESSENGER 
 
In addition to its intracellular signalling mode, S1P can act extracellularly in an autocrine or a 
paracrine way (86). Newly discovered ABC transporters are involved in the translocation of 
S1P to the external leaflet of the PM or to the extracellular space, as well in its import into 
the cytosol or in the cytosolic leaflet of the PM (46) (87) (88) (89). The precise translocation 
mechanism has not yet been deciphered (90). 
S1P receptors were originally named EDG, standing for endothelial differentiation gene and 
were first described in 1998 (91). S1P receptors 1-5 are differentially expressed and coupled 
to various G-proteins (figure 1-11, right), themselves involved in various signalling pathways 
(table 1-3): extracellular signal-regulated kinase (ERK), Jun amino terminal kinase (JNK), 
small GTPases of the Rho family (Rho and Rac), phospholipase C (PLC), adenylyl cyclase-cyclic 
AMP (AC), phosphatidylinositol-3 kinase (PI3K) (66) (4). Typical cellular responses following 
activation of S1P receptors are: angiogenesis and vascular maturation (92), heart 
development (93) and immunity (94) (95) (96). 
S1P receptor 1 plays a crucial role in the maintenance of the immune system (86). T-cells 
exhibit chemotaxis against a gradient of S1P actively maintained between the lymphoid 
tissues and the blood stream by S1P lyase (SPL) (97) (78). In lymphoid tissues the 
concentration of S1P is kept low (in the nanomolar range) by high SPL activity, whereas it 
reaches micromolar range in the blood. The main sources of S1P in the blood are the 
vascular endothelium (98), the erythrocytes (45), and the platelets (44). S1P is also present 
in bound form to lipoproteins and to albumin (99). S1P receptor 1 is externalized in lymphoid 
tissues and permits the egress of T-cells to the blood along the S1P gradient. Disruption of 
this gradient by inhibiting SPL results in lymphopænia (100). Interestingly, following 
inflammation, tissue S1P concentration increases, modifying the immune cells trafficking 
(101). 
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Table 1-3. S1PR signalling pathways 
 
S1PR COUPLED G-PROTEIN ACTIVATEDDOWNSTREAM PATHWAYS 
1 Gi 
AC
PLC 
2 
Gi 
Gq 
G12/13 
Rac
PI3K 
AC 
PLC 
Rho 
3  
4 Gi ? G12/13 
ERK
PLC 
? Rho 
5 Gi G12/13 
ERK
PLC 
Rho 
JNK 
 
1.4. S1P METABOLYZING ENZYMES 
 
The enzymes directly involved in the regulation of S1P are sphingosine kinase, catalysing the 
synthesis of S1P, S1P phosphatase, responsible for the reverse reaction, and S1P lyase for its 
irreversible degradation (figure 1-12). 
 
Figure 1-12. S1P metabolism 
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1.4.1. SPHINGOSINE KINASE (SK) 
 
SK is evolutionary conserved, with activity detected in humans, mice, yeast and plant. Both 
mammalian isoforms 1 and 2 possess five conserved domains (figure 1-13) termed C1-C5. 
The domains C1-3 encompass the catalytic core of the enzyme, where the C2 domain binds 
ATP. The catalytic core displays high sequence similarity with the diacylglycerol kinase 
family. The presence of transmembrane domains in SK2 is still a matter of debate (43) (42) 
and its role is not well understood. It has been shown to phosphorylate the competitive 
inhibitor FTY720 (fingolimod), an immunosuppressive drug (102). SK1 and SK2 display 
different kinetic properties, tissue distribution and temporal expression patterns during 
development. Thus, they may carry out different functions (43). 
 
Figure 1-13. SK topology (adapted from (43)) 
 
 
 
1.4.2. SPHINGOSINE-1-PHOSPHATE PHOSPHATASE (SPP) 
 
S1P phosphatase activity was first detected in yeast, where it plays a role in heat-stress 
response (103) (104) (105). Two isoforms of SPP were identified in mammals (106) (107) 
(108) based on sequence similarity to the lipid phosphate phosphatase (LPP) family. Both 
mammalian SPP isoforms, similarly to their yeast counterpart, are integral membrane 
proteins located in the ER (figure 1-14). SPP1 and 2 are differentially expressed in tissues, 
where SPP1 is most expressed in liver, kidney and placenta and SPP2 in kidney and heart 
(109). This indicates that, despite their overall similarities, SPP1 and 2 might be differently 
regulated and carry out different cellular functions. With regard to substrate specificity, SPP1 
and 2 are more specific to S1P than to dihydro-S1P (58). Overexpression of SPP1 in 
mammalian cells induces accumulation of ceramide by the inhibition of ceramide trafficking 
from the ER to the Golgi. The regulation of ceramide levels in the ER by SPP1 is not well 
understood (109). SPP2 has a shorter N-terminus compared to SPP1 (figure 1-14) but this 
does not exert any effect on activity, since both isoforms display similar substrate specificity 
and activity (107). 
 
Figure 1-14. SPP topology (adapted from (43)) 
 
 
 
Part 1: Introduction 
34 
1.4.3. SPHINGOSINE-1-PHOSPHATE LYASE (SPL) 
 
Localisation and topology 
The SPL gene has been first identified in budding yeast (Saccharomyces cerevisæ) (110) and 
the human gene was cloned in 2000 (61). The SPL gene is present in many organisms 
including fungi, plants and mammals (111). Yeast and mammalian SPL are predicted single-
pass membrane proteins with the transmembrane helix residing within the first fifth of the 
protein (figure 1-15, beige box). Mammalian and yeast SPL are located in the ER membrane 
(112) but may localize to other organelles (113) (114) (115). Their N-terminus is situated in 
the ER lumen, where it undergoes glycosylation in yeast (112) and their active site is exposed 
to the cytosol (115). Mammalian SPL can be functionally expressed in yeast (116). 
Recently, a SPL gene from the facultative intracellular pathogen Legionella pneumophila 
(named LegS2) has been cloned and could be functionally expressed in yeast (117). 
Interestingly, a phylogenetic analysis indicates that LegS2 has a eukaryotic origin but the 
protein surprisingly localizes in the mitochondria when expressed in mammalian cells. In 
addition, LegS2 contains a C-terminal extension that is absent in eukaryotic SPLs and is 
required for infection, even if the precise role of the enzyme in the pathogenicity of the 
bacterium remains elusive. Other bacteria, for example Myxococcus xanthus and 
Symbiobacterium thermophilum also carry a gene coding for a S1P lyase. 
 
Figure 1-15. SPL topology (adapted from (43)) 
 
 
 
Function and regulation 
Yeast SPL, called Dpl1p (dihydrosphingosine-1-phosphate lyase 1), is involved in resistance to 
heat stress (105) (118) and nutrient deprivation (119), in calcium homeostasis (85) as well as 
in endocytosis (120). In mammals, SPL plays a crucial role in the migration of T-cells from 
lymphoid tissues by maintaining the S1P gradient necessary for T-cells to egress from the 
lymph nodes into the blood stream (see section 1.3.2.) (78). SPL activity is also linked with an 
increase in ceramide levels in response to stress factors and is involved in apoptosis (114). 
The SPL gene is a transcriptional target of platelet-derived growth factor (PDGF) (121). PDGF 
regulates critical cellular events like cell growth, differentiation and migration and is involved 
in cancer, inflammation, wound healing and production of the extracellular matrix (122). The 
SPL gene is ubiquitously expressed with the exception of erythrocytes (123) and platelets 
(44) and its expression is linked to tissues undergoing rapid cell turnover, like the intestine, 
the colon, the thymus and the liver (111). SPL gene expression is down-regulated in colon 
cancer (124), whereas it is high in enterocytes under normal conditions, where the protein is 
involved in metabolizing dietary sphingolipids (125). SPL triggers p53-dependent activation 
of PIDD (p53-inducible death domain protein), which in turn activates caspase 2. Caspase 2 
primes the apoptotic cascade (activation of caspase 3, release of cytochrome c from 
mitochondria, PARP (poly-ADP-ribose polymerase) cleavage, exposure of phosphatidylserine 
at the cell surface, and cell death). Consistently with the powerful effects SPL exerts, the 
transcription of its gene is tightly regulated (111). Notably, SPL is up-regulated in certain 
malignant tissues, for example in ovarian cancers (126). Up-regulation of SPL is also found in 
the skin of patients suffering from atopic dermatitis (127). Additionally, SPL is involved in 
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developmental events, especially in vascular maturation (111). Furthermore, the human 
protein is nitrosylated, a modification that probably alters the cofactor or substrate binding 
to the enzyme (128). 
 
Reaction, substrate and inhibition 
SPL is a pyridoxal 5'-phosphate (PLP)-dependent enzyme. PLP is covalently bound to the 
enzyme via a Schiff base between the aldehyde group of the PLP and the side chain amine of 
a nearby lysine. The PLP-lysine complex is called an internal aldimine (figure 1-16). 
 
Figure 1-16. Internal aldimine lysine-PLP 
 
 
 
SPL is a member of the carbon-carbon lyase subclass of aldehyde-lyases. SPL cleaves its 
substrate between carbon atoms 2 and 3 yielding a hydrophobic product, a so-called long 
chain aldehyde, and a hydrophilic product, invariably phosphoethanolamine (PE) (figure 1-
12). The function of SPL was initially considered to be restricted to S1P degradation. 
Interestingly, it has recently been proposed that the products of the cleavage of S1P may be 
involved in further metabolic pathways, like the synthesis of phospholipids (129) (130) (35) 
(see section 1.2.2.). Hexadecenal, the long-chain aldehyde, is thought to be in equilibrium 
with the corresponding long-chain alcohol and carboxylic acid (figure 1-17) (131). 
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Figure 1-17. Irreversible cleavage of S1P by SPL and stability of hexadecenal 
 
 
 
The pH optimum of SPL is in the range of 7.2 to 7.4. The enzyme is poorly active in Tris 
buffer, or in any kind of buffer containing a primary amine, which can compete with the 
substrate for binding to PLP (21). SPL shows a high level of specificity toward the 
stereochemistry of the substrate and cleaves exclusively the naturally occurring D-eythro 
(2D,3D configuration) sphingolipids. On the other hand, the enzyme exhibits very little 
specificity with respect to chain length, degree of insaturation and substitution, as it cleaves 
sphingosine-1-phosphate, dihydrosphingosine-1-phosphate, phytosphingosine-1-phosphate, 
as well as methyl- or dimethylsphingosine-1-phosphate (figure 1-18) (132) (133) (111). When 
the amino group of phosphosphingolipids is modified, for example by acetylation (N-
acetyldihydrosphingosine-1-phosphate) or by methylation (N,N-dimethylsphingosine-1-
phosphate), the substrate is not cleaved (132). 
 
Figure 1-18. Known substrates of SPL 
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The classical PLP-dependent enzyme inhibitors semicarbazide, iodoacetamide, N-
methylmaleimide (figure 1-19) inhibit SPL to various extent, presumably by binding to either 
the cofactor (for semicarbazide) or a sulfhydryl group from a cysteine (111). 
Deoxypyridoxine also inhibits SPL, possibly by competing with PLP (21). 
 
Figure 1-19. PLP-dependent enzyme inhibitors 
 
 
 
There are known substrate analogues that inhibit SPL (figure 1-20), for example 1-
deoxydihydrosphingosine-1-phosphonate (134), the threo isomer of dihydro-S1P (135), and 
2-vinyldihydro-S1P (136). FTY720 (also called fingolimod as recommended International 
Nonproprietary Name) (figure 1-20) is an immunomodulatory drug phosphorylated by 
sphingosine kinases 1 & 2 (137) (138) that targets the S1P receptors 1, 3, 4 and 5 (139). 
Interestingly, cell exposure to an extracellular concentration of 1 μM S1P and of P-FTY720, 
the phosphorylated form of the drug, leads to the internalization of S1PR1, which does not 
impair Gi protein-mediated signalling (139). P-FTY720 might bind and maintain the receptor 
in an active conformation. Hence, FTY720 and its phosphorylated form have a complex 
mechanism of action on S1P receptors. FTY720 inhibits SPL in vivo, when orally administered 
to mice, and in vitro (the assay uses a cell extract of mammalian cells expressing SPL). 
Inhibition by FTY720 modifies neither SPL gene expression levels nor S1P levels in tissues 
(140). THI (2-acetyl-4-tetrahydroxybutyl-imidazole), found in the food colorant caramel colorant 
III, (figure 1-20) also inhibits SPL in vivo (78) although the mechanism of inhibition is not 
understood (111). The divalent cations Ca2+ and Zn2+ have also been reported to inhibit the 
activity of SPL (113). SPL activity is also sensitive to non-ionic and zwitterionic detergents 
even at concentrations below their critical micelle concentration. Octylglucoside (OG), 
lauryldimethylammonium oxide (LDAO), octanoyl-N-methylglucamide and CHAPS all inhibit 
SPL (113). 
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Figure 1-20. SPL inhibitors 
 
 
 
It should be noted that biochemical results in the literature have been so far nearly 
invariably obtained using crude extracts or cell fractionation samples. Given the tight 
interconnectivity of the S1P-related enzymes, this approach might introduce non-negligible 
bias. 
 
Mechanism 
SPL is associated with the ER membrane via a single predicted transmembrane helix, while 
its active site is located in the cytosol. The mechanism of accommodation and cleavage of 
the substrate and of release of the hydrophilic and hydrophobic products is not yet 
elucidated. The protein might contain a hydrophobic recognition site that interacts with the 
hydrophobic moiety of the substrate while the hydrophilic head might be accommodated 
within the active site and can be then cleaved (figure 1-21) (21). 
 
Figure 1-21. Schematic view of eukaryotic membrane-bound SPL (adapted from (21)) 
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Recent results on yeast SPL (Dpl1p) mutagenesis support the view that part of the lumenal 
domain and the transmembrane helix (residues 59-81) are required for in vivo but not in 
vitro activity (112). A lumenal domain truncation of human SPL (HsSPL) has been previously 
reported as active (61) (figure 1-22), even if the results might be controversial (hence 
"active" is italicized in the figure). The transmembrane domain of Dpl1p contains three polar 
(C65, S70, N71) and one charged (K67) residues, proposed to mediate the formation of an 
active oligomer and to retain the protein in the ER. A lysine side chain adjacent to the 
cytoplasmic side of the ER membrane might interact with the phosphate head of the 
substrate and help directing it to the active site. 
 
Figure 1-22. In vivo and in vitro activity of N-terminal truncations of Dpl1p and HsSPL 
 
 
 
Biochemical studies are hindered by the poor solubility of phosphorylated sphingolipids, 
albeit zwitterionic in nature (21). Electrostatic and hydrophobic intermolecular interactions 
are presumably responsible for this phenomenon (141). Triton X-100 is so far considered the 
best detergent and is widely used to solubilise phosphorylated sphingolipids, since a number 
of other neutral and zwitterionic detergents inhibit enzymes of their metabolism (21). 
Development of new biochemical tools will hopefully allow in-depth analysis of the kinetics 
of the cleavage of S1P by SPL (142) (143) (131). 
Already in 1976 and 1993 a reaction mechanism was proposed based on general knowledge 
of the biochemistry of PLP-dependent enzymes. Moreover, SPL is sensitive toward sulfhydryl 
reagents, its reaction is stereospecific, and one proton is stereospecifically added in 
phosphoethanolamine (PE) (144) (21). The mechanism proposed in 1993 encompasses the 
following steps: once the substrate is in the active site, its primary amine replaces the lysine 
residue of the enzyme in the Schiff base with the PLP, forming a species called an external 
aldimine (figure 1-23, step III). The substrate is held in place and ready to undergo a 
nucleophilic attack carried out by the sulfhydryl anion of a cysteine (step IV). The attack is 
proposed to be on carbon 3 of S1P, carrying the hydroxyl group. Mutating conserved 
cysteines in human SPL is deleterious for activity (61). The formed thiohemiacetal 
decomposes into a long-chain aldehyde that is released from the active site (step V) and a 
sulfhydryl. PE is still bound to the PLP and forms a quinonoid intermediate (step VI). A 
solvent proton is stereospecifically incorporated (step VII) onto PE (step VIII) before 
hydrolysis takes place, releasing PE from the active site (step IX) and reforming the native 
state internal aldimine (step I). 
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This mechanism is partly supported by a recent mutagenesis study of Dpl1p using an in vivo 
complementation activity assay. The mutants were designed based on bioinformatic analysis 
and structure prediction (112). The internal aldimine mutant (K380A) is fully inactive, as 
expected. Another lysine (K386) is strictly required for activity. Surprisingly, the mutant 
targeting the predicted nucleophile cysteine (C344A) shows only partly impaired activity. 
Interestingly, a tyrosine (Y554) located on the very C-terminus of the protein is involved in 
enzymatic function, because mutating it to either alanine or phenylalanine reduces the 
activity. 
 
Figure 1-23. SPL reaction mechanism proposed in the literature (adapted from (21)) 
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1.5. X-RAY STRUCTURES OF SPHINGOLIPID-RELATED ENZYMES 
 
1.5.1. SPHINGOMYELINASE (SM'ase) 
 
The structure of Listeria ivanovii SM'ase C (SmcL) was determined at 1.9 Å resolution in 2005 
(145). Unlike the mammalian neutral SM'ase which is bound to the membrane via either N- 
or C-terminal extensions (table 1-2), SmcL is a secreted neutral SM'ase acting as a 
membrane-damaging virulence factor and interfering with the sphingomyelin-ceramide 
signalling pathway. The protein adopts a DNase I-fold, that is a central β-sandwich flanked by 
helices and loops (figure 1-24). The active site is located in a solvent-accessible pocket and is 
surrounded by hydrophobic loops that help accommodating sphingomyelin into the active 
site. One phosphate ion presumably mimics the position of the substrate. (145). 
Mutagenesis studies carried out with Bacillus cereus SM'ase (see below) revealed that 
mutating the nearby residues H185 and H325 (corresponding to B. cereus SM'ase residues 
H151 and H296) knocks the activity out (146). Two aspartate residues, D282 and D229 (B. 
cereus SM'ase D254 and D195, not shown) are strictly conserved among sphingomyelinases 
and are found in the vicinity of the catalytic histidine pair. The protein lacks predicted 
transmembrane helices but a β-hairpin (coloured brown in figure 1-24) and a loop 
containing exposed tryptophan, tyrosine and phenylalanine residues (in green) have been 
proposed to penetrate the lipid bilayer and allow the transport of the substrate into the 
active site. Similarly, three structures of Bacillus cereus sphingomyelinases (Bc-SMase) were 
solved in 2006 in complex with Mg2+, Co2+, Ca2+ at 1.8, 1.8 and 1.4 Å resolution, respectively 
(147) (not shown). The enzyme shows a very similar fold to SmcL. The metal ions bind to two 
clefts within the active site and a variable number of them can bind in one cleft. The enzyme 
complexed with Co2+, Mn2+, Mg2+ has a higher catalytic activity than with Ca2+ or Sr2+. A 
bound molecule of MES provides an additional hint on the substrate binding mode. 
 
Figure 1-24. X-ray structure of SmcL 
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In 2005 also two structures of sphingomyelinase D from spider (Loxosceles laeta) venom 
were solved at 1.85 Å (148) and 1.75 Å (149) resolution in complex with Mg2+. This cation 
may stabilize the phosphonate intermediate formed during sphingomyelin catalysis. In 
contrast to its bacterial counterparts, the arachnidan protein is a distorted (α/β)8 barrel (TIM 
barrel) (figure 1-25). A flexible loop (coloured blue) close to the sulphate binding site adopts 
various conformations in the sulphate-free (not shown) and sulphate-bound forms. The 
catalytic loop (coloured green) contains a disulfide bridge and forms a hairpin. It carries H47, 
one of the two catalytic histidines found in the conserved active site pocket. In addition to 
H47 the active site pocket is composed of H12, D34, D91, E32, K93 and W230 (149). 
 
Figure 1-25. X-ray structure of spider SM'ase D 
 
 
 
1.5.2. CERAMIDASE (CER'ase) 
 
The structure of neutral CER'ase from Pseudomonas aeruginosa (PaCD), unbound and bound 
to an artificial substrate C2-ceramide, has been solved very recently at 1.4 and 2.2 Å 
resolution, respectively (150). Neutral ceramidases from different origins exist in either 
soluble form or as type II integral membrane proteins. Unlike its mammalian counterparts 
(table 1-2) and similarly to bacterial sphingomyelinases (see section 1.5.1.), prokaryotic 
ceramidase is a soluble protein secreted in the external milieu and functions as exotoxin. The 
membrane retention of mammalian neutral ceramidases is effected by a mucin-like domain 
at the N-terminus, domain that is absent in the bacterial ceramidases. Mammalian 
ceramidases can be secreted after processing of their N-terminal membrane anchor (151). 
PaCD consists of an N-terminal and a C-terminal domain (figure 1-26). Divalent cations, Zn2+ 
and Mg2+ or Ca2+, are found at their interface. Mg2+ or Ca2+ may stabilize the two domains 
whereas Zn2+ is directly involved in catalysis. The highly conserved residues H97, H204, Y448, 
E411 either bind or coordinate Zn2+ and are strictly required for activity, as indicated by 
mutagenesis studies (150). The active site is covered by flexible loops (I and II) sitting above 
the Zn2+ binding site. The loops are moved aside in the substrate-bound structure (figure 1-
26, blue and green, respectively). Interestingly, the sphingoid base of ceramide points 
towards the surface whereas its fatty acid chain is more buried in the active site cavity.  
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Figure 1-26. X-ray structure of PaCD 
 
 
 
1.5.3. CERAMIDE TRANSPORT PROTEIN (CERT) 
 
CERT is only found in Metazoa and carries out the non-vesicular transport of ceramide from 
the ER to the Golgi, where ceramide is converted to sphingomyelin (19). CERT consists of an 
N-terminal pleckstrin homology (PH) domain that specifically recognizes the 
phosphatidylinositol 4-monophosphate (PI4P) of the Golgi membrane, a middle region 
containing a FFAT motif able to bind the ER marker protein VAP, and a START (steroidogenic 
acute regulatory protein-related lipid transfer) domain that specifically extracts ceramide 
from the ER (figure 1-27). 
 
Figure 1-27. CERT topology 
 
 
 
Although the precise mechanism of transfer remains unknown, two models were proposed 
(19). The first one involves swinging of the C-terminal domain containing the START domain 
while CERT remains bound to the Golgi and the ER via the PH domain and the FFAT motif, 
respectively (figure 1-28). The second model implies that CERT detaches from the ER after 
ceramide binding and shuttles to the Golgi (not shown). In both cases, CERT must undergo 
large conformational changes upon binding and transfer of ceramide. 
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Figure 1-28. Proposed mechanism for the transfer of ceramide from the ER to the Golgi 
(adapted from (19)) 
 
 
 
The structure of the START domain of CERT bound to ceramides of various chain lengths was 
solved in 2008 at resolutions ranging from 1.4 to 2.2 Å (20). Ceramide is buried in an 
amphiphilic cavity in the centre of the protein. The sphingoid chain is invariably more 
exposed to the solvent than the fatty acid chain (figure 1-29). Surprisingly, the Cα chains of 
START bound to a ceramide and unbound do not exhibit any significant differences, 
indicating that the START domain alone does not undergo large rearrangements upon 
ceramide binding. 
 
Figure 1-29. X-ray structure of the START domain of CERT bound to C18-ceramide 
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1.5.4. GLYCOLIPID TRANSFER PROTEIN (GLTP) 
 
Glycolipid transfer protein (GLTP) is involved in the non-vesicular trafficking of 
glycosylceramide from the cytosolic leaflet of the Golgi membrane to the inner leaflet of the 
PM and its fold is conserved among mammals (152) (153) (154). The structures of bovine 
and human GLTP in complex with various glycosylceramides have been solved recently at 
resolutions ranging from 1.36 to 2.3 Å (152) (153) (154). The protein exhibits a 2-layer all-α-
helix fold and possesses a conserved sugar binding pocket and a flexible hydrophobic 
channel (figure 1-30). 
Mutagenesis studies of the residues W96, N52, D48 and H140 revealed that they play crucial 
roles in binding of the sugar head of lactosylceramide. Residues K55 and Y207 are also 
involved in activity, but seem less critical (152). Those residues presumably also mediate the 
conformational changes undergone by the hydrophobic channel to bind substrates of 
various lengths and degrees of insaturation (figure 1-31). Mutating L136, L165, F148, F103, 
I45 and F183 into polar residues impairs binding of lactosylceramide (figure 1-32) but the 
effect is less pronounced than for the sugar binding residues (152). Interestingly, like in CERT 
and neutral ceramidases, the sphingosine moiety of the substrate is the last to enter the 
channel, and is thus more exposed to the external milieu than the fatty acid chain and may 
even point outside the protein when the sphingoid bases are longer than 18 carbon atoms 
(figure 1-30). 
 
Figure 1-30. Sugar head binding pocket of the human GLTP bound to 18:1 lactosylceramide 
and to 24:1 galactosylceramide 
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Figure 1-31. GLTP hydrophobic channel gating and conformational changes 
 
 
 
Figure 1-32. 18:1 lactosylceramide hydrophobic chain accommodation in human GLTP 
 
 
 
1.5.5. SERINE PALMITOYL-TRANSFERASE (SPT) 
 
Serine palmitoyl-transferase (SPT) belongs to the type I fold family of PLP-dependent 
enzymes. The enzyme catalyzes the formation of 3-keto-dihydrosphingosine from serine and 
palmitoyl-coA, the rate-limiting step in sphingolipid synthesis. In yeast and mammals, SPT is 
an ER membrane-associated complex. It consists of a heterodimer of two strictly related 
subunits plus a third subunit that confers substrate specificity (56) (155). One subunit of the 
heterodimer lacks the residues involved in the accommodation of PLP and is thus 
catalytically inactive, albeit strictly required for activity. The single catalytic site is located on 
the cytoplasmic side of the membrane, at the interface between two monomers. 
Heterodimers might form a higher-order complex, presumably an octamer (55). 
The bacteria Sphingomonas paucimobilis EY2395T, Sphingobacterium multivorum, 
Sphingobacterium spiritivorum and the bacteria-predating bacterium Bdellovibrio stolpii 
carry SPT homologues that have recently been identified and characterized (156) (157). 
Unlike Sphingomonas paucimobilis SPT, which is a cytosolic enzyme, the latter two SPTs are 
peripheral inner membrane proteins. Notably, the physiological function of the sphingolipids 
in bacteria is unknown. 
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The structure of Sphingomonas paucimobilis EY2395T SPT (SpSPT) was solved in 2007 at 1.3 Å 
resolution (158) (figure 1-33). The first twenty and the last nine residues of the SpSPT 
sequence are not visible in the electron density map. Unlike eukaryotic SPTs, the enzyme is a 
homodimer with one active site per monomer. The active site is composed of residues from 
both subunits. The role of the Mg2+ ions remains to be clarified. 
 
Figure 1-33. X-ray structure of SpSPT (adapted from (158)) 
 
 
 
The enzyme produces an absorption spectrum characteristic of PLP-dependent enzymes, 
featuring a 416-426 nm- (ketoenamine) and a 332-338 nm-peak (enolimine), the ratio of 
which is modified upon addition of serine, the hydrophilic substrate. The two peaks 
correspond to the two tautomers of the internal aldimine that PLP forms with K265 of the 
enzyme (figure 1-16, section 1.4.3. & figure 1-34). Addition of serine causes decrease of the 
enolimine peak. In some instances also a transient 505-515 nm-peak, characteristic of a 
quinonoid intermediate, is observed. This peak invariably occurs upon addition of the fatty 
acyl-CoA substrate (159) (157) (160). 
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Figure 1-34. The PLP forms different species in the absence of substrate and upon reaction: 
the two tautomers (left and centre) of the internal aldimine with K265 and the 
quinonoid intermediate (right). 
 
 
 
The reaction mechanism of SPT has been extensively studied, mainly using the characteristic 
UV-visible spectra of the protein at various stages of the enzymatic reaction of the wild-type 
and mutant proteins (161) (160) (159). Briefly, the internal aldimine between PLP and K265 
undergoes transaldimination with L-serine to yield PLP-L-serine external aldimine. Binding of 
the second substrate, a fatty acyl-CoA, triggers the α-deprotonation of serine yielding a first 
quinonoid intermediate. The resulting carbanion attacks the fatty acyl-CoA to generate a 
condensation product, which is then decarboxylated to yield a second quinonoid 
intermediate. Protonation at Cα gives the external aldimine with the product, 3-keto-
dihydrosphingosine, which is released from the active site. The conserved residue H159 
plays crucial roles in catalysis (figure 1-33) (159). It stacks the pyridine ring of PLP, recognizes 
and anchors the carboxylate group of serine, regulates the conformation of the serine-PLP 
external aldimine to prevent unwanted reactions, and acts as acid catalyst in the 
condensation reaction. In June 2009, the structure of the external aldimine PLP-L-serine of 
Sphingomonas paucimobilis SPT was reported (160), highlighting the crucial role of N100* 
from the neighbouring subunit in binding the carboxylate of the external aldimine (160). The 
residue R378 is involved in the stabilization of the quinonoid intermediate although it is not 
conserved in all SPTs (160). 
At the same time, a structural and functional study of Sphingobacterium multivorum SPT 
(SmSPT) was published (162). The structure, solved at 2.3 Å resolution, displays similar 
features as those previously described for SpSPT, with the exception of minor differences in 
the N-terminal region (158). 
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1.5.6. SUMMARY TABLE 
 
PROTEIN NAME ORGANISM TYPE FIG. REF. PDB(1) 
NEUTRAL 
SPHINGOMYELINASE 
(SM'ASE) 
SmcL Listeria ivanovii (Prokaryotes) 
Soluble 
(Secreted) 1-24 (145) 1ZWX 
 Bc-SMase Bacillus cereus (Prokaryotes) 
Soluble 
(Secreted)  (147) 
2DDT (Mg2+) 
2DDR (Ca2+) 
2DDS (Co2+) 
 SMase D Loxoceles sp. (Arachnida) Soluble 1-25 
(148)
(149) 
2F9R 
1XX1 
NEUTRAL 
CERAMIDASE 
(CER'ASE) 
PaCD 
Pseudomonas 
aeruginosa 
(Prokaryotes) 
Soluble 
(Secreted) 1-26 (150) 
2ZWS 
2ZXC 
START DOMAIN OF 
CERAMIDE 
TRANSPORT 
PROTEIN 
(CERT) 
 
CERT 
START 
Homo sapiens 
(Mammals) Soluble 1-29 (20) 
2E3S (C24-CER) 
2E3Q & 2E3R (C18-CER) 
2E3O & 2E3P (C16-CER) 
2E3N (C6-CER) 
2E3M (apo form) 
GLYCOLIPID 
TRANSFER 
PROTEIN 
GLTP Homo sapiens (Mammals) Soluble 1-30 
(152)
(153) 
1SWX (apo form)
1SX6(18:1 Lacto-CER) 
2EUM (8:0 Lacto-CER) 
2EVD (12:0 Lacto-CER) 
2EVL (18:2 Gal-CER) 
2EUK (24:1 Gal-CER) 
  Bos Taurus (Mammals) Soluble  (154) 
1WBE (apo form)
2BV7 (GM3) 
1TFJ (fatty acid) 
SERINE PALMITOYL- 
TRANSFERASE 
(SPT) 
SpSPT 
Sphingomonas 
paucimobilis 
(Prokaryotes) 
Soluble
(membrane-
associated) 
1-33 (158) 2JG2 2JGT 
 SmSPT 
Sphingobacterium 
multivorum 
(Prokaryotes) 
  (162) 3A2B 
 
(1) The structure shown in the respective figure is highlighted in bold. 
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2. BACKGROUND & AIMS 
 
2.1. STRUCTURE OF Escherichia coli GLUTAMATE DECARBOXYLASE (GadB) 
 
Glutamate decarboxylase (GadB) is a PLP-dependent enzyme that plays a key role in the 
glutamate-based acid resistance system of Escherichia coli (163). The enzyme consumes 
protons in the decarboxylation of glutamate to γ-amino butyric acid (GABA). The structure of 
E. coli GadB was solved in 2003 at pH 4.6 and 7.6 (164). The protein is a two-layered, disc-
shaped trimer of dimers (dimers are the basic functional units of PLP-dependent enzymes) 
(figures 2-1 & 2-2). Upon activation by a decrease of pH in the cytosol, GadB undergoes 
conformational changes causing it to migrate to the PM (164). This behaviour is mediated by 
the first 14 residues of the protein, which group to form two triple α-helical bundles in an 
acidic environment (figure 2-1). Truncating the first 14 residues produces a protein that is 
unable to interact with the membrane (164). At neutral pH the N-termini are disordered 
(figure 2-2). In cristallo pH shift experiments of GadB revealed that at pH 5.9 only one triple 
helical bundle exists, whereas the other three N-termini are disordered (165). At neutral pH 
(7.6) the last 14 C-terminal residues are ordered and enter the active site of the cognate 
subunit, thereby preventing the entry of the substrate (164). 
 
Figure 2-1. X-ray structure of E. coli GadB at pH 4.6 (PBD code 1PMM) 
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Figure 2-2. X-ray structure of E. coli GadB at pH 7.6 (PBD code 1PMO) 
 
 
 
The penultimate residue of the C-terminal tail, H465, forms a substituted aldamine with the 
cofactor, acting as a covalent lock (figure 2-3) [3] (PDB code 2DGK). When the pH drops, 
protonation causes the aldamine to dissociate and the C-terminal tail (figure 2-4, coloured 
brown) is released, taking a flexibly disordered conformation. Thus, at pH 4.6 the active site 
is accessible to glutamate. 
 
Figure 2-3. PLP-H465 substituted aldamine of E. coli GadB Δ1-14 (PDB code 2DGK) 
 
 
 
Figure 2-4. Conformation of the C-termini of E. coli GadB at pH 7.6 and 4.6 
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2.2. SEARCH FOR E. coli GadB STRUCTURAL RELATIVES AMONG METAZOA 
 
Putative structural relatives of E. coli GadB in animals were searched for by running Blastp 
(166) versus the UniProt database (http://www.uniprot.org) (167). The search was carried 
out with a taxonomic filter to limit the search to animals. The top non-fragment hits in the 
search were proteins annotated as sphingosine-1-phosphate lyase (SPL) and sharing about 
25% sequence identity with E. coli GadB.  
 
2.3. SEARCH FOR PROKARYOTIC HOMOLOGUES OF SPL 
 
Prokaryotic putative homologues of Saccharomyces cerevisiæ (yeast) Dpl1p were searched 
for by running Blastp (166) versus the UniProt database (http://www.uniprot.org) (167). The 
search was carried out with a taxonomic filter to exclude eukaryotic or archæal proteins. A 
507-residue long protein from the thermophilic bacterium Symbiobacterium thermophilum 
(UniProt entry name Q67PY4_SYMTH / accession number Q67PY4) was the top hit in the 
search, sharing 37% identity and 57% similarity with Dpl1p (UniProt entry name SGPL_YEAST 
/ accession number Q05567) over 517 aligned residues. Table 2-1 summarizes the identity 
and similarity values for bacterial, yeast and human SPLs, obtained from BLAST alignments. 
 
Table 2-1. Identity and similarity of S. thermophilum, yeast and human SPLs 
 
1st Protein 2nd Protein Identity (%) Similarity (%) Number of aligned residues 
(including gaps) 
S. thermophilum SPL 
Q67PY4 
Yeast Dpl1p 
Q05567 
37 57 517 
 Human SPL 
O95470 
45 62 477 
Yeast Dpl1p 
Q05567 
 41 61 501 
 
The research question arose, whether the S. thermophilum protein was a real homologue of 
Dpl1p. Unlike its yeast and human counterparts, Symbiobacterium thermophilum SPL lacks a 
predicted transmembrane helix, while the PLP-containing catalytic domain is well conserved 
in the three organisms (figure 2-5). Compared to E. coli GadB, all three SPLs have a 30- to 50-
residue long C-terminal extension (figure 2-5). The experiments showing that 
Q67PY4_SYMTH is a prokaryotic SPL are described in part 3 and chapter 4.7. of this thesis. 
 
Figure 2-5. Predicted topology of E. coli GadB and SPLs 
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Symbiobacterium thermophilum is an obligately symbiotic thermophile originally isolated 
from compost at Hiroshima (Japan) in a mixed culture with a Bacillus strain. The bacterium 
lacks carbonic anhydrase and consumes the carbon dioxide produced by its symbiont (168) 
(169). Symbiobacterium thermophilum is also found in soil, animal faeces, intestinal tract, 
feeds (170) and seashells and other marine samples from the Pacific coast of Japan (171). 
Molecular taxonomy using the 16S rRNA gene indicates that the bacterium represents a 
novel phylogenetic branch in the Gram-positive bacterial group although it is negative by 
traditional Gram stain, which makes it unique in terms of taxonomy (171). Its membrane, 
viewed by electron microscopy, has a three-layered structure outside the cytoplasmic 
membrane: an electron-transparent layer is flanked by two electron-dense layers (168). The 
bacterium is able to form endospore-like structures under specific culture conditions (figure 
2-6) (172). Its genome was sequenced in 2004 and displays a high (nearly 70%) GC content, 
typical for thermophilic organism (172). 
 
Figure 2-6. Formation of endospore-like cellular structures in Symbiobacterium 
thermophilum viewed by optical micrography (source: (172)) 
 
 
 
2.4. RESEARCH AIMS 
 
In spite of their biological relevance, the enzymes of sphingolipid metabolism are 
biochemically not well characterized. Only few structures of sphingolipid-related proteins 
have been determined (see chapter 1.5.). The aim of this thesis work was to produce, purify, 
biochemically characterize and determine the X-ray structure of prokaryotic and eukaryotic 
SPLs. For this purpose, three target proteins were chosen: a prokaryotic homologue, 
Symbiobacterium thermophilum SPL, Saccharomyces cerevisiæ (yeast) Dpl1p and Homo 
sapiens (human) SPL. 
The above research aims have been achieved to a very large degree; the next chapters of 
this thesis describe in detail the results and their interpretation. 
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3. PUBLISHED RESULTS 
 
The following manuscript was published in Structure the 11th of August 2010. 
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SUMMARY
Sphingosine-1-phosphate lyase (SPL), a key enzyme
of sphingolipid metabolism, catalyzes the irrevers-
ible degradation of sphingoid base phosphates. Its
main substrate sphingosine-1-phosphate (S1P) acts
both extracellularly, by binding G protein-coupled
receptors of the lysophospholipid receptor family,
and inside the cell, as a second messenger. There,
S1P takes part in regulating various cellular
processes and its levels are tightly regulated. SPL
is a pivotal enzyme regulating S1P intracellular
concentrations and a promising drug target for the
design of immunosuppressants. We structurally
and functionally characterized yeast SPL (Dpl1p)
and its ﬁrst prokaryotic homolog, from Symbiobacte-
rium thermophilum. The Dpl1p structure served as
a basis for a very reliable model of Homo sapiens
SPL. The above results, together with in vitro and
in vivo studies of SPLmutants, reveal which residues
are involved in activity and substrate binding and
pave the way to studies aimed at controlling the
activity of this pivotal enzyme.
INTRODUCTION
Sphingolipids are ubiquitous constituents of cell membranes
and their metabolites play the role of signaling molecules in
eukaryotic cells (Hannun and Obeid, 2008). A very important
sphingolipid is sphingosine-1-phosphate (S1P), which acts as
a second messenger and takes part in the regulation of cell
proliferation, motility, invasiveness, and apoptosis (Hait et al.,
2009; Spiegel and Milstien, 2003). The effects of S1P have
been described in a wide spectrum of organisms, ranging from
Arabidopsis thaliana (Dunn et al., 2004; Pata et al., 2009;
Tsegaye et al., 2007), Saccharomyces cerevisiae to Caenorhab-
ditis elegans (Oskouian and Saba, 2004),Mus musculus (Forrest
et al., 2004), and Homo sapiens (Oskeritzian et al., 2007; Rivera
et al., 2008; Saba and Hla, 2004). S1P is unique in that it can act
both as an intracellular second messenger (Hait et al., 2009) and
as a ligand for G protein-coupled cell-surface receptors
belonging to the lysophospholipid receptor family (Hla et al.,
2001; Takabe et al., 2008).
The intracellular levels of S1P are kept under tight control by
three enzymes, the ﬁrst of which, sphingosine kinase, catalyzes
S1P synthesis, while the other two, sphingosine-1-phosphate
phosphatase and sphingosine-1-phosphate lyase (SPL, EC
4.1.2.27), catabolize it. While sphingosine-1-phosphate phos-
phatase catalyzes the reversible dephosphorylation of S1P,
SPL degrades it irreversibly to phosphoethanolamine (PE) and
hexadecenal (Bandhuvula and Saba, 2007). This complex regu-
lation of S1P levels is biologically very signiﬁcant in light of the
so-called ‘‘sphingolipid rheostat,’’ whereby cell fate depends
on the ratio of intracellular S1P, which is a proliferative stimulus,
and sphingosine and ceramide, which induce apoptosis (Spiegel
and Milstien, 2003).
Notably, SPL was found to play an important role in regulating
the immune system. Schwab and Cyster (2007) and Schwab
et al. (2005) showed that 2-acetyl-4-tetrahydroxybutylimidazole
(THI), a component of the food colorant caramel III, inhibits
SPL, which normally maintains a steep S1P concentration
gradient between the lymphoid tissues and the vascular circula-
tion. T cells egress from lymphoid tissues by navigating along the
S1P gradient. SPL inhibition by THI leads to disruption of the S1P
gradient, thus preventing the egress of T cells into the blood
stream and causing a logjam in lymphoid tissues (Schwab and
Cyster, 2007; Schwab et al., 2005). There is also evidence of
SPL involvement in tumor-suppressor and cancer surveillance
pathways (Oskouian et al., 2006) and resistance to cisplatin.
Control of SPL expression and activity may prove useful in the
future in adjuvant and reproductive cell-protecting approaches
to cancer therapy (Bandhuvula and Saba, 2007).
SPL belongs to the superfamily of PLP (pyridoxal 50-phos-
phate)-dependent enzymes. Its activity was ﬁrst characterized
more than 40 years ago (Stoffel et al., 1968); more recently, the
genes for C. elegans (Mendel et al., 2003), yeast (Saba et al.,
1997), mouse (Zhou and Saba, 1998), plant (Nishikawa et al.,
2008), and human SPL (Van Veldhoven et al., 2000) were cloned.
To date, there is scarce data about the structure and biochem-
istry of SPL. The enzyme is known to be located in the ER
(endoplasmic reticulum) and to possess an N-terminal lumenal
domain, a transmembrane segment and a soluble PLP-binding
domain, responsible for the catalytic activity (Ikeda et al., 2004;
Van Veldhoven and Mannaerts, 1991).
The biological relevance and the growing amount of interest
around SPL as a drug target (Bandhuvula and Saba, 2007; Fyrst
and Saba, 2008; Han et al., 2009; Kumar and Saba, 2009)
mandated, as the next step, high-resolution structural character-
ization of this enzyme, which had to date been shown to exist
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only in eukaryotes. To this end, we ﬁrst used a bioinformatically
identiﬁed putative prokaryotic homolog, the product of gene
STH1274 from the commensal thermophilic bacterium Symbio-
bacterium thermophilum (Ueda et al., 2004), whichwe character-
ized as a bona ﬁde sphingosine-1-phosphate lyase and named
StSPL. This in turn allowed us to solve the structure of Saccha-
romyces cerevisiae SPL, called Dpl1p, and obtain a reliable
homology model of the human counterpart, SPL. Both StSPL
and Dpl1p exhibit ﬂexible stretches in regions surrounding the
active site. These ﬂexible regions carry crucial residues for
activity, as shown by our thorough mutagenesis-based func-
tional analysis. Altogether, our structural and functional studies
of StSPL andDpl1p allowed us to propose a reactionmechanism
for the cleavage of long-chain base phosphates by SPL.
RESULTS AND DISCUSSION
Structure of Full-Length StSPL: Symmetries
and Asymmetries
In a previous study (Mukhopadhyay et al., 2008), we had
described a parsed homology model of the active site of
Dpl1p, based on the active site of Escherichia coli glutamate
decarboxylase (GadB) (Capitani et al., 2003; Gut et al., 2006),
which shares 23% sequence identity with Dpl1p over a 251
residue stretch. Mutations based on that limited model and
assumed to inﬂuence the enzyme activity were conﬁrmed by
cell biology data (Mukhopadhyay et al., 2008). As the next
step, we embarked on a structure determination program,
encompassing not only Dpl1p but also a putative prokaryotic
SPL homolog in Symbiobacterium thermophilum (Uniprot code
Q67PY4), which we had identiﬁed by a BLAST search (Altschul
et al., 1997) of Dpl1p taxonomically limited to prokaryotes and
named StSPL. We cloned the gene encoding Q67PY4 from the
genome of S. thermophilum, expressed it in E. coli, and obtained
pure protein and diffraction-quality crystals. The structure of
StSPL was solved ﬁrst, with a molecular replacement approach.
A dimer from the GadB hexamer was used as the search model.
Two StSPL structures were reﬁned at 2.0 and 3.0 A˚ resolution
(Table 1), respectively, from two different crystal forms, the
ﬁrst (St_1) (Figure 1A) containing a symmetric StSPL dimer in
the asymmetric unit (a.u.), the second (St_2) (Figure 4) also con-
taining one dimer per a.u. but featuring clear conformational
asymmetry between subunits A and B. The asymmetry was not
only limited to the protein chains but involved cofactor binding
as well. While in St_1 both active sites contain a PLP molecule
covalently bound to K311 to form an internal aldimine, in St_2
one active site is PLP-free and contains a phosphate ion at
the place of the cofactor phosphate moiety (Figure 4B). The
following structural description of the StSPL structure refers to
St_1 (Figure 2A): each subunit can be divided into a N-terminal
disordered region (called hereafter Nt-FLEX), spanning residues
1–57 and corresponding to absent or poor electron density, and
a folded core encompassing residues 58–507. The core exhibits
a typical type 1 PLP-dependent enzyme fold, attributed by the
Table 1. Data Collection and Reﬁnement Statistics for the Structures St_1-4 and Dpl1p
Structure code St_1 St_2 St_3 St_4 Dpl1p
Space group P212121 P212121 C2221 P212121 F222
Unit cell parameters (A˚) a = 57.6
b = 126.8
c = 137.1
a = 84.2
b = 84.9
c = 131.3
a = 64.4
b = 243.4
c = 280.7
a = 57.7
b = 127.0
c = 136.8
a = 151.1
b = 156.9
c = 201.6
Number of polypeptide chains per a.u. 2 2 4 2 2
Resolution rangea (A˚) 29.5–2.0
(2.1–2.0)
30.0–2.97
(3.10–2.97)
29.9–2.9
(3.0–2.9)
30.0–2.05
(2.2–2.05)
48.0–3.15
(3.32–3.15)
Completenessa (%) 98.8 (98.6) 98.7 (92.8) 97.6 (92.7) 98.9 (95.0) 99.9 (100.0)
Redundancy 4.4 5.4 6.0 6.7 6.5
Unique reﬂections 67,856 19,779 48,405 63,157 20,848
I/s a 9.6 (2.5) 13.7 (4.3) 11.9 (2.8) 16.4 (4.5) 15.1 (2.6)
Rsym
a (%) 9.2 (60.3) 11.0 (44.2) 12.6 (57.9) 7.9 (43.1) 8.7 (70.7)
No. of reﬂections (test) 67,794 (950) 19,768 (988) 48,401 (2420) 63,122 (875) 20,686 (610)
No. of atoms 7268 6480 13845 7478 6634
Rwork (%) 21.0 20.0 22.9 18.1 24.1
Rfree (%) 24.7 26.5 25.2 21.8 30.0
rmsd bonds (A˚) 0.005 0.006 0.005 0.007 0.002
rmsd angles () 0.98 0.97 0.96 1.09 0.52
NCS restraints applied No Yes Yes No Yes
Ramachandran plot regions (MolProbity)
Favored (%) 97.5 95.4 96.7 97.8 92.3
Allowed (%) 100.0 99.9 100 100 99.0
Number of outliers 0 1 (K311 B) 0 0 8b
See also Table S2.
a Values for the outermost resolution shell in brackets.
b S233, G312, S347, G415 in each of the two chains.
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SCOP database (Andreeva et al., 2008) to the pyridoxal-depen-
dent decarboxylases subfamily. Its closest structural relative
is GadB, with a rmsd of 2.2 A˚ over 363 common Ca atoms. The
StSPL core can be divided into an N-terminal domain (residues
58–97), a large domain containing the cofactor binding K311
(residues 98–382) and a small C-terminal domain (residues
383–471). This domain structure is common with pyridoxal-
dependent decarboxylases like GadB. StSPL, however, pos-
sesses a fourth C-terminal domain, dubbed C-terminal exten-
sion (Ct-EXT, residues 472–507).
Structure of Dpl1p D1-102: Similarities and Differences
to StSPL
Using the structure of the K311A StSPL mutant (Bourquin, 2010)
(at the time it was the highest quality structure of StSPL available)
as search model, we could solve and reﬁne the structure of
Dpl1p D1-102 at 3.15 A˚ resolution (Table 1) (space group F222,
with two Dpl1p D1-102 subunits per a.u., creating two different
dimers by crystallographic symmetry). The use of a high-
resolution, well-reﬁned model of StSPL was instrumental to
locating the two Dpl1p D1-102 subunits with Phaser (McCoy,
2007). The solution found reﬁned well in Phenix (Zwart et al.,
2008). The two reﬁned Dpl1p D1-102 dimers are conformation-
ally very similar but differ by cofactor binding, since one of
them (Dpl1p-S) contains PLP in both active sites (Figure 1B),
while the other (Dpl1p-A, mainly apo) exhibits very low occu-
pancy of the cofactor (not modeled) (Figure 3A). As in subunit
B of St_2 (Figure 4B), the missing cofactor is partly replaced by
a phosphate ion.
The overall structure of Dpl1p D1-102 is very similar to that of
StSPL, with a rmsd between the Dpl1p-S and St_1 dimers of
1.2 A˚ over 399 common Ca atoms (Figure 3B) and of 1.2 A˚
over 396 common Ca atoms between the Dpl1p-A and St_1
dimers and 42% sequence identity. Notably, even though the
Nt-FLEX of StSPL and Dpl1p differ substantially, with the latter
containing a predicted lumenal domain, followed by a transmem-
brane region and a cytoplasmic spacer (Figure 7A), their end is
spatially very well conserved: the observed folded core of
Dpl1p D1-102 starts with residue N131, superimposing well
onto residue K58 of St_1 (Figure 3B). The same degree of
conservation is observed also with respect to the domain struc-
ture. In the folded core of Dpl1p D1-102, the N-terminal domain
spans residues 131–167, the large domain containing the
cofactor-binding K380 extends from 168 to 451, the small
domain from 452 to 540 and the Ct-EXT from 541 to 589 (Fig-
ure 2B). The only signiﬁcant structural difference between St_1
and Dpl1p D1-102 resides in Ct-EXT, where Dpl1p-S residues
541 to 563 (566 in Dpl1p-A) and 580 to 589 are conformationally
disordered and correspond to absent or very poor electron
density (Figures 1B, 2B, 2D, and 3). This difference appears to
have important functional implications as Dpl1p D1-102 was
found to be inactive in vitro (see section on activity andmutagen-
esis studies) even though its boundaries correspond perfectly to
those of the folded core of StSPL (Figure 3B), which is active
in vitro. Since full-length (FL) Dpl1p is active in vivo (Figure 7B),
we assume that Nt-FLEX (residues 1–130) plays a key role for
activity, presumably in substrate presentation to the active site,
and the absence of its ﬁrst 102 residues may be correlated
with the disorder of Ct-EXT. This is corroborated by the observa-
tion that in StSPL residues 473–488 constitute the ‘‘bottomwall’’
of a long hydrophobic pocket adjacent to the active site, which is
not present in GadB and most likely accommodates the long
hydrophobic chain of the substrate before its entrance into the
active site (Figure 2C). In the crystal structure of Dpl1p D1-102
the aforementioned hydrophobic pocket lacks the ‘‘bottom
wall’’ (Figure 2D) since residues 541–563 are disordered.
The Region around the Active Site in StSPL: More
Asymmetries and Comparison to Other Enzymes
As mentioned above, the St_2 structure of FL WT (wild-type)
StSPL exhibits clear asymmetries between subunits A and B,
in contrast to the symmetry shown by the St_1 dimer. The
Figure 1. Cartoon Representation of FL WT
StSPL (Structure St_1) and Dpl1p D1-102
(Structure Dpl1p-S)
(A) Subunit A of St_1 appears in light gray, subunit
B in dark gray. The cofactor (PLP) and phosphate
ion of both subunits, together with the covalently
bound side chain of K311 (see Figure 2), are in
ball-and-stick representation in the color of the
respective subunit and atom colors. Nt-FLEX (resi-
dues 1–57) is not visible and its end is represented
by dashed lines in the color of the corresponding
subunit. The N and C termini of each subunit are
indicated.
(B) Subunit A of Dpl1p-S is in green, subunit B in
dark brown. Color coding is as above. StSPL
K311 corresponds to Dpl1p K380. The end of Nt-
FLEX (corresponding to residues 103–130) and
stretches 541–563, as well as residues 580–589,
are represented by dashed lines of the color of
the corresponding subunit. All structural ﬁgures
were prepared with PyMOL (DeLano, 2002).
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asymmetries of St_2 are not limited to the lack of PLP in subunit
B but involve the protein conformation around the active site
(Figure 4): while in subunit A the regions surrounding the active
site are ordered and a chloride ion is found at the position occu-
pied by a phosphate ion in St_1 (Figure 2A), in subunit B no chlo-
ride or phosphate ion is observed and the loop comprising resi-
dues 90–107 is mostly disordered, with only residues G102 to
Y105 corresponding to interpretable density (Figure 4B). The
Ct-EXT of subunit A is again partly disordered, with only residues
475–483 and 490–507 corresponding to interpretable density.
The entire Ct-EXT of subunit B is disordered. As a consequence,
the hydrophobic pocket of subunit B of St_2 partly lacks its
‘‘bottom wall’’ (Figure 2C), while its counterpart in subunit A is
nearly complete since its Ct-EXT is partly ordered. Yet another
element of asymmetry in St_2 is the S123*-S135* loop (residues
followed by an asterisk belong to the neighboring subunit),
exhibiting markedly higher B-factors in chain A (lining the active
site of subunit B) than in chain B (<B > = 60 A˚2 in the former
versus 41 A˚2 in the latter).
Crystallographic and biochemical studies of the two isoforms
of human glutamate decarboxylase, GAD65 and GAD67 (Fenalti
et al., 2007), showed the importance of a ‘‘catalytic loop’’ (resi-
dues 432*–442* in GAD67) being ordered or disordered for the
control of enzyme activity. The active site loop of human GAD
is not conserved in SPL, where it is replaced by a b-hairpin
Figure 2. Subunit Structure and Domains of
StSPL and Dpl1p D1-102
(A) Cartoon representation of subunit A of FL WT
StSPL (structure St_1). The cofactors, together
with the covalently bound side chain of K311 (in
StSPL) and K380 (in Dpl1p), appear as described
in Figure 1. The end of Nt-FLEX is depicted as
dotted green line; the N-terminal domain is
colored green, the large domain white, the
C-terminal domain beige and Ct-EXT blue. The
b-hairpin of subunit A, covering the active site of
subunit B (not shown), is boxed with a dashed line.
(B) Cartoon representation of subunit A of
Dpl1pD1-102 (structure Dpl1p-S). Details as in (A).
(C and D) Surface representation of StSPL (struc-
ture St_1) and Dpl1p D1-102 (structure Dpl1p-S)
showing the active site entry channel. (C) Subunit
A of St_1. The N-terminal domain is colored green
while Ct-EXT is colored blue. The ﬁrst histidine of
the C-terminal His-tag is labeled. K311, PLP, and
phosphate ion are shown as sticks. (D) Subunit A
of Dpl1p-S. Color coding is as in (C).
(residues 334*–349* in StSPL) (Figure 2A),
but it suggests a functional role for the
aforementioned asymmetric elements of
St_2, all of which are located nearby.
Another enzyme involved in sphingoli-
pid metabolism, serine palmitoyl-trans-
ferase (SPT), exhibits peculiar asymmetry
with respect to PLP binding: it is a hetero-
dimer composed of two strictly related
subunits plus a third subunit conferring
substrate speciﬁcity (Han et al., 2009;
Hornemann et al., 2009). One of the two
subunits of the heterodimer lacks the residues for PLP binding
even though it is required for activity, as modeled from the struc-
tures of Sphingomonas paucimobilis (Yard et al., 2007) and
Sphingobacterium multivorum (Ikushiro et al., 2009) SPTs. St_2
features asymmetry in cofactor binding in spite of being a homo-
dimer. Modulation of cofactor binding thus appears to be a
feature common to several eukaryotic PLP-dependent enzymes.
Altogether, our structural studies of StSPL and Dpl1p D1-102
reveal that both proteins share the same fold and that the
disorder in the N terminus (Nt-FLEX domain) is a conserved
feature. Moreover, variations are found in the cofactor occu-
pancy in some forms of both enzymes. One signiﬁcant difference
between StSPL and Dpl1p D1-102 is that the latter lacks part of
Ct-EXT covering the active site. Asymmetries between both
subunits of one crystal form of StSPL were mapped in three
regions surrounding the active site. We assumed that this ﬂexi-
bility is functionally relevant and performed mutagenesis studies
of residues carried by these loops (see below).
Cofactor Binding Mode and Active Site in FL StSPL and
Dpl1p D1-102 and Model of Substrate Accommodation
The cofactor binding mode and the active site in general are
very well conserved between StSPL and Dpl1p: in both cases
the phosphate moiety of PLP is held in place by a classical
‘‘phosphate cup’’ motif (Denesyuk et al., 2003) with residues
Structure
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(StSPL numbering) G168, T169, H310, and S353* hydrogen-
bonding the phosphate oxygen atoms (see Figures S1A and B
available online). The pyridinium ring of PLP is sandwiched
between residues C276 and H201 in StSPL, corresponding to
residues C344 and H268 in Dpl1p. Another common feature is
a phosphate ion found at the same position in both proteins, in
the vicinity of the cofactor. The ion interacts with the phenolic
moiety of Y105, the imidazolium ring of H129*, the main chain
amide nitrogen of A103 and the carboxamide group of N126*
(distances 2.6, 2.7, 2.8, and 3.2 A˚, respectively, in subunit A of
St_1). The corresponding phosphate-binding residues in the
active site of Dpl1p are Y174, H198*, and A172. The conserved
binding mode of the phosphate ion mimics the binding mode
of the phosphate moiety of the natural substrate of the enzyme,
S1P. This is conﬁrmed by the structure of StSPL K311A in
complex with the product PE at 2.9 A˚ resolution (structure
St_3) (Table 1; Figure 5A). PE is one of the two products of the
SPL reaction and contains the polar part of the substrate. No
Figure 3. Dpl1p-A, Dpl1p-S and StSPL
(A) Cartoon representation of Dpl1p-A dimer.
Subunit C appears in green, subunit D in dark
brown. Color coding is as in Figure 1.
(B) Superposition, in cartoon representation, of the
Dpl1p-S dimer structure onto StSPL (structure
St_1). The color coding is as in Figure 1. The ﬁrst
ordered residue of each protein (K58 for StSPL
and N131 for Dpl1p-S) is denoted by an arrow.
Figure 4. Cartoon Representation of the
Two Subunits of the Asymmetric Form of
StSPL (Structure St_2)
(A) Subunit A appears in light gray with the
same color conventions as in Figure 1. Addition-
ally, structural elements exhibiting asymmetry
between the two subunits of St_2 are depicted
as follows: residues A89–D108 in brown, P472–
V507 (Ct-EXT) in blue, and K58–F64 in green.
The chloride ion bound in the active site of subunit
A is shown in beige in space-ﬁll model. The loop
S123*–S135*, which completes the active site
environment, is colored according to its B-factors
(blue corresponds to lower B-factors). Disordered
regions are represented by dashed lines.
(B) Same as above with view vertically rotated by
180 and focusing on subunit B. The active site
lacks the cofactor (the trace of PLP in the subunit
A is depicted by a red dashed line), which is partly
replaced by a phosphate ion.
signiﬁcant conformational changes were
observed between St_1 and St_3 (rmsd
value of 0.3 A˚ over 446 common Ca
atoms). PE was seen to form a Schiff
base with PLP and its phosphate group
replaced the phosphate ion found in the
active sites of St_1 and Dpl1p D1-102
(Figures 2A and 2B). Based on St_3, we
modeled the substrate S1P bound in
WT StSPL (Figure S1C) and carried out
mutagenesis studies on residues A103,
Y105, H129*, C276, K311, K317, and Y482 (Figure 5B). The
mutants were designed on the basis of the well-described
biochemistry of PLP-dependent enzymes (Eliot and Kirsch,
2004; Toney, 2005) as well as by taking into account the mech-
anism proposed in Van Veldhoven and Mannaerts (1993) and by
assuming that residues found in ﬂexible stretches of Dpl1p
D1-102 and St_2 (Figures 2B and 2D, and Figure 4, respectively)
might be involved in activity (see previous sections). Residues
A103 and Y105 (StSPL numbering) are located on the active-
site ﬂanking loop that is disordered in subunit B of St_2 (Figure 4,
dark brown loop). H129* and K317 sit near the phosphate moiety
of the active site-bound substrate, even though K317 is too
distant (nearly 5 A˚) to hydrogen-bond the phosphate. In an early
study of SPL (Van Veldhoven et al., 2000), the residue corre-
sponding to C276 had been proposed to be the nucleophile
required for bond cleavage and was therefore included into our
mutagenesis study. The activity of mutants of the corresponding
residues in Dpl1p (A172, Y174, H198*, C344, K380, K386, and
Structure
Pro- and Eukaryotic Sphingosine-1-Phosphate Lyase
1058 Structure 18, 1054–1065, August 11, 2010 ª2010 Elsevier Ltd All rights reserved
Figure 5. Close-up View of the Active Sites of StSPL and Dpl1p D1-102
(A) Stereo representation of the reaction product PE bound to PLP (PLP-PE) in the active site of StSPL K311A (structure St_3). Color coding is as in Figure 1A.
(B) Same as (A), showing themodeled external aldimine intermediate with S1P (PLP-S1P). Color coding is as in Figure 4. The residues studied bymutagenesis are
labeled. The model, based on the structure of St_3, is to be considered tentative, especially with respect to the C2-C3 (see Figure 8, step II) torsion angle and to
the conformation of the hydrophobic chain. The optimal conformation for retro-aldol cleavage is with the C3-hydroxyl moiety of S1P antiperiplanar to the amino
group of the aldimine (Dunathan, 1966). In our modeling attempt, such a conformation led to steric clashes with Y249 (Figure S1C).
(C) Stereo representation of a superposition of Dpl1p D1-102 (Dpl1p-S) onto FLWT StSPL (structure St_1), showing the residues of Dpl1p presumably involved in
activity. Color coding is as in Figure 1. See also Figures S1 and S2.
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Y554) was compared using an in vivo assay (Mukhopadhyay
et al., 2008). The active sites of St_1 and Dpl1p-S superimpose
very well and the above-mentioned residues occupy structurally
equivalent positions in both enzymes, except for Y554 (Y482
in StSPL), which is found in the disordered region of Ct-EXT of
Dpl1p (Figure 5C).
Importantly, Dpl1pD1-102 shares 45% sequence identity over
420 residues with its medically important human counterpart,
SPL (UniProt code O95470): we could calculate a reliable
homology model of SPL (Figure S1D), showing that the active
site is conserved between the two proteins, with the exception
of T148 in SPL (A172 in Dpl1p). A multiple sequence alignment
of StSPL, Dpl1p and SPL with the predicted secondary structure
elements can be found in Figure S2. The structural features and
the functionally important residuesdescribed in this studyprovide
a solid basis for futuremutagenesis and inhibition studies of SPL.
Activity and Mutagenesis Studies
of StSPL and Dpl1p
The visible spectrum of FL WT StSPL exhibits a shoulder at
340 nm and a broad peak at 420–460 nm, presumably resulting
from the contribution of two species centered at 425 and 450 nm
(Figure 6A, dotted line), respectively. The 340 and 425 nm
species correspond to tautomers of the internal aldimine (Gut
et al., 2009), while the 450 nm band represents an unknown
Figure 6. Spectrophotometric Activity
Assay of StSPL Using S1P As Substrate
(A) FL WT control for (B) and (C). The visible spec-
trum (320–500 nm) of the enzyme before and after
addition of substrate is depicted by a dotted and
a solid line respectively. Spectra were recorded
each min over 5 min. The transient peaks at 403
and 420 nm as well as changes in the 450 nm
regions are indicated with arrows.
(B) Same as (A) for K311A.
(C) Same as (A) for Y105F.
(D) Same as (A) for Y482F except that the spectra
were recorded during 30 min. FL WT control is
shown in (F).
(E) C276A. FL WT control is shown in (F).
(F) FL WT control for (D) and (E). Spectra of (E) and
(F) were recorded as in (D). See also Figures S3,
S4, and S5.
species. The spectra of mutants K311A
and C276A (Figures 6B and 6E, dotted
lines) and of construct DCt-EXT (lacking
residues 472–507) (Figure S3B, dotted
lines) differ markedly from that of FL WT.
They feature a peak at 345 nm, which
may correspond to the hydrated form of
PLP, as seen in the structure of StSPL
K311A (Bourquin, 2010).
Mutagenesis studies were carried out
on the residues listed above as well as
on Nt-FLEX and Ct-EXT truncation vari-
ants of StSPL (Figure 2A). There are
many SPL activity assays available,
based on the detection of ﬂuorescent
species (Bedia et al., 2009; Bandhuvula et al., 2007, 2009). In
the present work, the activity of StSPL mutants and variants
compared with FL WT was assessed by spectrophotometry
and mass spectrometry (MS). The ﬁrst method monitors varia-
tions occurring in the environment of PLP upon catalysis, as
shown for serine palmitoyltransferase (Ikushiro et al., 2009;
Raman et al., 2009; Shiraiwa et al., 2009), and thereby indirectly
monitors the activity of the protein, while the latter monitors
substrate cleavage. Both tests provided qualitative information.
Quantitative analysis was hindered by variations in the amount of
soluble material, presumably due to discrepancies in the purity
of S1P from various batches of chemical synthesis or of extrac-
tion from natural sources, to the inherently poor solubility of S1P
(Garcı´a-Pacios et al., 2009) and to the challenging reproducibility
of the solubilization procedure, as well as by variations when de-
salting the sample before MS. As a consequence, an accurate
concentration of S1P was difﬁcult to obtain, resulting in different
response intensities in the activity assays. Therefore, the activity
of mutants or variants of StSPL has to be compared with that of
the FL WT StSPL puriﬁed in parallel and tested under similar
conditions.
The spectrophotometric activity assay monitors the appear-
ance and disappearance of transient peaks at 403 and 420 nm,
accompanied by a decrease in the absorption at 450 nm, that
appeared upon mixing FL WT StSPL with S1P (Figures 6A
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and 6F; Figures S3C and S3G), dihydrosphingosine-1-phos-
phate (DHS1P) (Figure S3H) or phytosphingosine-1-phosphate
(PS1P) (Figure S3I). We tentatively interpret those peaks as the
external aldimine species PLP-S1P and PLP-PE (Figure 8, steps
III and VII). The 420 nm band may correspond to the external
aldimine with PE, since a spectrum of StSPL K311A incubated
with PE shows a slowly appearing, broad band centered at
about 425–430 nm (Bourquin, 2010). It is noteworthy that no
similar changes were observed upon incubating StSPL WT and
PE (Bourquin, 2010). The above transient spectrophotometric
changes correlate with the cleavage of S1P, as shown by MS
(Figures S4C and S4D). The time elapsed until disappearance
of the peaks (relaxation time) is assumed to be proportional to
the amount of enzyme and its degree of activity. When FL WT
StSPLwas incubatedwith semicarbazide, a general PLP-depen-
dent enzyme inhibitor, the 420–460 nm peak disappeared and
was replaced by a 360 nm peak with a clear isosbestic point
(Figure S5C), and only very faint transient peaks were observed
upon substrate addition (Figure S5D). The PLP-semicarbazone
adduct (Figure S5B) formed by the inhibitor with the cofactor
was found by crystallography (structure St_4) to have left the
active site (Figure S5A). This correlates with the observation
that cocrystals of StSPLwith 10-foldmolar excess of semicarba-
zide are colorless, while the native crystals are bright yellow
(Bourquin, 2010). In St_4, the nearby residue Y249 (Figure S1C)
partly replaces the pyridinium ring of the PLP but is likely not
involved in catalysis, since mutant Y249F behaves similarly as
FL WT (Figures S5E and S5F, respectively). StSPL mutants
K311A and Y105F did not exhibit signiﬁcant time-dependent
changes in the spectrophotometric (Figures 6B and 6C, respec-
tively) and MS (Figures S4H and S4I, respectively) assays and
were categorized as inactive. Mutants A103P and K317A
(Figures S3E and S3F, respectively) exhibited no transient peaks
at 403 and 420 nm and no activity in the MS assay (Figure S4J
and S4K, respectively). All the above mutants were categorized
as inactive. StSPL Y482F, C276A (Figures 6D and 6E, respec-
tively), H129A and DCt-EXT (Figures S3D and S3B, respectively)
exhibited a signiﬁcantly longer relaxation time and much less
intense transient peaks (especially for H129A) and were thus
assumed to be partly active. StSPL DNt-FLEX behaved similarly
(albeit with an altered relaxation time) as FLWT (Figure S3A). The
Dpl1p truncation D1-102 used for structure determination did
not exhibit any visible spectrum alterations upon addition of
S1P, DHS1P nor PS1P (Figures S3J, S3K, and S3L, respectively)
and was therefore considered as inactive in vitro.
The Nt-FLEX of FL Dpl1p (residues 1–130) is assumed to
consist, from its N to C terminus, of a lumenal domain (residues
1–57), a transmembrane helix (residues 58–82), a linker and
a spacer (Figure 7A). A yeast synthetic lethality test (Mukhopad-
hyay et al., 2008) was used to assess the activity of mutants and
of the lumenal domain truncation of Dpl1p. Dpl1p D1-57 and FL
Dpl1p Y174F, H198A, Y554F are partly active, C344A is probably
slightly less active as the WT, while K380A, A172P, and K386A
are inactive (Figure 7B). The mutagenesis results of Dpl1p are in
good agreement with those of StSPL, except for Y174F
(corresponding to StSPL Y105F). This single difference might
arise from the very different time scale of the in vitro experiments
compared with the in vivo experiments or from other sources of
bias. For instance, we do not know which enzymatic parameters
(Km, Kcat) aremost crucial for the in vivo experiment. Alternatively,
the precise role of this residue might not be conserved between
StSPL and Dpl1p, as a result of different modes of regulation.
Importantly, Y174 of Dpl1p is conserved in SPL (Y150). Dpl1p
Y174F was found to be partly active: a possible role for this
residue is that of inﬂuencing the protonation state of K386 and
this might represent a regulation mechanism of eukaryotic SPLs.
Further analysis is required to conﬁrm that StSPL Y105F is fully
inactive since our in vitro assays are not quantitative. Based on
Figure 7. Function of Dpl1p Variants In Vivo
(A) Proposed arrangement of the catalytic domain of Dpl1p with respect to the ER membrane. The two subunits are depicted as in Figure 1B. TMH, transmem-
brane helix.
(B) Yeast strain RH4863 carrying FL WT Dpl1p, Dpl1p D1-57, FL mutants A172P, Y174F, H198A, C344A, K380A, K386A, and Y554F or an empty vector (desig-
nated dpl1pD) were 5-fold serially diluted and spotted onto SD plates without leucine or on SD plates with uracil and 5-ﬂuoroorotic acid (5-FOA). Only strains
carrying a functional Dpl1p can grow in presence of 5-FOA (Mukhopadhyay et al., 2008). The colonies were photographed after 3 days of incubation at 30C.
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our model (Figure 5B) residues (StSPL numbering) Y105 and
H129*, found close to the phosphate head of the substrate, are
important for substrate binding. The side-chain amino group of
K317 is also close to the phosphate location but not within
hydrogen-bonding distance (4.8 A˚ in St_1, subunit A). A103
appears to keep the loop 89–108, containing Y105 (Figure 4A,
dark brown), in a conformation able to bind the phosphate
moiety of the cofactor. The corresponding residue of SPL,
T148, might provide additional stabilization by interacting with
H174* and N171* (Figure S1D).
Figure 8 summarizes the reaction mechanism we propose
based on the structural, biochemical and literature information
available. Step III is a retro-aldol cleavage whereby a base
(depicted as B:) nucleophilically attacks the proton of the
hydroxyl moiety of the substrate. Based on our current model
of the external aldimine with S1P (Figure 5B) the identity of that
base is not clear and its elucidation will require further structural
and biochemical studies. Notably, for serine hydroxymethyl-
transferase, another PLP-dependent enzyme catalyzing
a retro-aldol cleavage, ﬁnding the corresponding base has
proved similarly difﬁcult (Schirch and Szebenyi, 2005). The
quinonoid reprotonation step (step VI), resulting in the formation
of the external aldimine PE-PLP and in the subsequent release of
PE (steps VII and VIII, respectively) may be carried out by StSPL
K311 or by the nearby Y105 (K380 and Y174 in Dpl1p, K353 and
Y150 in SPL). K317 of StSPL (K386 in Dpl1p and K359 in SPL) for
sure electrostatically contributes to the binding of the phosphate
moiety of the substrate and may also play an indirect role in the
reprotonation. The partial activity of the alanine mutant of C276
(C344 and C317), a PLP stacking residue, indicates that its role
is mostly structural, keeping the cofactor in an optimal position
for reactivity. This is consistent with the observation that the
side chain thiol of C276 points away from the substrate instead
of toward it. Y482 (Y554 and Y526) appears to play an important
role in activity, possibly in substrate accommodation since it
belongs to the ‘‘bottom wall’’ region discussed above. Further
analysis is required to decipher the precise role of all residues
involved in the reaction mechanism of SPL.
As mentioned above, the extent of disorder or ﬂexibility of
the N termini (Nt-FLEX) seems to be conserved from StSPL to
Dpl1p D1-102 (Figure 3B) and may reﬂect a functional role,
presumably in accommodating the substrate embedded in
Figure 8. Proposed Mechanism of S1P Cleavage by SPL
The incoming S1P (step II) replaces the catalytic lysine (311 in StSPL and 380 in Dpl1p) as Schiff base partner of PLP, forming an external aldimine (step III). Retro-
aldol cleavage occurs at the hydroxyl group of carbon atom 3 of S1P (step III) and the long-chain aldehyde product (called hexadecenal in case S1P is the
substrate) is released (step IV). The second external aldimine (step VII) results from reprotonation (step VI) of the quinonoid intermediate (step V). PE is then
released (step VIII) and the internal aldimine is re-formed (step I): the enzyme is now ready for a second turnover.
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the membrane. Since StSPL lacks a transmembrane helix, the
precise mechanism of accommodation is most probably not
conserved, because StSPL DNt-FLEX behaves as FL WT in
the in vitro activity test (Figure S3A), and Dpl1p D1-102 is
inactive in vitro, while Dpl1p D1-57 is only partly active in vivo
(Figure 7B).
The N and C termini of StSPL, and most probably of Dpl1p,
surround the active site entry channel (Figures 2C and 2D,
respectively) and might act as a gate that isolates the sub-
strate-bound active site from solvent and thus promotes catal-
ysis. Indeed, StSPL DCt-EXT appears to be less active than FL
WT StSPL (Figure S3B).
Our functional analysis of StSPL and Dpl1p clearly indicates
that the ﬂexible regions described in the ﬁrst sections carry
residues crucial for activity. Our results allow a better under-
standing of the mode of action of this very important enzyme.
Given the similarity of the active sites and the high degree
of conservation between StSPL, Dpl1p and SPL (Figures 5C,
S1 and S2), the proposed mechanism can serve as basis for
further studies on the human counterpart.
In conclusion, this study provides the ﬁrst structural character-
ization of a eukaryotic SPL, identiﬁes critical residues for activity,
sheds light on the reaction mechanism, and demonstrates
the existence and functionality of a prokaryotic homolog of
the enzyme. Modulating the cofactor occupancy seems to be
a common feature of both StSPL and Dpl1p. Moreover, our
results allowed the generation of a high-quality homology model
of the human enzyme, pinpointing the conservation of the above
described residues. Most importantly, they provide a solid foun-
dation for structure-based drug design on SPL.
EXPERIMENTAL PROCEDURES
Chemicals
All chemicals and reagents were of the highest commercially available grade.
Plasmid Constructs and Protein Expression and Puriﬁcation
Plasmid construction and expression and puriﬁcation of StSPL and Dpl1p
D1-102 are described in Supplemental Information.
Activity Assays
UV-visible spectra were recorded on a Cary-50 spectrophotometer (Varian)
using 1 cm light path quartz precision cells (Hellma). Protein concentration
was estimated using an average value of the extinction coefﬁcient of a fully
reduced and a fully oxidized protein as calculated with ProtParam (Gasteiger
et al., 2005). The value used for FL WT StSPL was 790400 M-1cm-1 and
500500 M-1cm-1 for Dpl1p D1-102. S1P was purchased from Acros, Alexis
Biochemicals or Avanti Polar Lipids, while DHS1P and PS1P were from Avanti
Polar Lipids. The phosphosphingolipids were solubilized in 1% (w/v) Triton
X-100 (Fluka or Acros) to 1 mg/ml (corresponding to 2.6 mM). The suspension
was incubated at 37C for 30minwith 1min vortexing every 4min. After 10min
soniﬁcation and further vortexing, insoluble material was separated by a
10min centrifugation step at 14,0003 g at room temperature. Protein concen-
tration in the cell was set at 22 mM (1.2 mg/ml), for a total volume of 100 ml.
Seventy microliters of phosphosphingolipid solution was added to the protein
and brieﬂy homogenized with a pipette. The buffer corresponded to the SEC
buffer containing 1 mM KPi. Spectra were recorded every minute from
500 to 320 nm until no or only slight spectral changes could be observed.
The yeast synthetic lethality test was carried out as described in Mukhopad-
hyay et al. (2008).
Semicarbazide (Fluka) was mixed to FL WT StSPL set at 14 mM to a molar
excess of 100-fold over active sites and spectra were recorded as described
above. After 1 hr incubation, S1P was added and the spectra recorded as
described above.
ForMSactivity assay,S1PcleavagebyStSPLwascarried out under thesame
conditions as the spectrophotometric activity assay except that S1P was solu-
bilized in 100% ethanol. The reaction mixture was desalted using C18 ZipTip
pipettes tips (Millipore) and diluted in 50% acetonitrile, 0.2% formic acid (pH
2)before injection.Massesweremeasured in thepositivemodeonaquadrupole
mass spectrometer equipped with an electrospray (ESI) ionization source and
a time of ﬂight (TOF) ion separation device (Q-TOFUltima API,Waters Corpora-
tion). Multiple-charged protein ion signals were deconvoluted to produce zero-
charge spectra using theMaximumEntropyTM1 (MaxEnt1) algorithm in theMi-
cromass MassLynx software package (Thermo Scientiﬁc).
Protein Crystallization and Structure Determination
Native StSPL and Dpl1p were crystallized by vapor diffusion (sitting drop) at
20C. For cocrystallization with PE, StSPL K311A (7 mg/ml) was incubated
for 10 min on ice with an equimolar amount of PLP. StSPL K311A and PE
(Fluka) at a 10-fold molar excess over protein subunit were then incubated
overnight at 4C and concentrated prior to crystallization. Bright yellow (struc-
tures St_1, St_2 and Dpl1p), pale yellow (structure St_3) or colorless (structure
St_4) crystals appeared after 2–15 days. Crystallization conditions are listed in
Table S2. Crystals were cryoprotected by adding ethylene glycol (EG) to the
well solution (which, in cocrystallization experiments, was supplemented
with the corresponding compound at the appropriate concentration)
(Table S2). Crystals were ﬂash-frozen by rapid immersion in liquid propane.
Data sets were collected at 100K at the X06SA beamline of the Swiss Light
Source (SLS; Villigen, Switzerland). Data were processed with XDS (Kabsch,
1993). The ﬁrst structure of StSPL (code St_2) was solved by molecular
replacement with Phaser (McCoy, 2007) using a polyserine dimer of GadB
(PDB entry 2DGK) as search model. FL WT StSPL set at 3 mg/ml was cocrys-
tallized with semicarbazide according to the same procedure as for PE omit-
ting the initial incubation with PLP and with 45 min incubation at 4C prior to
crystallization.
Crystallographic Reﬁnement and Validation
Reﬁnement was carried out with CNS (Bru¨nger et al., 1998) and Phenix (Zwart
et al., 2008). The structure of Dpl1p D1-102 was solved with Phaser (McCoy,
2007) using a reﬁned dimeric model of StSPL K311A (Bourquin, 2010). NCS
restraints were employed by default and manually edited during reﬁnement,
unless data resolution was high enough to render them superﬂuous (Table 1).
Models were rebuilt with Coot (Emsley and Cowtan, 2004) and validated with
ProCheck (Laskowski et al., 1993) and MolProbity (Davis et al., 2007). PDB
entry codes are 3MAD (St_1), 3MAF (St_2), 3MAU (St_3), 3MBB (St_4), and
3MC6 (Dpl1p).
Modeling of SPL and of StSPL K311A in Complex with S1P
A dimeric homology model of the folded core of SPL was computed based on
the structure of Dpl1pD1-102 using the programModeller 9v6 (Sali, 1995). The
PLP cofactor was also included in the calculation as a rigid-body residue. The
model, including the internal aldimine linkage of the cofactor with K353, was
geometry minimized with Phenix (Zwart et al., 2008).
A tentative model of StSPL K311A containing the external aldimine interme-
diate with the substrate S1P was prepared with Coot based on the structure of
St_3 (Figure S1C). The S1P ligand was obtained from PDB entry 3I9G (Wojciak
et al., 2009), manually coupled with PLP and optimized with the PRODRG
server (http://davapc1.bioch.dundee.ac.uk/prodrg/). The S1P hydrophobic
chain was positioned such that it interacts with a hydrophobic region encom-
passing residues L128*, Y249, L344*, Y345*, F346*, V496, L497, and F500. The
model was energy-minimized with Phenix.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
ﬁve ﬁgures, and two tables and can be found with this article online at
doi:10.1016/j.str.2010.05.011.
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Figure S1. Close-up view of the active sites of StSPL, Dpl1p ?1-102 and SPL 
(A) Active site of StSPL (structure St_1) showing residues involved in the 
accommodation of PLP. Color coding is as in Figure 1A. 
(B) Same as in (A) for Dpl1p ?1-102 (structure Dpl1p-S). Color coding is same as 
Figure 1B. 
(C) Stereo representation of a model of StSPL K311A containing the external 
aldimine intermediate with the substrate S1P (PLP-S1P, in green and atom color). The 
peptide backbone is represented as ribbon. Subunits A and B are in light and dark 
gray, respectively. Ct-EXT is colored blue. Several hydrophobic residues likely 
interacting with the hydrophobic moiety of the substrate are shown in stick 
representation and labeled. 
(D) Stereo representation of a superposition of SPL onto FL WT StSPL (structure 
St_1). Color coding is as in Figure 5C, except that the subunit A and B of SPL, 
colored medium grey and blue, respectively, are depicted instead of Dpl1p ?1-102. 
Note that SPL T148 replaces StSPL A103 (A172 in Dpl1p). 
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Figure S2 related to Figure 5 
 
 
 
Figure S2. Multiple sequence alignment of StSPL, Dpl1p and SPL 
The predicted transmembrane helices of Dpl1p and SPL are highlighted in blue. The 
observed ?-helices and ?-strands of StSPL, assigned with PROMOTIF (Hutchinson et 
al., 1996) are shown in red and in green, respectively, in the top line. The sequences 
were aligned with T-Coffee (Notredame et al., 2000) and the figure was prepared with 
Genedoc (http://www.psc.edu/biomed/genedoc). 
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Figure S3 related to Figure 6 
 
 
 
Figure S3. StSPL and Dpl1p ?1-102 spectrophotometric activity assay using S1P, 
DHS1P and PS1P as substrate 
(A-G) Assay of StSPL FL WT, variants and mutants with S1P used as substrate. 
(A) Same as Figure 6A for StSPL ?Nt-FLEX. The FL WT control is depicted in (C). 
(B) Same as (A) for StSPL ?Ct-EXT except that the spectra were recorded during 30 
min. For clarity, the spectrum before addition of S1P (dotted line) is raised by 0.06 
absorbance units with respect to the other curves. 
(C) FL WT StSPL control for (A) and (B). 
(D-I) 15 ?M of StSPL was used instead of 22 and the changes upon addition of 
substrate were recorded over 30 min (D-F) or 20 min (G-I). FL WT control for (D), 
(E) and (F) is depicted in (G). The arrow in (D) shows the faint peaks at 420 nm 
appearing after addition of substrate. Arrows in (E) and (F) indicate alterations in the 
visible spectrum in the 430 nm, 380 nm and 330-340 nm regions, which did not 
correlate with S1P cleavage (Figure S4J and K respectively). 
(D) StSPL H129A. 
(E) StSPL A103P. 
(F) StSPL K317A. 
(G) FL WT StSPL control for (D-F). 
(H) Same as (G) except that DHS1P was used as substrate. 
(I) Same as (G) except that PS1P was used as substrate. 
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(J-L) same as (G-I) for Dpl1p ?1-102. The protein concentration in (K) was set to 36 
?M, while it was 29 ?M in (J) and (L). The spectra in (J) were recorded 1, 2, 5, 10 and 
20 min after addition of S1P. 
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Figure S4 related to Figure 6 
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Figure S4. In vitro activity assay of FL WT StSPL and mutants K311A, Y105F, 
A103P and K317A by MS 
(A) Chromatogram of PE. Under the ionization conditions, PE exhibits a peak at 
163.06 Da, which may correspond to a potassiated 5-membered cyclophosphane (Han 
et al., 1996). 
(B) Chromatogram of S1P. Under the ionization conditions, S1P produced a peak at 
163.07 Da, presumably corresponding to PE. The ratio between the 380 and 163 Da 
peaks was constant during the time of the experiment, as shown in (E). 
(C) Chromatogram of a mixture of S1P and FL WT StSPL immediately after addition 
of S1P to the enzyme. 
(D) Same as (C) after 75 min incubation at 20°C. The disappearance of the 380 Da 
peak reflects the activity of the protein. 
(E) Same as in (B) after 105 min at 20°C. 
(F) S1P control for (G-K), measured as in (B) with another S1P batch. 
(G) FL WT StSPL control for (H-K). The experiment was performed under the same 
conditions as in (D), except for the incubation time (4 h). 
(H-K) Same as (G) for the mutants K311A (H), Y105F (I), A103P (J) and K317A 
(K). 
Note that only the mutants which did not exhibit the 420 and 403 nm peaks upon 
substrate addition (Figure 6 and Figure S3) were analyzed by MS. 
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Figure S5 related to Figure 6 
 
 
 
Figure S5. StSPL inhibition with semicarbazide.\ 
(A) Stereo representation of the active site of StSPL crystallized in presence of a 10-
fold molar excess of semicarbazide (structure St_4). The phenol ring of Y249 
encountered a modification in ortho, most likely an amination resulting from the 
attack by semicarbazide. 
(B) Scheme of the condensation reaction yielding to PLP-semicarbazone. 
(C) Semicarbazide-induced spectral changes. A 100-fold molar excess of 
semicarbazide over StSPL active site was added to the protein and the spectra were 
recorded between 320 and 500 nm at regular intervals over 1 h. 
(D) Same as (C) except that S1P was added to a mixture of StSPL and semicarbazide 
incubated 1 h at room temperature. 
(E-F) Same as Figure 6 except that 33 ?M of enzyme subunit was used. The spectra 
were recorded over 5 min. 
(E) Y249F. 
(F) FL WT control. 
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Table S1. Primer sequences for StSPL and Dpl1p constructs  
The sequences are written from 5' to 3'. 
 
Construct name Forward (5') primer Reverse (3') primer 
pQE60-StSPL FL WT GGAAGATCTCTTTCGGCGTTTTC
CCCGC 
CCCAAGCTTACTAGTGATGGTGA
TGGTGATGCACCTCGTACAGCAG
GTCG 
pQE70-StSPL FL WT CATGCATGCCACTTTCG 
GCGTTTTCCCCGC 
CCCAAGCTTACTAGTGATGGTGA
TGGTGATGCACCTCGTACAGCAG
GTCG 
pQE70-StSPL ?Nt-FLEX 
WT 
CATGGCATGCCAAAGCCTTACCG
CGACCGCT 
CCCAAGCTTACTAGTGATGGTGA
TGGTGATGCACCTCGTACAGCAG
GTCG 
pQE70-StSPL ?Ct-EXT WT GGAAGATCTCTTTCGGCGTTTTC
CCCGC 
AGCTAAGCTTACTAGTGATGGTG
ATGGTGATGGGCCCGGACCTGAG
CCAC 
pQE70-StSPL FL A103P CTCCGGCCCCGTCTACC GGTAGACGGGGCCGGAG 
pQE70-StSPL FL Y105F CGCCGTCTTCCACGGCG CGCCGTGGAAGACGGCG 
pQE70-StSPL FL H129A AACCCGCTCGCCCCGGACCTC GAGGTCCGGGGCGAGCGGGTT 
pQE70-StSPL FL Y249F GCCGGGCTTCCCCCACG CGTGGGGGAAGCCCGGC 
pQE70-StSPL FL C276A GGACGCCGCCCTGGGCG CGCCCAGGGCGGCGTCC 
pQE70-StSPL FL K311A GCGTACGGCTACGGGGCCAA GTGGGTGTCGGCCGAGAC 
pQE70-StSPL FL K317A CGGGGCCGCGGGAACGT ACGTTCCCGCGGCCCCG 
pQE70-StSPL FL Y482F CCCCGGTCTTCGGCATGGC GCCATGCCGAAGACCGGGG 
pET28a+-Dpl1p ?1-102 CATGCCATGGGATCACCATTTTT
GAGGGGTACC 
CCGCTCGAGCTTGGTGGCGGTAT
CCTCT 
pRS415-Dpl1p FL A172P GGAAAGGTCTCTGGTCCCGTTTA
CCACGGTGGTGATGATTTG 
CAAATCATCACCACCGTGGTAAA
CGGGACCAGAGACCTTTCC 
pRS415-Dpl1p FL Y174F GGTCTCTGGTGCCGTTTTCCACG
GTGGTGATGATTTGATCC 
GGATCAAATCATCACCACCGTGG
AAAACGGCACCAGAGACC 
pRS415-Dpl1p FL H198A GCGTTGCCAATCAATTAGCTCCC
GATGTCTTTCCTGCCG 
CGGCAGGAAAGACATCGGGAGCT
AATTGATTGGCAACGC 
pRS415-Dpl1p FL WT (Mukhopadhyay et al., 2008) (Mukhopadhyay et al., 2008) 
pRS415-Dpl1p ?1-57 WT (Mukhopadhyay et al., 2008) (Mukhopadhyay et al., 2008) 
pRS415-Dpl1p FL C344A (Mukhopadhyay et al., 2008) (Mukhopadhyay et al., 2008) 
pRS415-Dpl1p FL K380A (Mukhopadhyay et al., 2008) (Mukhopadhyay et al., 2008) 
pRS415-Dpl1p FL K386A (Mukhopadhyay et al., 2008) (Mukhopadhyay et al., 2008) 
pRS415-Dpl1p FL Y554F (Mukhopadhyay et al., 2008) (Mukhopadhyay et al., 2008) 
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Table S2, related to Table 1. Crystallization conditions for the structures St_1-4 
and Dpl1p 
 
Protein 
code Sample 
Protein 
concentration 
Ratio protein-
to-well solution Well solution
 % 
EG 
St_1 
pQE70-StSPL 
FL WT 
native 
21 mg/ml 1:1 (2 ?l : 2 ?l) 
0.1 M Tris (HOAc) pH 8.4 
0.15 M KSCN 
16 % PEG 5K MME 
22 
St_2 
pQE60-StSPL 
FL WT 
native 
28 mg/ml 1:1 (400 nl : 400nl) 
0.1 M Tris (HOAc) pH 8.3 
0.2 M MgCl2  
25 % PEG 2K MME 
20 
St_3 
pQE70-St SPL 
FL K311A 
PE 
15 mg/ml 2:1 (2 ?l :1 ?l) 
0.1 M Tris (HOAc) pH 8.2 
0.15 M KSCN 
17 % PEG 5K MME 
20 
St_4 
pQE70-StSPL 
FL WT 
semicarbazide 
21 mg/ml 1:1 (2 ?l : 2 ?l) 
0.1 M Tris (HOAc) pH 8.6 
0.15 M KSCN 
17 % PEG 5K MME 
20 
Dpl1p pET28a+-Dpl1p ?1-102 10 mg/ml 
1:1 
(2 ?l : 2 ?l) 
0.1 M Na-cacodylate 
(HOAc) pH 6.7 
0.2 M Li2SO4 
18 % PEG 4K 
18 
 
 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Plasmid constructs 
The gene of FL (omitting to first methionine, that is corresponding to residues 2-507) 
WT Symbiobacterium thermophilum SPL (NCBI database accession number 
YP_075103 (Ueda et al., 2004)) was amplified by PCR from genomic DNA according 
to standard procedure and cloned into pQE60 (Qiagen) using BglII and HindIII and 
into pQE70 using SphI and HindIII with the primers listed in Table S1. Truncations of 
the protein were obtained with the same procedure, except that the plasmid pQE70-
StSPL FL WT was used as PCR template. The Dpl1p ?1-102 gene (NCBI database 
accession number Q05567 (Saba et al., 1997)) was amplified by PCR using a whole 
cell lysate of baker's yeast purchased from a local supermarket. This construct 
comprised residues 103-589. Yeast cells were suspended in water, vortexed with 425-
600 ?m glass beads (Sigma) and frozen/thawed. The cell lysate was serially diluted 
and various amounts were used as PCR template. The PCR product was cloned into 
pET28a+ (Novagen) using NcoI and XhoI with the primers listed in Table S1. The 
construct contains point mutations I308V and N469D possibly originating from lack 
of homogeneity of the yeast strains used for PCR. StSPL WT FL and variants as well 
as Dpl1p ?1-102 were fused to a C-terminal 6x His-tag. The QuikChange Site 
directed-mutagenesis kit (Stratagene) was used to insert the desired mutations into 
pQE70-StSPL FL WT and into pRS415 Dpl1p FL WT for the synthetic lethality test 
(see below) according to the manufacturer's instructions with the primers listed in 
Table S1. 
 
Protein expression and purification 
Variants and mutants of StSPL carried by pQE60 or pQE70 transformed into 
Escherichia coli M15 competent cells (Qiagen) were grown for 3 h at 37°C in LB 
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(Luria broth) medium (Invitrogen) containing 100 ?g/ml of ampicillin, 50 ?g/ml of 
kanamycin and 0.1 g/l pyridoxine. The culture was then cooled down to 30°C and 
protein expression was induced at an OD600 nm (optical density) of 0.8 by adding 
ethanol to 2 %, pyridoxine to 0.1 g/l and IPTG to 0.1 mM. The cells were harvested 
after 4 h, resuspended in 50 mM KPi pH 7.2 and frozen overnight at -20°C. The cell 
suspension was thawed and diluted with an equal volume of 50 KPi pH 7.2, 2 mM 
DTT, 0.4 mM PLP, 200000 U/ml lysozyme (Fluka), 0.02 mg/ml DNase I (Roche) and 
2x Protease inhibitor cocktail (Roche). The suspension was incubated for 30 min on 
an orbital shaker at room temperature. DTT was supplemented to a total concentration 
of 1.5 mM and cells were disrupted with a high pressure homogenizer (AVESTIN, 
Canada). EDTA was immediately added after lysis to a final concentration of 1 mM. 
The sample was then incubated at 60°C for 1 h and spun down 30 min at 50000 g at 
25°C. The supernatant was incubated with Ni2+-NTA agarose beads (Qiagen) for 30 
min at room temperature on an orbital shaker prior to purification according to the 
manufacturer's instructions. The protein was eluted in 50 or 1 mM KPi pH 7.2, 100 
mM imidazole, 5 mM EDTA, 1 mM DTT, 0.2 mM PLP and 1x Protease inhibitor 
cocktail. StSPL was then concentrated using an Amicon Ultra-15 centrifugal filter 
unit (Millipore) with a MW (molecular weight) cut-off of 50 kDa according to the 
manufacturer's instructions with gradually decreasing the temperature from 15 to 4°C. 
The concentrated protein was injected on a SEC (size-exclusion chromatography) 
column (Superdex-200 10/300 HR, GE Healthcare) and eluted at 4°C in 50 or 1 mM 
KPi pH 7.2, 100 mM NaCl, 1 mM EDTA, 1 mM DTT and 0.01 mM PLP at a flow 
rate of 0.5 ml/min. The protein MW was estimated using the calibration curve of 
known molecular mass standards (GE Healthcare) and by analytical 
ultracentrifugation (Bourquin, 2010). The fractions of the two peaks eluting at 11 
(corresponding to approximately 200 kDa, i.e. a tetramer) and 13 ml (corresponding 
to approximately 100 kDa) were analyzed by 10 % SDS-PAGE (sodium dodecyl 
sulfate polyacrylamide gel electrophoresis). The fractions of the peak eluting at 13 ml 
were pooled and concentrated at 4°C as mentioned above. Dpl1p ?1-102 was 
expressed in Escherichia coli HMS174(DE3) in LB containing 50 ?g/ml of 
kanamycin and 10 mM glucose according to the same protocol as for StSPL with the 
following modifications: the culture was carried out at 30°C throughout, ethanol was 
not added at induction and cells were harvested 24 h after induction. The cell pellets 
were resuspended in 50 mM KPi pH 7.2, 1 mM DTT, 0.1 mM PLP, 100000 U/ml 
lysozyme (Fluka), 0.01 mg/ml DNase I (Roche) and 1x Protease inhibitor cocktail 
(Roche) and incubated for 1 h at 4°C prior to overnight storage at -20°C. Subsequent 
purification steps were exclusively carried out at 4°C in the same way as for StSPL, 
except that cell debris and unbroken cells were removed by a 45-min centrifugation 
step at the same speed and all buffers contained 50 mM KPi. The fractions 
corresponding to the single peak eluting at 13 ml were pooled and concentrated prior 
to crystallization. 
 
SUPPLEMENTAL REFERENCES 
?
Bourquin F. (2010). Questioning the Sphinx: structural and functional studies of 
sphingosine-1-phosphate lyase. Ph.D. Thesis, Institute of Biochemistry, University of 
Zurich, Zurich, Switzerland. 
 
Han X., Gross R.W. (1996). Structural Determination of Lysophospholipid 
Regioisomers by Electrospray Ionization Tandem Mass Spectrometry. J Am Chem 
Soc 118, 451–457. 
 
  
 
 12 
Hutchinson E.G., Thornton J.M. (1996). PROMOTIF--a program to identify and 
analyze structural motifs in proteins. Protein Sci 5, 212-220. 
 
Mukhopadhyay D., Howell K.S., Riezman H., Capitani G. (2008). Identifying key 
residues of sphinganine-1-phosphate lyase for function in vivo and in vitro. J Biol 
Chem 283, 20159-20169. 
 
Notredame C., Higgins D.G., Heringa J. (2000). T-Coffee: A novel method for fast 
and accurate multiple sequence alignment. J Mol Biol 302, 205-217. 
 
Saba J.D., Nara F., Bielawska A., Garrett S., Hannun Y.A. (1997). The BST1 gene of 
Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. J Biol Chem 272, 
26087-26090. 
 
Ueda K., Yamashita A., Ishikawa J., Shimada M., Watsuji T.O., Morimura K., Ikeda 
H., Hattori M., Beppu T. (2004). Genome sequence of Symbiobacterium 
thermophilum, an uncultivable bacterium that depends on microbial commensalism. 
Nucleic Acids Res 32, 4937-4944. 
 
 
 
Part 4: Results & Discussion Symbiobacterium thermophilum SPL (StSPL) 
80 
4. RESULTS & DISCUSSION Symbiobacterium thermophilum SPL (StSPL) 
 
4.1. FULL-LENGTH (FL) SPL CONSTRUCTS DESIGN 
 
Full-length wild-type SPL from Symbiobacterium thermophilum (named thereafter FL WT 
StSPL ) was successfully cloned and expressed as described in Materials & Methods (sections 
8.2.1. and 8.3.1.) and in part 3 (manuscript) SI Text. The protein carries a C-terminal 6x His 
tag directly after the last residue of the WT sequence and various additional residues at the 
N-terminus due to the cloning procedure (figure 4-1). 
 
Figure 4-1. FL WT StSPL cloned in pQE60 or pQE70 
 
 
 
4.2. EXPRESSION IN E. coli AND SOLUBILITY ASSAY 
 
4.2.1. EXPRESSION 
 
The expression conditions were optimized as described in Materials & Methods: the 
resulting optimized conditions are summarized in table 4-1. Protein production was 
monitored by 10 % SDS-PAGE and anti-His tag protein immuno-detection (Western blot) 
(figure 4-2). The protocol includes addition of pyridoxine, which is a precursor of the 
cofactor of SPL, PLP. Ethanol supplemented to the medium at induction of protein 
expression elicits a stress-response in E. coli that apparently triggers the production of the 
chaperones groEL and groES together with the protein of interest (173). 
 
Table 4-1. Optimized expression conditions for FL WT StSPL 
 
Expression system pQE 
E. coli strain M15 
Medium composition LB (10 g tryptone, 5 g yeast extract, 10 g NaCl) 
0.1 g/l pyridoxine 
Appropriate antibiotics 
Starting OD600 nm (500 ml medium) 0.02 
OD600 nm at induction 0.8 
IPTG concentration 0.1 mM 
Chemicals added at induction 2% (v/v) ethanol 
0.1 g/l pyridoxine 
Temperature during protein 
expression 
30°C 
Expression duration 4 hours 
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Figure 4-2. Expression of pQE60 and pQE70 FL WT StSPL in E. coli 
 
 
 
4.2.2. CELL LYSIS BUFFER COMPOSITION AND SAMPLE TREATMENT 
 
The composition of the cell lysis buffer was screened for with the aim of increasing the yield 
of soluble protein. The optimal buffer composition is summarized in table 4-2. The amount 
of soluble protein is significantly decreased in 50 mM KPi pH 6.5 and 6.0, in 50 mM KOAc at 
pH 5.0 and 3.6 and in the presence of 1, 10 and 100 mM MgCl2 and CaCl2. Adding 300 mM 
NaCl does not have an effect on the amount of soluble protein (not shown). It has to be 
mentioned that this test cannot discriminate between an impaired solubility of SPL and a 
decreased activity of lysozyme, which lyses the cell wall and helps cell lysis. Both factors, in 
fact, result in a decreased amount of soluble protein. 
 
Table 4-2. Optimal cell lysis buffer for FL WT StSPL in small-scale assays 
 
KPi 50 mM pH 7.2 (20°C, KOH) 
DTT 1 mM 
PLP 200 μM 
Protease inhibitor cocktail 
without EDTA (Roche) 
1x 
Chicken egg white lysozyme 100000 U/ml 
DNase I 10 μg/ml 
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Heating the samples after cell lysis positively influences the amount of soluble protein. An 
incubation of 30 min at 60°C results in a several-fold increase of soluble material compared 
to incubation on ice (figure 4-3 lanes 1 and 1' compared to 4 and 4', respectively). Moreover, 
heating denatures host cellular components and significantly increases the purity of the 
sample, an effect that has often been exploited in the purification of thermophilic and 
hyperthermophilic proteins. One hour incubation at 60°C was routinely used as a purification 
step after cell lysis and prior to immobilized metal affinity chromatography (IMAC) 
purification. 
 
Figure 4-3. Effect of heating on the amount of soluble FL WT StSPL after cell lysis 
 
 
 
4.3. PURIFICATION 
 
FL WT StSPL was purified according to a three-step purification protocol. The protocol 
involved sample heating at 60°C followed by IMAC with Ni-NTA (nitrilotriacetic acid) agarose 
beads, performed at room temperature, and size-exclusion chromatography (SEC) (gel 
filtration) at 4°C (see Materials & Methods, section 8.3.1. and part 3 (manuscript) SI Text). 
The heating step alone leads to a many-fold purification of the protein (lane 1 compared 
with 2 in figure 4-4). A non-negligible amount of protein does not bind to the Ni-NTA 
agarose beads and is found in the flow-through (lane 3). This stems either from unfolded 
protein or from an excess of protein compared to the available binding sites on the beads. 
Washing the beads with 20 bead volumes of buffer containing 0 and 10 mM imidazole 
further increases protein purity (lanes 4 and 5). The protein is eluted with 100 mM imidazole 
and 5 mM EDTA (lane 6). Only a small amount of protein cannot be eluted under these 
conditions (lane 7), due either to an alternative stronger protein binding mode or to protein 
precipitation. The amount of pure and soluble material is strongly decreased when the IMAC 
step is performed at 4°C (data not shown). After IMAC, the protein is immediately 
concentrated at gradually decreasing temperatures of 15 to 4°C and kept on ice or at 4°C in 
all subsequent steps. The concentrated sample (lane 9) is loaded on a SEC column. 
In addition to the main 55 kDa band (yellow star), a faint 110 kDa band (green star) and a 30 
kDa band (black star) are visible on the Coomassie-stained SDS-PAGE. The 110 kDa species 
reacts with anti-His tag antibodies (lane 10), indicating that this species is either a SDS-
resistant dimer (most likely, given its apparent molecular mass), or a covalently modified 
StSPL species, or an impurity that binds to the Ni-NTA beads and likewise reacts with the 
anti-His tag antibodies. 
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Figure 4-4. pQE70 FL WT StSPL purification steps 1 and 2: 60°C heating and IMAC 
 
 
 
Two peaks elute from the SEC column (figure 4-5), a Superdex-200 10/300. Both peaks 
contain FL StSPL, as confirmed by Coomassie-staining SDS-PAGE, protein immunodetection 
(inlet figure 4-5), N-terminal sequencing of the respective 55 kDa bands and mass 
spectrometry (data not shown). The calculated mass of the protein from the primary 
sequence is 55.8 and 55.4 kDa depending on the expression vector (in pQE60 and pQE70, 
respectively). The peaks eluting at 11 and 13 ml correspond to a 320 kDa and a 140 kDa 
globular species, respectively, and can be assigned to a tetramer and a dimer of StSPL 
respectively. These molecular masses derive from calibration runs carried out with soluble 
protein mass standards. Pooled fractions of the 11 ml- (called thereafter the tetramer peak) 
and 13 ml-peak (dimer peak), as indicated with the stars in the inlet of figure 4-5, 
respectively contain an additional 120 kDa band, as seen on SDS-PAGE, and a 30 kDa 
smeared band. Nevertheless, the estimated purity of each sample exceeds 98%. 
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Figure 4-5. FL WT StSPL purification step 3: SEC 
 
 
 
The tetramer-to-dimer peak (abbreviated 4mer-to-2mer) ratio increases with sample 
concentration. Interestingly, the two peaks exhibit a different behaviour or overall stability 
upon concentration. Pooled fractions of the tetramer peak concentrated to 6 mg/ml and 
subjected again to SEC generate a significant peak at 13 ml retention volume, whereas 
pooled fractions of the dimer peak concentrated to 25 mg/ml mainly run as a sharp 13 ml 
peak (table 4-3). The tetramer species thus seems more prone to dissociate into dimers than 
the dimer species is prone to oligomerize into a tetramer. 
 
Table 4-3. Influence of the concentration on the intensity of the tetramer and dimer peaks 
 
 Concentration(1) 4mer-to-2mer ratio 
Sample after IMAC 16 40 : 100 
Tetramer peak reloaded 6 100 : 30 
Dimer peak reloaded 3 1 : 100 
Dimer peak reloaded 25 2 : 100 
 
(1) Indicated as mg/ml of monomer (peptide chain). 
 
The purification outcomes are similar for FL WT StSPL expressed in pQE60 or pQE70, 
meaning that the additional residues at the N-terminus, MGGSRS in case of pQE60 and MP in 
case of pQE70, do not alter the biophysical properties of the FL protein. Adding 1 mM EDTA, 
using HEPES or NaPi instead of KPi (at the same concentration and pH), replacing NaCl by KCl, 
running the SEC without pH-buffering agents have no effect on the elution profile (data not 
shown). When pooled fractions of the 13 ml-peak kept for one week at 4°C, -20°C or -80°C 
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either in non-concentrated or in five-fold concentrated form are subjected to SEC, the 
protein runs as a single sharp peak eluting at 13 ml. This indicates that the protein does not 
aggregate or unfold upon storage. Nevertheless, all crystallisation trials and activity assays 
were performed with material as fresh as possible, unless otherwise stated. Both SEC peaks 
were subjected to crystallisation trials. 
 
4.4. BIOPHYSICAL CHARACTERIZATION 
 
4.4.1. UV-VIS SPECTRUM 
 
Free PLP (vitamine B6) exhibits two peaks in the visible range, the main one being centred at 
385 nm with a shoulder at 330 nm (figure 4-6 orange trace). The features of the visible 
spectrum of PLP-dependent enzymes depend on the protonation state and 
microenvironment of the cofactor (174) (175). The UV-Vis spectrum of FL WT StSPL is 
characterized by a broad peak located at 420-460 nm (figure 4-6) presumably resulting from 
two contributions, one centred at 425 nm and the other at 450 nm. The latter species is 
unknown. The 425-nm species presumably corresponds to the ketoenamine form of the 
internal aldimine, which is the covalent complex between K311 and PLP (see section 1.5.5. 
figure 1-34). Mutating the internal aldimine lysine is known to alter the spectrum and to 
inactivate the enzyme. The spectrum of StSPL K311A (FL) shows a 350 nm peak which 
probably corresponds to the hydrated form of PLP in one of the active sites of structure 
St_10 (figures 4-7 & 4-8) (176) (177). 
 
Figure 4-6. UV-Vis spectra of free PLP, StSPL FL WT and K311A 
 
 
 
Note: the protein spectra were normalized to 1 at 280 nm whereas the maximal absorbance 
of PLP was adjusted to 0.5 at 385 nm. 
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Figure 4-7. PLP internal aldimine and hydrated form 
 
 
 
Figure 4-8. Hydrated form of PLP in one active site of StSPL K311A (structure St_10) 
 
 
 
Note: the crystallisation and the structure are described in sections 4.5.4. and 4.6.7., 
respectively. 
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4.4.2. PRIMARY SEQUENCE ANALYSIS 
 
FL WT StSPL expressed in pQE60 and pQE70 was subjected to N-terminal sequencing and 
mass spectrometry after SEC. Both methods indicate that the first methionine (Met1) was 
cleaved off of the protein and are in full agreement with the expected sequences and 
molecular masses (table 4-4). 
 
Table 4-4. Calculated and experimental MWs of FL WT StSPL constructs lacking Met1 
 
 N-terminal 
sequence 
Calculated 
(without Met1) 
Measured 
In pQE60 GGSRSLSAFS 55 781 Da 55 784 Da 
In pQE70  55 434 Da 55 436 Da 
 
Note: the molecular masses were calculated from the primary sequences including all 
additional residues except Met1 using ProtParam 
(http://www.expasy.org/tools/protparam.html (178)). 
 
Mass spectrometry reveals the presence of two species under the conditions tested, the 
protein lacking its cofactor (called apo-form) and the protein with the covalently bound 
cofactor (called holo-form) (figure 4-9). 
 
Figure 4-9. pQE70 FL WT StSPL mass spectrometry analysis 
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4.4.3. ANALYTICAL ULTRACENTRIFUGATION 
 
The 11 ml- (tetramer) and 13 ml-peak (dimer) of the SEC purification step were analysed by 
AUC with the aim of confirming their oligomeric state. After pooling (see chapter 4.3. figure 
4-5 green and yellow stars) the respective fractions of the 11 ml- and 13 ml-peaks, part of 
each sample was diluted to 0.4 mg/ml whereas the other part was concentrated to 15 and 
33 mg/ml, respectively. The sedimentation of the 0.4 mg/ml samples was monitored by their 
absorbance at 320 nm whereas the sedimentation of the more concentrated samples was 
monitored using interference. The data obtained using the latter detection method were too 
noisy to be analysed in a reproducible way and are therefore not shown. The outcomes of 
the data analysis of the low concentration samples are presented in figure 4-10. Three 
species are present in the SEC tetramer peak sample, corresponding to a dimer, a tetramer 
and probably to a hexamer whereas only one tailed peak appears in the SEC dimer sample 
with a mass corresponding to a dimer. These results are in good agreement with the 
molecular masses estimated from the SEC column calibration runs. 
 
Figure 4-10. AUC analysis of pQE60 FL WT StSPL SEC tetramer and dimer peaks (0.4 mg/ml) 
 
 
 
Note: the starting frictional ratio (f/f0) was set to 1.3 and corresponded to the default value 
recommended for globular proteins using the program SedFit (179). The rmsd of a 
relevant fit should be significantly lower than 0.01 fringes. 
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4.5. CRYSTALLISATION AND DATA COLLECTION 
 
The SEC tetramer and dimer peaks were subjected to initial crystallisation trials as described 
in Materials & Methods (chapter 8.8.). In comparison with material from the dimer peak, 
fewer and smaller colourless crystals or crystal-like material grew from the tetramer peak. 
Therefore, all the crystals presented in this section arose exclusively from the SEC dimer 
peak (eluting at 13 ml). All crystals shown were grown at 20°C. Only the crystals used to 
determine the structures presented in the next chapter (4.6.) are described. The resolution 
of the datasets as well as a summary of the crystallisation conditions of structures St_5-10 
can be found in table 4-6 of section 4.5.5., while those of structures St_1-4 are listed in part 
3 (manuscript) table S2. The numbering of the structures was chosen according to the 
manuscript (see part 3) and therefore does not follow the order presented here. 
 
4.5.1. NATIVE FL WT StSPL  
 
Native FL WT StSPL, cloned either in pQE60 or pQE70, crystallised in a pH range from 8.0 to 
8.5 in the presence of 0.15 potassium thiocyanate (KSCN) and in typically 16 to 18 % PEG 5K 
MME or 25 % PEG 2K MME (figures 4-11, 4-13, 4-14). In one single case, displayed in figure 
4-12, crystals grew in the presence of Mg2+ from an initial heavy precipitate. This condition 
could not be reproduced to date. The crystals of StSPL grown in presence of Sr2+ grew at pH 
7.5 in 0.3 M NaOAc and 15 % PEG 4K (figure 4-15). The crystals are yellow due to the 
presence of PLP. In all cases, the crystals producing high resolution datasets were plate- or 
needle-like shaped, appeared after one week and reached their full size after approximately 
two weeks. Crystals growing in the presence of Sr2+ reached their full size after 
approximately one month. Bulkier and bigger crystals appeared within one to two days but 
did not diffract to high resolution (pictures not shown). 
 
Figure 4-11. Crystals of pQE70 FL WT StSPL STRUCTURE St_1 
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Figure 4-12. Crystals and diffraction pattern of pQE60 FL WT StSPL STRUCTURE St_2 
 
 
 
Figure 4-13. Crystals and diffraction pattern of pQE60 FL WT StSPL STRUCTURE St_5 
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Figure 4-14. Crystals of pQE70 FL WT StSPL used for soaking trials with MgCl2 resulting in 
STRUCTURES St_6-8 
 
 
 
Figure 4-15. Crystals of pQE70 FL WT StSPL in presence of SrCl2 resulting in STRUCTURE St_9 
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4.5.2. FL WT StSPL IN COMPLEX WITH SEMICARBAZIDE 
 
Crystals of pQE70 FL WT StSPL in complex with the PLP-dependent enzymes inhibitor 
semicarbazide (see part 3 (manuscript) and section 4.7.1.) grew in conditions similar those of 
the native enzyme and exhibit similar shapes. Unlike those of the native enzyme, the crystals 
are colourless (figure 4-16). 
 
Figure 4-16. Crystals of pQE70 FL WT StSPL in the presence of 10-fold molar excess of 
semicarbazide over monomer, resulting in STRUCTURE St_4 
 
 
 
4.5.3. StSPL K311A IN COMPLEX WITH PE 
 
After an overnight incubation at 4°C with PE, the spectrum of pQE70 StSPL K311A (FL) 
exhibits a new broad peak at 425 nm (figure 4-17) characteristic of an aldimine, like the 
internal aldimine of StSPL WT (figure 4-6 section 4.4.1.). This indicates that PE formed a 
covalent complex with PLP (called thereafter external aldimine). 
 
Figure 4-17. PE-induced spectral changes of StSPL K311A 
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Crystals of the protein in complex with PE grew in similar conditions as the native enzyme 
and have similar shapes (figure 4-18). 
 
Figure 4-18. Crystals of StSPL K311A in presence of PE, resulting in STRUCTURE St_3 
 
 
 
SOAKING TRIALS WITH A LONG-CHAIN ALDEHYDE 
The purchased cis-11-hexadecenal (Fluka) was obtained as a suspension, which was diluted 
to 5 mM with Triton X-100 and used to soak crystals of StSPL K311A in complex with PE as 
described below for S1P in StSPL K311A (see section 4.5.4.). No high-resolution datasets 
were obtained from these attempts. 
 
4.5.4. StSPL K311A IN COMPLEX WITH S1P 
 
SOAKING TRIALS 
Crystals of pQE70 StSPL K311A (FL) grew in similar conditions and had similar shapes as other 
crystals of WT StSPL that are not presented in section 4.5.1. These crystals were used for 
substrate soaking trials as described in Materials & Methods (section 8.8.5.). S1P was either 
suspended in the corresponding well solution (figure 4-19) or was solubilised in the well 
solution supplemented with 1 % Triton X-100 (not shown) before addition to the crystal. 
When Triton X-100 was present the crystals diffracted only to low resolution. 
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Figure 4-19. Crystal and diffraction pattern of StSPL K311A soaked with S1P, resulting in 
STRUCTURE St_10 
 
 
 
CO-CRYSTALLISATION TRIALS 
The attempts and outcomes thereof are summarized in table 4-5. 
Co-crystallisation with S1P either suspended in the protein solution or solubilised in Triton X-
100 or ethanol prior to addition to the protein sample was attempted. Unexpectedly, no 
spectral changes were observed after overnight incubation at 4°C. The formation of the 
external aldimine with the substrate (that is the covalent complex between PLP and S1P) 
should result in spectral changes that can be monitored (180) (181), as for StSPL K311A 
mixed with PE (see section 4.5.3. figure 4-17). The co-crystallisation experiment was 
nevertheless continued. Increasing concentrations of Triton X-100 in the protein sample 
markedly reduced the number of crystals per drop and their size compared to native SPL. In 
one attempt, the protein sample mixed with Triton X-100-solubilised S1P was subjected to a 
SEC purification step to remove the detergent prior to crystallisation. High resolution 
datasets were obtained but no positive difference electron density corresponding to S1P was 
observed. This indicates that Triton X-100 has a deleterious effect on the crystal packing and 
should be removed for structural work. 
Replacement of Triton X-100 with ethanol produced crystals diffracting to high resolution 
but their electron density maps lacked a significant signal for S1P. 
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Table 4-5. Outcome of the crystallisation trials of StSPL K311A in complex with S1P 
 
ATTEMPT METHOD S1P SOLVENT REMOVAL CRYSTALS 
HIGH-
RESOLUTION 
DIFFRACTION 
S1P 
VISIBLE 
1 SOAKING Suspended in well solution No solvent Yes (survived) Yes No 
2  
Solubilised in well solution 
supplemented with 1 % 
Triton X-100 
No  No  
3 CO-CRYSTALLISATION 
Suspended in protein 
solution No solvent Yes Yes No 
  Solubilised in 0.08 % 
(1) 
Triton X-100 No Yes
(2) No  
  Solubilised in 0.16 % 
(1) 
Triton X-100     
  Solubilised in 1 % 
(1) 
Triton X-100     
4  Solubilised in 1 % Triton X-100 SEC Yes Yes No 
5  Solubilised in 50 % ethanol No Yes Yes No 
   30 min at 60°C  No  
 
(1) Corresponding to 0.5, 1, and 6 times the CMC value of Triton X-100, respectively. 
(2) A decreasing number of crystals per drop correlated with an increase of the Triton X-100 
concentration and the crystals had different morphologies. 
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4.5.5. SUMMARY 
 
Table 4-6. Crystallisation conditions and resolution of St_5-10 
 
PART STRUCTURE CODE SAMPLE 
PROTEIN 
CONC. 
[mg/ml] 
RATIO 
PROTEIN:WELL 
SOLUTION 
WELL SOLUTION (1) 
CRYO
[%EG 
(v/v)] 
RES. 
(Å) 
4.5.1. St_2(2)       
 St_5 
Native 
pQE60 
FL WT StSPL  
32 1:1 (400 nl each) 
0.1 M Tris (HOAc) 
pH 8.5  
0.15 M KSCN 
18% PEG 5K MME 
20 3.4 
 St_1(2)       
 St_6 
pQE70 
FL WT StSPL  
soaked in 
10 mM Mg2+ 
21 2:1 (2 μl:1 μl) 
0.1 M Tris (HOAc) 
pH 8.0 
0.15 M KSCN 
18% PEG 5K MME 
20 2.4 
 St_7 
pQE70 
FL WT StSPL  
soaked in 
50 mM Mg2+ 
    2.7 
 St_8 
pQE70 
FL WT StSPL  
soaked in 
100 mM Mg2+ 
    3.4 
 St_9 
pQE70 
FL WT StSPL  
co-cryst. with 
Sr2+ 
9 2:1 (800 nl:400 nl) 
0.1 M Tris (HOAc) 
pH 7.5 
0.3 M Na-acetate 
15% PEG 4K 
25 2.6 
4.5.2. St_4(2)       
4.5.3. St_3(2)       
4.5.4. St_10 
pQE70 
StSPL K311A 
soaked with 
S1P 
15 2:1 (800 nl:400 nl) 
0.1 M Tris (HOAc) 
pH 8.5 
0.2 M KBr 
10% PEG 8K 
10% PEG 1K 
25 1.9 
 
(1) All hits were obtained at 20°C. 
(2) See part 3 (manuscript) table S2. 
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4.6. StSPL STRUCTURES 
 
The statistics of the presented datasets are found in part 3 (manuscript) table S3 (St_1-4 
only) and in section 4.6.8 for St_5-10. For clarity, the disordered regions are not displayed on 
the figures. The disorder of St_5-10 was identical to that of St_1 (part 3), i.e. the Nt-FLEX 
domain (residues 1-57) was not visible. 
 
4.6.1. FL WT StSPL HOMODIMER (STRUCTURE St_1) 
 
See part 3 (manuscript). 
 
4.6.2. FL WT StSPL HOMODIMER WITH CONFORMATIONAL HETEROGENEITIES 
(STRUCTURE St_2) 
 
See part 3 (manuscript). 
 
4.6.3. FL WT StSPL HOMOTETRAMER (STRUCTURE St_5) 
 
Crystals containing two dimers in the asymmetric unit were found in the same drops as the 
above-described crystals with one dimer per a.u. (figure 4-20). Only one subunit of each 
dimer interacts with the other dimer to form the tetramer (subunits B and D, coloured dark 
grey on figure 4-20). PLP is present in all subunits, whereas phosphate ions are only found in 
subunits B and C. The interface area between two dimers spans about 520 Å2, while it spans 
about 6280 and 6190 Å2 between monomers A-B and C-D, respectively. The surface areas 
were calculated with the CCP4 version of PISA (182). For comparison, interface A-B of the 
St_2 homodimer, which exhibits conformational heterogeneities, spans 5340 Å2. 
Further analysis with the CRK tool (to be published) indicates that the tetramer most 
probably arises from a crystal contact and has no biological relevance. Mutants with a 
significantly decreased 4mer-to-2mer ratio on SEC are also found as tetramers, supporting 
the hypothesis of a non-biologically relevant oligomer (see structures St_3 and St_10 in 
sections 4.6.6. and 4.6.7., respectively, and the SEC profile of StSPL K311A in chapter 4.9.2. 
figure 4-38 right panel). 
 
Figure 4-20. Structure St_5 
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The N- and C-termini of subunits B and D are close to each other and might be involved in 
tetramer formation (figure 4-21). The first 57 residues (corresponding to the Nt-FLEX 
domain) that are not visible on the structure might extend the interface under particular 
biochemical conditions. 
 
Figure 4-21. Localisation of N- and C-termini in the tetramer in structure St_5 
 
 
 
4.6.4. EFFECT OF DIVALENT CATIONS 
 
Divalent cations such as Ca2+ and Zn2+ were reported to inhibit SPL activity (113) even if this 
could not be confirmed under the experimental conditions tested (see section 4.7.1.). It was 
nevertheless thought that Mg2+ present in the well solution triggered the conformational 
heterogeneities observed in structure St_2. To test this hypothesis, crystal soaking and co-
crystallisation with divalent cations were attempted. 
 
CRYSTAL SOAKING WITH Mg2+ (STRUCTURES St_6-8) 
Crystals from the same drop were soaked with the well solution supplemented with 10, 50 
and 100 mM Mg2+ and were found to diffract to 2.4, 2.7 and 3.4 Å, respectively. Assuming 
that this effect doesn't result from the initial properties of the respective crystal used for 
soaking, high concentrations of Mg2+ seem to promote conformational changes that disturb 
the crystal lattice. Unlike structure St_2, the protein is present as a tetramer and PLP and 
phosphate ions are found in all subunits of all three structures. The decreasing quality of 
diffraction data with increasing Mg2+ concentration makes comparisons of the three 
structures partly unreliable. In the case of the 50 mM and 100 mM structures, non-
crystallographic symmetry restraints on the four subunits had to be imposed due to their 
poor observations-to-parameters ratio. A Mg2+ binding site is observed on the surface of the 
protein (carbonyl groups of residues R393, I395 and L398) (figure 4-22), with no apparent 
influence on conformation, as indicated by the low rmsd values between the three 
structures (table 4-7). Importantly, no conformational heterogeneities could be mapped. 
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Figure 4-22. Mg2+ binding site and residues involved in Mg2+ accommodation 
 
 
 
Table 4-7. Effect of Mg2+ on the conformation of FL WT StSPL (subunit A) 
 
STRUCTURE 1 STRUCTURE 2 RMSD (Å) ALIGNED C-ATOMS 
St_6 St_7 0.13 446 
 St_8 0.25 445 
St_7  0.24 450 
 
CO-CRYSTALLISATION WITH Sr2+ (STRUCTURE St_9) 
To identify other putative binding sites of divalent cations, FL WT StSPL was co-crystallised 
with Sr2+ and a dataset was collected. St_9 is a dimer containing PLP and phosphate ions in 
both subunits. Unfortunately, no divalent cation could be localized and no significant 
conformational change was observed compared to the native protein, as indicated by a rmsd 
value of 0.25 Å over 450 aligned C-atoms between structures St_1 (native FL WT StSPL) and 
St_9. Presumably, only smaller cations like Mg2+, Zn2+ and Ca2+ can bind to the protein (table 
4-8). 
 
Table 4-8. Pauling ionic radii of divalent cations 
 
ELEMENT ATOMIC RADIUS [pm](1)
Mg(II) 65 
Zn(II) 74 
Ca(II) 99 
Sr(II) 113 
Ba(II) 135 
 
(1) Values found on http://www.webelements.com from (183). 
 
4.6.5. SEMICARBAZIDE-INACTIVATED FL WT StSPL (STRUCTURE St_4) 
 
See part 3 (manuscript). 
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4.6.6. StSPL K311A IN COMPLEX WITH PE (STRUCTURE St_3) 
 
See part 3 (manuscript). 
 
S1P EXTERNAL ALDIMINE MODEL 
 
See part 3 (manuscript). 
 
Figure 4-23. Accommodation of S1P modelled in the active site of StSPL K311A (stereo view) 
 
 
 
Note: See part 3 (manuscript) Fig. 3B for details. 
 
4.6.7. StSPL INACTIVE MUTANT K311A: SOAKING WITH S1P (STRUCTURE St_10) 
 
St_10 is a tetramer containing one cofactor molecule and one phosphate ion per subunit. 
The interface area between two dimers spans approximately 696 Å2, while it spans 6313 and 
6160 Å2 between monomers A-B and C-D respectively. This mutant exhibits a significantly 
reduced tetramer-to-dimer peak ratio on SEC, confirming that the tetramer is in equilibrium 
with the dimer form (section 4.9.2. figure 4-38 green line). No significant positive electron 
density is found in the active site of St_10 (figure 4-24). Likewise, no significant 
conformational changes can be observed, as indicated by a rmsd value of 0.27 Å over 451 
aligned C-atoms between the chain A of structure St_1 (native FL WT StSPL) and St_10 and 
of 0.3 Å over 452 aligned C-atoms between the chain A of structure St_3 (StSPL K311A in 
complex with PE) and structure St_10. 
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Figure 4-24. Traces of S1P in the active sites of structure St_10 
 
 
 
Note: the 2FOFC map was contoured at 1σ and depicted in black. The FOFC map was 
contoured at 3σ and is coloured green for positive electron density and red for 
negative. The putative trace of S1P is surrounded by a dashed line. 
 
The active site is solvent-accessible, as shown in Fig. S1D in part 3 (manuscript). One single 
channel is observed in the structure, leading to the PLP. This channel might serve both for 
substrate entry and product exit; alternatively, the protein would have to undergo large 
conformational changes to build other defined compartments. Given the different physico-
chemical properties of the substrate and the reaction products (see section 1.4.3.) the 
second hypothesis would make sense. In this respect, the N-terminal part (highlighted in 
green in Fig. S1D), comprising Nt-FLEX (residues 1-57) and N-terminal domain (residues 58-
97), and Ct-EXT (residues 472 to 507, highlighted in blue in Fig. S1D) are the best candidates 
for compartmentalizing the reaction, as they are flexible (as seen in structure St_2 for Ct-
EXT) and already line the single channel observed. 
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4.6.8. DATA COLLECTION AND REFINEMENT STATISTICS 
 
Table 4-9. Data collection and refinement statistics for structures St_5-10. Refinement for 
these datasets was not brought to completion but only to the (advanced) level 
necessary to assess their significance in providing biochemical information. 
 
STRUCTURE CODE St_5 St_6 St_7 St_8 St_9 St_10 
SPACE GROUP C2221 C2221 C2221 C2221 P21 C2221 
UNIT CELL 
PARAMETER (Å/°) 
a = 59.4 
b = 244.9 
c = 282.3 
a = 59.6 
b = 243.9 
c = 283.2 
a = 57.8 
b = 245.8 
c = 283.1 
a = 61.3 
b = 246.1 
c = 282.1 
a = 72.1 
b = 85.0 
c = 84.6 
=111.0 
a = 59.3 
b = 243.1 
c = 281.3 
RESOLUTION 
RANGE(1) 
(Å) 
29.5-3.36 
(3.5-3.36) 
49.3-2.3 
(2.4-2.3) 
30-2.7 
(2.8-2.7) 
30-3.3 
(3.4-3.3) 
30.0-2.6 
(2.7-2.6) 
30.0-1.9 
(20.0-1.9) 
COMPLETENESS(1) 
(%) 
95.9 
(66.9) 
97.4
(95.9) 
96.4
(78.9) 
99.5
(99.8) 
99.7 
(100.0) 
97.7
(934) 
REDUNDANCY 4.2 3.0 3.3 3.5 5.3(2) 3.8 
UNIQUE 
REFLECTIONS 28831 172367 106691 61710 57 657 156574 
I/σ (1) 
(%) 
10.6 
(3.1) 
9.5
(1.9) 
9.8
(2.4) 
9.1
(1.5) 
7.6 
(3.8) 
7.2
(2.0) 
RSYM 
(1) 
(%) 
17.1  
(49.7) 
7.7 
(56.5) 
8.7 
(40.3) 
8.9
(82.7) 
21.8 
(43.3) (2) 
12.6
(47.5) 
No. OF REFLECTIONS 
(TEST) 
28812 
(1008) 
172344 
(2071) 
106679
(2132) 
61670
(1870) 
57657 
(2073) 
156569
(1566) 
No. OF ATOMS 13679 14339 13809 13805 6868 14 826 
RWORK 
(%) 22.1 21.4 20.9 25.4 20.8 20.7 
RFREE 
(%) 27.9 25.1 24.3 30.0 25.4 25.6 
RMSD BONDS 
(Å) 0.007 0.008 0.006 0.008 0.008 0.009 
RMSD ANGLES 
(°) 1.08 1.09 0.96 1.02 1.15 1.20 
RAMACHANDRAN 
PLOT 
REGIONS 
      
FAVOURED  
%) 99.5 97.6 96.8 94.0 96.8 97.4 
ALLOWED 
(%) 91.7 100 99.9 99.4 100 100 
NUMBER OF 
OUTLIERS  9 0 2 10 0 0 
 
(1) Into brackets: values for the outermost resolution shell. 
(2) Data processing with anomalous signal; the Friedel pairs were treated as different 
reflections in the calculation of absorption correction factors. 
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4.7. ACTIVITY ASSAY 
 
4.7.1. MONITORING OF UV-VIS SPECTRAL CHANGES (SPECTROPHOTOMETRIC ACTIVITY ASSAY) 
 
See part 3 (manuscript). 
 
As already pointed out in the introduction (section 1.4.3.), the poor solubility of S1P hinders 
precise biochemical investigations. The solubility of S1P was assayed in various solutions (as 
described in Materials & Methods (section 8.4.2.)) and the outcome is summarized in table 
4-10. S1P was partly insoluble above approximately 0.05 mg/ml in all solutions tested. This 
means that a pellet was still visible after spinning down the sample at the end of the 
solubilisation procedure. Unfortunately, spectroscopic changes on FL WT StSPL could not be 
detected at this concentration of substrate (data not shown). Despite the partial insolubility 
of S1P, solutions at higher concentrations were used, with the disadvantage of ignoring the 
precise concentration of S1P (only an upper bound for the concentration is known, value 
reported in Table 4-10). The amount of solubilised S1P was maximal when S1P was initially 
suspended to at least 1 mg/ml, as reflected by a more intense 403 nm- and 420 nm-peaks 
after addition of the solution to FL WT StSPL (data not shown). Slight variations in solubility 
were observed for S1P purchased from different companies and from different batches. 
 
Table 4-10. Influence of the S1P solubilisation procedure on the StSPL spectrophotometric 
activity assay outcome 
 
SOLUTION CMC S1P MAXIMAL CONC.(1) 
VOLUME 
ADDED 
(μl) (2) 
403 & 420 nm-PEAKS REMARK 
1 % Triton X-100 6x 1 70 Yes  
  2   REFERENCE figure 4-25 bottom right 
0.16 % Triton 
X-100 CMC 1 70 Yes  
  2    
0.1 % DDM 10x 2 70 Less intense than REF.  
0.25 % digitonin 10x 2 70 Very faint  
100 % DMSO  1 70 Yes but aggregation  
  2 7 No  
   70 Less intense than REF. & aggregation figure 4-25 bottom left 
100 % ethanol  1 30 Less intense than REF. & aggregation  
  2 10 No  
   15 Very faint  
   20 Less intense than REF.  
   30 Less intense than REF. & aggregation figure 4-25 upper panels 
   35 Yes but strong aggregation  
50 % 
ethanol/water  1 20 No  
   40   
4 mg/ml BSA  0.5 70 No  
  1 35   
   70   
 
(1) In mg/ml. 0.5, 1 and 2 mg/ml S1P correspond to 1.3, 2.6 and 5.2 mM respectively. 
(2) To 100 μl protein solution. 
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Interestingly, the aggregation observed upon addition of S1P solubilised in ethanol to SPL 
was less pronounced in a protein buffer lacking KPi (figure 4-25 upper left panel) than in 50 
mM (figure 4.25 upper right panel). This indicates that the solubility of S1P is prone to large 
variations and represents a bottle-neck in the study of SPL. 
 
Figure 4-25. Transient changes on FL WT StSPL induced by S1P solubilised in ethanol in the 
presence (left panel) or absence (right) of 50 mM KPi and by S1P solubilised in 
DMSO (bottom) 
 
 
 
Note: the reference (FL WT StSPL) is shown in the bottom right panel. 
 
Two approaches were used to validate the spectrophotometric activity assay. First, the assay 
was performed with the internal aldimine mutant K311A, a mutation known to inactivate 
PLP-dependent enzymes. When S1P was added to StSPL K311A under the same conditions as 
the WT, no spectral changes were observed (see part 3 (manuscript) Fig. 4B). This indicates 
that mixing an inactive protein with S1P does not result in the formation of peaks at 403 and 
420 nm. It must be mentioned that the test reflects changes occurring to the cofactor, 
changes that might be only indirectly linked to the cleavage of the substrate. Therefore, the 
absence of 403 nm and 420 nm-peaks does not necessarily correlate with enzyme inactivity. 
One can nevertheless safely assume that only an active protein can produce the 
characteristic transient peaks. 
Semicarbazide (see part 3, Fig. S5B), an inhibitor of PLP-dependent enzymes, was used to 
further validate the spectrophotometric activity assay. An equimolar amount, as well as 10-, 
25- or 100-fold molar excess, respectively, of semicarbazide was added to FL WT StSPL. 
Spectra were recorded and S1P was added to the mixture either immediately after the 
inhibitor or after one hour incubation at room temperature protected from light. The 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  105 
internal aldimine 425 nm-peak of native FL WT StSPL was progressively shifted towards 360 
nm (see part 3, Fig. S5C). When a 100-fold molar excess of semicarbazide over monomer was 
used, the equilibrium was reached after one hour. Semicarbazide is a carbonyl-reactive 
compound. The 360 nm-peak presumably corresponds to PLP-semicarbazone, a covalent 
complex between PLP and semicarbazide (see part 3, Fig. S5B) (184) (185). In structure St_4 
(see part 3, Fig. S5A) PLP-semicarbazone has left the active site and residue Y249 partly 
takes the place of the pyridinium ring of PLP. FL WT StSPL incubated 30 minutes at room 
temperature with semicarbazide showed minor spectral changes at 420 nm upon addition of 
S1P (see part 3, Fig. S5D and figure 4-26 left panel). When semicarbazide was added 
together with S1P to the enzyme, strong 403 nm- and 420 nm-peaks appeared (figure 4-26 
right panel), indicating that semicarbazide requires incubation to fully inhibit SPL. 
 
Figure 4-26. FL WT StSPL inactivation by semicarbazide 
 
 
 
Iodoacetamide, a sulfhydryl reagent (section 1.4.3. figure 1-19), was reported to inhibit the 
activity of mouse SPL (113). It was tested as inhibitor of FL WT StSPL at 100-fold molar excess 
over active site under the same conditions as semicarbazide. Incubation with iodoacetamide 
did not result in alterations of the visible spectrum of the protein and 403 nm- and 420 nm-
peaks appeared upon addition of substrate as for native FL WT STSPL (data not shown). 
Thus, iodoacetamide does not inhibit FL WT StSPL or it does it to a far lower extent than 
semicarbazide under the same experimental conditions; the compound may not be able to 
access its target site or cysteine residues may not strictly be required for the activity of 
StSPL. 
The sensitivity of SPL from rat liver microsomes to BSA concentrations higher than 25 μM, to 
non-ionic and zwitterionic detergents (DDM, OG, CHAPS, LDAO) and to divalent metal 
cations (Ca2+, Zn2+, Mg2+, Ni2+, Mn2+, Co2+, Fe2+, Cu2+) was reported in 1991 (113) (reviewed in 
(132)). In the same study, SPL activity was shown to be stimulated by chelators such as 
EDTA. This effect might also arise from the inhibition of sphingosine kinase (present in rat 
liver microsomes) and not only from the stimulation of SPL. To date, no further evidence of 
either the inhibitory effect of divalent cations or of the stimulating effect of chelators on SPL 
has been published. The inhibition of FL WT StSPL by some of those compounds was 
assayed. A 20-min incubation in a 3-fold molar excess of BSA over FL WT StSPL active sites 
results in less intense 403 nm- and 420 nm-peaks (data not shown) confirming the inhibition 
of the enzyme by BSA. The zwitterionic detergent LDAO significantly increased the relaxation 
time of the FL WT StSPL spectrum, i.e. the time until no spectral changes occur anymore, at 
least by a factor 10 (data not shown). LDAO most probably competes with S1P for binding 
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within the active site. A 100-fold molar excess of Mg2+, Sr2+, Ba2+, Ca2+ over FL WT StSPL 
active sites did not result in a significant inhibition (data not shown). The counter-ion of the 
divalent cation solutions used in the assay was chloride, as well as acetate for Ca2+ and Zn2+. 
THI (2-acetyl-4-tetrahydroxybutyl-imidazole), a compound present in the food colorant 
caramel colorant III was recently identified as an inhibitor of mouse thymic SPL (see section 
1.4.3. figure 1-20) (78). In the assay, mice thymus extracted after intravenous injection of 
THI was used as source of SPL and the cleavage of radioactive substrate was estimated on 
thin-layer chromatography (TLC). Importantly, THI was recently shown to be unable to 
inhibit mouse SPL using the same assay when the mice had no prior contact to THI before 
tissue extraction (186). Thus, THI is assumed to undergo chemical modifications to become a 
potent inhibitor of SPL, for example phosphorylation or acylation. THI was nevertheless 
tested for its ability to inhibit FL WT StSPL. The compound was purchased and solubilised in 
either water or ethanol 100 % to 10 mM. The compound was poorly soluble in these 
solvents, even at 1 mM. The test was carried out as the assay with semicarbazide, except 
that the precise molar excess of THI over active site was unknown due its incomplete 
solubility. The incubation time before addition of substrate was set to 3 h at room 
temperature. Under those conditions, no significant inhibition of FL WT StSPL was observed 
(data not shown). Preliminary crystallographic analysis of StSPL K311A indicates that THI can 
access the active site and sits close to PLP and the phosphate ion (data not shown). This 
indicates either that THI is specific to human SPL (unlikely) or that THI must be modified to 
inhibit StSPL. 
Fingolimod (FTY720) (140) and its phosphorylated form (P-FTY720), other inhibitors of 
human SPL, were assayed for their inhibition effect on FL WT StSPL in vitro using the above 
described spectrophotometric assay. Various solvents and detergent solutions were used, as 
described in Materials & Methods (section 8.4.4.). FTY720 and P-FTY720 behaved differently 
from S1P upon solubilisation. In all conditions tested, the addition of the FTY720 or P-FTY720 
solution to FL WT StSPL resulted in strong aggregation, and in some case precipitation of the 
compound or of the protein (data not shown). 
 
4.7.2. MASS SPECTROMETRY 
 
MS activity assay was performed on mutants which did not exhibit peaks at 403 and 420 nm 
upon addition of substrate (see part 3 (manuscript) Fig. S4). 
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4.7.3. OTHER APPROACHES 
 
Two further approaches were attempted to monitor the cleavage of S1P by FL WT StSPL. The 
first one involved the identification of the long-chain aldehyde product after derivatization 
with 2,4-dinitrophenylhydrazine (DNPH) using UV-Vis spectroscopy. Under the conditions 
tested, the control long-chain aldehydes hexenal (6C) and tridecenal (13C) produce a peak at 
378 nm, absent when they are replaced with S1P (figure 4-27). When a FL WT StSPL reaction 
mixture before and after two different lipid extraction protocols (see Materials & Methods 
section 8.11.2.) was analysed under the same conditions, the long-chain aldehyde product of 
the SPL cleavage could not be detected (data not shown). Importantly, the peak intensities 
of the internal positive controls, that is hexenal and tridecenal added to the SPL reaction 
mixture and subjected to lipid extraction, were significantly lower than those of the 
corresponding external positive controls. They were in particular much lower for tridecenal 
than for hexenal. This indicates that the lipid extraction procedures used might not be 
suitable to isolate sufficient amounts of the C16-aldehyde resulting from the cleavage of S1P 
by FL WT StSPL. A recent functional study of SPL carried out with a fluorescent substrate and 
mice microsomes as a source of SPL (131) suggests that the long-chain aldehyde is in 
equilibrium with its cognate alcohol and carboxylic acid (see section 1.4.3. figure 1-17, left). 
Altogether, this indicates that the detection of the long-chain aldehyde product of SPL by 
DNPH is not a promising approach. 
 
Figure 4-27. UV-Vis spectra of hexenal, tridecenal and S1P reacted with DNPH 
 
 
 
The second approach foresaw the identification of the uncleaved substrate (S1P), if any, and 
the soluble SPL product PE with naphthalene-2,3-dicarboxaldehyde (NDA). NDA is non-
fluorescent until it reacts with a primary amine (in S1P as well as in PE) in the presence of an 
excess of cyanide (see Materials & Methods section 8.11.3.). NDA-derivatized S1P and PE are 
then separated using a HPLC C18 reverse-phase chromatography column. Assay parameters 
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such as solvent or detergent for S1P (ethanol or Triton X-100), concentration of KPi in the 
reaction buffer, amount of NDA and cyanide, and incubation time at 50°C were optimized. 
The positive controls S1P and PE, theoretically set at the same concentration (corresponding 
to the maximal achievable concentration of S1P, see above), yielded signals of different 
intensities (figure 4-28). PE yields a 10-fold more intense signal than S1P when tested under 
the same experimental conditions. It is important to note that the PE reaction mixture was 
also supplemented with detergent. As a consequence, it appears that the effective S1P 
concentration is lower than the PE concentration or that the primary amine of S1P is less 
available for derivatization than that of PE. The latter effect might result from intermolecular 
interactions or interactions with the solvent or detergent. 
 
Figure 4-28. UV-Vis spectra of PE and S1P reacted with NDA 
 
 
 
HPLC separation of NDA-S1P and NDA-PE was nevertheless attempted. In good agreement 
with the spectrophotometric measurements, PE produced a much stronger signal than S1P. 
PE-NDA eluted with a main peak at 13.3 min, a 150-fold weaker peak at 19.9 min and a 
1000-fold weaker peak at 22.4 min (figure 4-29 upper left). The main elution peak of S1P-
NDA was found close to noise level at 22.4 min (figure 4-29 upper right). The reaction 
mixture of SPL and S1P (solubilised in 1 % Triton X-100) after 3 hours incubation at 37°C 
originated two peaks that were close to noise level, at the retention times specific for PE and 
S1P (figure 4-29 bottom). These were not present when SPL alone subjected to the 
derivatization procedure was eluted under the same conditions. This test indicates that FL 
WT StSPL is able to cleave S1P. The sensitivity of the test might be improved by detecting the 
NDA-derivatized species using fluorescence rather than UV-Vis absorption. 
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Figure 4-29. Elution profile of PE-NDA, S1P-NDA and FL WT StSPL reaction mix derivatized 
with NDA 
 
 
 
4.8. TRUNCATION STUDIES 
 
4.8.1. PREDICTION- AND STRUCTURE-BASED DESIGN OF CONSTRUCTS 
 
The first 60 residues of StSPL contain a strikingly high number of prolines (figure 4-30), 
suggesting a special structural or functional role. To test this hypothesis, N-terminal 
truncations were designed. 
 
Figure 4-30. N-terminal 60 residues of FL WT StSPL 
 
 
 
The first two N-terminal truncations were designed based on secondary structure prediction 
generated with the PSI-PRED server (187) (188) 
(http://bioinf.cs.ucl.ac.uk/psipred/psiform.html). The truncations started at residues P23 
and P39, respectively. They lacked the predicted unstructured region preceding the first 
predicted helix and all residues until around the middle of the first helix (figure 4-31), 
respectively. Those two truncations, named Δ1-22 and Δ1-38 respectively, were cloned into 
pQE60 (figure 4-32). 
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Figure 4-31. PSIPRED secondary structure prediction of FL WT StSPL 
 
 
 
The next truncations were designed based on the available structural information (see part 3 
(manuscript) Fig. S1A). The Nt-FLEX domain (residues 1-57) is not visible or corresponds to 
disordered or below-average density in the electron density maps of all StSPL structures 
determined so far, indicating that these residues are, depending on conditions, either 
disordered or more flexible than the residues following them. The PSIPRED prediction 
indicates that a long helix should span residues 25 to 56. All residues until the end of this 
predicted helix were truncated and the corresponding construct was named ΔNt-FLEX (Δ1-
57). The last two helices were removed in the construct named ΔCt-EXT (residues 1-471, that 
is Δ472-507) (see part 3 Fig. S1A, coloured blue). This stretch extends over the putative 
active site channel entry and gets in contact with the N-terminus of the protein (coloured 
green in Fig S1A and D part 3). These residues are conserved among members of the SPL 
family (see chapter 2.3. figure 2-5) and are absent in E. coli GadB. The last residue of GadB 
corresponds to residue 471 of StSPL FL WT. Truncations ΔNt-FLEX and ΔCt-EXT were cloned 
into pQE70 (figure 4-32). 
 
Figure 4-32. StSPL truncated variants cloned in pQE60 or pQE70 
 
 
 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  111 
4.8.2. EXPRESSION IN E. coli AND PURIFICATION 
 
The expression of pQE60 StSPL Δ1-22 and Δ1-38 was carried out according to the same 
protocol as FL WT StSPL (see Materials & Methods section 8.3.1. and part 3 (manuscript) SI 
Text). Neither truncation was expressed to a sufficient amount to be detected on a 
Coomassie-stained SDS-PAGE. Bands of StSPL Δ1-22 were hardly visible in the soluble 
fraction 4 h after induction using protein immuno-detection (figure 4-33). No signal is visible 
at all for StSPL Δ1-38. This indicates that both truncations are either not expressed or quickly 
degraded. It is difficult to determine whether this effect is due to the additional N-terminal 
residues MGGSRS (figure 4-32) that might destabilize the protein and promote its unfolding 
and subsequent degradation or is due to a crucial role that the residues 1-22 and 1-38 play in 
the folding and stability of StSPL. In light of the results showed thereafter on pQE70 StSPL 
ΔNt-FLEX, the first hypothesis seems more likely. 
 
Figure 4-33. Expression of pQE60 FL WT StSPL, Δ1-22 and Δ1-38 
 
 
 
Unlike StSPL Δ1-22 and Δ1-38 cloned in pQE60, StSPL ΔNt-FLEX and ΔCt-EXT cloned into 
pQE70 were expressed in equal or slightly higher amounts as FL WT StSPL and were stable 
upon purification using the previously described protocol (figure 4-34). The three proteins 
showed slightly different SEC elution profiles. The 4mer-to-2mer peak ratio of both 
truncations was strikingly lower than for the FL protein, despite the fact that higher protein 
concentrations of truncated SPL were loaded onto the column (figure 4-35). This is in accord 
with the fact that residues 1 to 57 and 472 to 507 are involved in the tetramer formation, as 
seen from structure of the StSPL tetramer (see section 4.6.3. figure 4-21). 
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Figure 4-34. IMAC purification of pQE70 StSPL ΔNt-FLEX, ΔCt-EXT and FL 
 
 
Figure 4-35. SEC purification of pQE70 StSPL ΔNt-FLEX, ΔCt-EXT and FL 
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4.8.3. UV-VIS SPECTRA 
 
StSPL ΔNt-FLEX and ΔCt-EXT produced altered visible absorption spectra compared to FL WT 
StSPL (figure 4-36). The spectrum of StSPL ΔNt-FLEX lacked the 345 nm small shoulder and 
StSPL ΔCt-EXT showed a broad peak at 345 nm with a shoulder at about 373 nm. Such 
differences observed in the latter SPL variant indicate that important changes occurred in 
the environment of the PLP (see section 4.4.1. figure 4-6). 
 
Figure 4-36. UV-Vis spectra of StSPL ΔNt-FLEX, ΔCt-EXT and FL WT StSPL 
 
 
 
4.8.4. SPECTROPHOTOMETRIC ACTIVITY ASSAY 
 
See part 3 (manuscript) Fig. S4A and B. 
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4.9.  MUTAGENESIS STUDIES 
 
4.9.1. STRUCTURE-BASED DESIGN OF MUTANTS 
 
StSPL mutants were designed with the aim to identify residues involved in activity, either in 
substrate polar head accommodation or in catalysis. Several sources were employed for the 
design. The structure of the PE-PLP complex and the derived model of S1P binding into the 
active site were used to localize residues presumably involved in substrate accommodation 
or close (within approximately 10 Å) to the bond to be cleaved (see part 3 (manuscript) Fig. 
3B and section 4.6.6. figure 4-23). The structure of the dimer of FL WT StSPL with 
conformational heterogeneities (structure St_2) was used to design mutations by identifying 
residues on stretches that were either disordered or more flexible in the cofactor-lacking 
subunit, like S101, A103 and Y105 (figure 4-37). Serine, lysine, histidine, cysteine and 
tyrosine residues can act as nucleophiles or be involved in proton transfers. Glycine, alanine 
and proline may be important to define the degree of flexibility of a loop. H129* (coming 
from the other subunit) was chosen because it is located close to the polar head of S1P and 
has a higher B-factor in the active site lacking the cofactor (see part 3). Tyrosine 249 (figure 
4-37) is seen to change conformation and partly replace the PLP in the structure of StSPL 
incubated with semicarbazide (structure St_4): it might also be involved in activity either in 
catalysis or in substrate accommodation, despite being replaced by phenylalanine in yeast 
and human SPLs (table 4-11). A recent mutagenesis analysis carried out on Dpl1p using an in 
vivo activity assay (112) showed that residues (StSPL numbering) C276, K311, K317 and Y482 
(figure 4-37) are involved in activity to various extents. C276 had already been reported to 
be critical for activity of human SPL (where it corresponds to C317) (61). Human SPL was 
shown to be nitrosylated on residues Y356 and Y366 (128), corresponding to Y314 and Y324, 
respectively, in StSPL. This modification, which may be specific to higher eukaryotic SPL, 
might indicate that those residues, despite being relatively far away from the active site, are 
involved in activity or in conformational changes. 
It should be mentioned that the present mutagenesis study was restricted to residues 
supposedly involved in catalysis or in the accommodation of the polar head of the substrate. 
Accommodation of the hydrophobic tail of the substrate was not addressed, since the 
structure of the protein with S1P was not known. The designed mutations, as well as the 
corresponding residues in yeast and human SPLs are listed in table 4-11. 
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Figure 4-37. Stereo view of WT StSPL active site showing the residues mutated in this study 
 
 
 
Table 4-11. FL StSPL mutagenesis studies (grey highlight) 
 
StSPL Mutation Putative role(s) Conservation Dpl1p HsSPL 
S101 S101A Active site loop conformation  Yes S170 S146 
A103 A103P Active site loop conformation No A172 T148 
Y105 Y105F Catalysis/ Substrate polar head accommodation Yes Y174 Y150 
N126  Substrate polar head accommodation Yes N195 N171 
L128  Substrate hydrophobic tail accommodation Yes L197 L173 
H129 H129A Substrate polar head accommodation / Catalysis Yes H198 H174 
P130  Substrate hydrophobic tail accommodation / Active site conformation Yes P199 P175 
H201  PLP pyridine ring stacking Yes H268 H242 
C276 C276A Catalysis/ PLP pyridine ring stacking Yes C344 C317 
Y249 Y249F Catalysis / Substrate accommodation No F317 F390 
H310  Cofactor binding Yes H379 H352 
K311 K311A Catalysis (internal aldimine) Yes K380 K353 
Y312  Active site conformation / Catalysis Yes Y381 Y354 
Y314 Y314F Active site conformation (nitrosilation in corresponding HsSPL residue) No 
F383 Y356 
K317 K317A Catalysis / Substrate polar head accommodation Yes K386 K359 
Y324 Y324F Protein conformation (nitrosilation in corresponding HsSPL residue) Yes Y393 Y366 
Y345  Substrate accommodation / Catalysis Yes Y414 Y386 
F346  Substrate hydrophobic tail accommodation No L413 I387 
Y482 Y482A/F Substrate accommodation / Regulation of activity and local conformation Yes 
Y554 Y526 
F500  Substrate hydrophobic tail accommodation Yes F573 F545 
L504  Substrate hydrophobic tail accommodation Yes L577 L549 
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4.9.2. EXPRESSION IN E. coli AND PURIFICATION 
 
FL SPL proteins carrying the desired mutation were cloned in pQE70, expressed in E. coli and 
purified according to the same protocol as WT StSPL (described in part 3 (manuscript) SI Text 
and in Materials & Methods section 8.3.1.). All mutants described below except A103P were 
expressed to a similar amount to that of WT StSPL. In comparison, the overall amount of 
StSPL A103P expressed was significantly lower. Purification of this mutant was nevertheless 
possible and the yield after SEC was similar to that of WT, as for all other mutants. The 
mutants A103P and K311A showed a significantly lower tetramer-to-dimer peak ratio on SEC 
than WT (figure 4-38 blue, green and black traces, respectively). 
 
Figure 4-38. SEC elution profile of StSPL WT, A103P and K311A 
 
 
 
4.9.3. UV-VIS SPECTRA 
 
All mutants except StSPL K311A (described in section 4.4.1.) and C276A exhibited a similar 
UV-Vis absorption spectrum as the WT. Compared to FL WT StSPL, C276A displayed a broad 
asymmetric peak at 335 nm and a lower peak at 425 nm (see part 3 (manuscript) Fig. 4A and 
E respectively). 
 
4.9.4. SPECTROPHOTOMETRIC ACTIVITY ASSAY 
 
StSPL mutants K311A, Y105F, Y482F, C276A, H129A, A103P, K317A and Y249F are described 
in part 3 (manuscript) Fig. 4, S5 and S6. 
 
StSPL mutants S101A, Y314F and Y324F behaved as WT StSPL upon addition of S1P (data not 
shown). StSPL S101A underwent spectral changes over time in the 380 nm region (figure 4-
39). Similar changes were also observed in the inactive mutants A103P and K317A and also 
in the nearly inactive H129A (part 3, Fig. S6). Since S101 and A103 are presumably involved 
in the accommodation of the polar head of S1P, the shift at 380 nm might be explained by an 
impaired positioning of the substrate resulting in changes in the cofactor environment. K317 
is at approximately 5 Å from the phosphate moiety, so it can shares with it a long-distance 
electrostatic interaction, and is likely involved in catalysis. StSPL Y482A behaved like Y482F 
(data not shown). 
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Figure 4-39. S1P-induced spectral changes of StSPL S101A 
 
 
 
Table 4-12. Summary of StSPL truncation and mutagenesis studies 
 
Variant Reference Native spectrum(1) 
403 &  
420 nm-
peaks(2) 
Relaxation 
time 
Back to native 
spectrum(3) ACTIVITY 
ΔNt-
FLEX 
Part 3 
Fig. S6A Similar to FL Yes 
Faster than 
FL Yes ACTIVE 
ΔCt-EXT Part 3 Fig. S6B 
Shoulders at 345 
& 373 nm & 
lower 425 nm-
peak 
Yes Slower than FL No 
PARTLY 
ACTIVE 
S101A Section 4.9.4. Similar to WT Yes Similar to WT No ACTIVE 
A103P Part 3 Fig. S6D Similar to WT No  No INACTIVE 
Y105F Part 3 Fig. 4 Similar to WT No   INACTIVE 
H129A Part 3 Fig. S6C Similar to WT Very faint  No 
PARTLY 
ACTIVE 
C276A Part 3 Fig. 4E 
Shoulder at 330 
nm & 
lower peak 425 
nm 
Yes Slower than WT No 
PARTLY 
ACTIVE 
Y249F Part 3 Fig. S5E Similar to WT Yes 
Similar to 
WT Yes ACTIVE 
K311A Part 3 Fig. 4B 
Shoulder at 330 
nm No   INACTIVE 
Y314F Section 4.9.4. Similar to WT Yes Similar to WT Yes ACTIVE 
K317A Part 3 Fig. S6E Similar to WT No  No INACTIVE 
Y324F Section 4.9.4. Similar to WT Yes Similar to WT Yes ACTIVE 
Y482F/A 
Part 3 
Fig. 4D & 
section 4.9.4. 
Similar to WT Yes Slower than WT Yes 
PARTLY 
ACTIVE 
 
(1) The spectrum of FL WT StSPL is taken as reference. 
(2) Upon addition of substrate. 
(3) Within the measurement time (usually 60 minutes). 
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4.10. DISCUSSION AND PERSPECTIVES 
 
4.10.1. EFFECT OF DIVALENT CATIONS 
 
The conformational heterogeneities observed between the subunits of structure St_2 might 
be explained by the presence of 100 mM MgCl2 in the crystallisation drop at plate setup. 
Crystals grew in one day following the appearance of the initial heavy precipitate (see 
section 4.5.1. figure 4-12). Those crystals could not be reproduced to date. Co-crystallisation 
trials were made in 100-fold molar excess of divalent cations over SPL active site that 
amounted to 10.7 mM divalent cations at plate setup. No bound cation was found and no 
significant conformational changes were observed in this structure (section 4.6.4. structure 
St_9) compared to the native enzyme (structure St_1). Soaking native crystals in solutions of 
increasing concentration of Mg2+ does not promote significant conformational changes (see 
section 4.6.4. structures St_6-8). Nevertheless, a decrease in resolution was observed with 
increased Mg2+ concentration in the soaking solution. This strongly suggests, but does not 
prove, that under the crystallisation conditions of St_6-8 binding of Mg2+ disturbs the crystal 
lattice. 
 
4.10.2. CONFORMATIONAL HETEROGENEITIES (STRUCTURE St_2) 
 
In structure St_2 (part 3 (manuscript) Fig. 2), a chloride ion is found in the active site instead 
of a phosphate ion in the other structures. The concentration of chloride in the drop at plate 
setup was 4 times higher (200 mM) than in the other structures that lack MgCl2 and was 8 
times higher than the phosphate concentration. Interestingly, chloride is found in the 
subunit containing PLP. 
A regulation mechanism of mammalian glutamate decarboxylases (GAD) activity rests on 
modulating the protein affinity towards PLP. One fraction of one isoform of GAD frequently 
lacks PLP and the ratio between the holo- and apo-forms varies upon stimulation depending 
on the tissue (189). Serine palmitoyl-transferase (SPT, see section 1.5.5.) shares this feature 
since one subunit of the heterodimer strictly required for activity lacks PLP. This confirms 
that the conformational heterogeneities observed in the subunit lacking PLP in structure 
St_2 correspond to regions involved in activity and that StSPL activity might be regulated by 
modulating the affinity towards PLP. 
 
4.10.3. PROPOSED REACTION MECHANISM 
 
Based on the outcome of the mutagenesis studies, a reaction mechanism for the hydrolysis 
of S1P by StSPL can be proposed (figure 4-40 and part 3 (manuscript) Fig. S7). The initial 
proton abstraction (figure 4-40 step III) may be carried out by residues K311, K317 or Y105, 
residues fulfilling both criteria of proximity to the proton on the C2 carbon atom of the 
substrate and of total inhibition upon mutation (mutant Y174F of Dpl1p, corresponding to 
StSPL Y105F, is however seen to be partly active). Mutant A103P is also fully inactive, 
confirming the role of residues 89 to 108 (see 4.6.2. and part 3 Fig. 2 and S6), which are 
disordered on the subunit lacking PLP of structure St_2. The quinonoid reprotonation step 
(step VI) could be carried out by residues C276, K311 or by a water molecule. Mutation of 
C276 does not inactivate the enzyme, but slows down the enzyme turn-over. The residue 
C276 is eclipsed behind PLP in the resting state but the active site might undergo moderate 
rearrangements upon catalysis (for instance, rotation of the cofactor). The C2-C3 bond to be 
cleaved is expected to be perpendicular to the cofactor ring and parallel to its  system, 
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according to Dunathan’s hypothesis (190). Mutating residue Y482 leads to a similar 
behaviour to that of the C276 mutant: given that Y482 is far from the cofactor and located in 
a region that is seen to undergo conformational asymmetry and disorder, it is tempting to 
speculate that this residue may involved in the regulation of enzymatic activity. Residue 
H129 is also very important for activity, even though the mutant H129A is not completely 
inactive in the spectrophotometric activity test. H129 is likely responsible for the 
accommodation of the phosphate head of the substrate (section 4.9.1. figure 4-38). 
 
Figure 4-40. Proposed mechanism for the cleavage of S1P by StSPL 
 
 
 
Further investigation of the role of other conserved residues among SPL, like N126, P130, 
H201, H310, Y312 and Y345 (see table 4-11 and figure 4-41) may provide additional 
information on the reaction mechanism. 
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Figure 4-41. Additional residues of StSPL putatively involved in activity 
 
 
 
Kinetics data aimed at determining the dissociation constant KM and the maximal enzymatic 
rate vmax are a prerequisite to validate the proposed reaction mechanism. To this purpose, a 
recently described fluorogenic substrate may be of interest (figure 4-42) (142). 
 
Figure 4-42. SPL activity assay using a fluorogenic substrate 
 
 
 
To discriminate between residues involved in substrate accommodation or in catalysis a S1P 
binding assay of StSPL WT and mutants may be performed using surface plasmon resonance 
(SPR) and isothermal titration calorimetry (ITC) (191). In all cases, optimized S1P 
solubilisation conditions are needed and SPL must be stable under those conditions. Circular 
dichroism (CD) may be a valuable technique to assess SPL folding and aggregation state 
under various conditions (192). 
The precise binding mode of S1P within the active site must be precisely known to validate 
and extend the proposed mechanism. Large conformational changes upon substrate binding 
are likely to happen given the hydrophobicity of the substrate and the cytoplasmic 
localisation of the active site of SPL. Assuming that these conformational changes do not 
prevent crystallisation and diffraction to high resolution, co-crystallisation seems to be the 
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method of choice since the addition of the substrate solution to a crystal may disturb its 
lattice, thus leading to poor resolution in diffraction experiments. Several other approaches 
may be considered. Another mutant instead of K311A may be used for co-crystallisation 
experiments, like Y105F. A shorter, non-natural compound can be used instead of S1P (18C). 
Such a substrate is to date not commercially available. It should be kept in mind that the 
binding mode of a less hydrophobic substrate analogue might not reflect all the 
conformational changes undergone by the enzyme to accommodate the natural substrate. 
Last but not least, the excess of S1P over active sites of SPL must be increased. At the 
maximal theoretical concentration of S1P (5 mM), the highest molar excess used in co-
crystallisation experiments was 20-fold, whereas it reached 100-fold in the 
spectrophotometric activity assay (where the protein concentration was set to 1.2 mg/ml 
before addition of 70 μl of S1P and reached 0.7 mg/ml after). Since the protein does not 
crystallise below a concentration of approximately 5 mg/ml (after dilution with well 
solution), the solubility of S1P must be improved to reach the desired molar excess. 
Neutralizing the negative charges of the polar head of S1P by addition of acid significantly 
increases the solubility of S1P in organic solvent (to at least 20 mM in acidic DMSO). The 
drawback is that the absence of negative charges in the polar head might prevent the 
(correct) substrate accommodation within the active site, especially in light of the fact that 
positively charged residues like K317 and H129 are very likely to bind the polar head of S1P 
(see above). Moreover, SPL might unfold in acidic conditions or at least loose some activity. 
Detergents, with the exception of Triton X-100, seem to inhibit the enzyme. Organic solvents 
may destabilize SPL (SPL precipitates in concentrations of ethanol higher than 15%) and 
might bind S1P too strongly, restricting the access of SPL to the substrate. Reconstituting S1P 
into cholesterol and phospholipid liposomes may mimic natural conditions and offers an 
alternative to organic solvents and detergents. 
Another approach is to add the complex PLP-S1P to an apo- StSPL inactive mutant (that is an 
enzyme lacking PLP). This approach was successfully used for the reported recently structure 
determination of LL-diaminopimelate aminotransferase (LL-DAP-AT) in complex with its 
substrate (193). Since PLP spontaneously forms a Schiff base with primary amines, as is the 
case with Tris (data not shown), a Schiff base between PLP and S1P is assumed to be formed 
similarly. The complex PLP-S1P is more hydrophilic than S1P and might allow reducing the 
amount of detergent or solvent required for its solubilisation. On the other hand, SPL might 
not be able to accommodate the bulkier and more hydrophilic complex, at least not via the 
same channel as S1P. Such a problem is not very likely to arise in light of the behaviour of 
the PLP-semicarbazide adduct, which is seen to be able to quantititatively leave the active 
site. 
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4.10.4. HOMOTETRAMER INTERFACE 
 
The tetramer-dimer equilibrium of StSPL naturally lends itself to mutagenesis studies. 
Mutating residues involved in the dimer-to-dimer contacts might disrupt the tetramer. This 
is rather tedious work given the number of involved residues and can lead to enzyme 
inactivation (see section 4.6.3 structure St_5). 
Both the N- and the C- terminal truncations lacking residues 1 to 57 and 472 to 507 (ΔNt-
FLEX and ΔCt-EXT), respectively, have a significantly lower tetramer content compared to FL 
WT StSPL (see section 4.8.2 figure 4-35). Since StSPL ΔNt-FLEX is active whereas the activity 
of StSPL ΔCt-EXT is impaired, StSPL ΔNt-FLEX might be screened for a C-terminal truncation 
still producing an active dimer. 
Varying the salt concentration and the surface net charges at different pHs might affect the 
relatively small interface (approximately 600 Å2). Therefore, pH, ionic strength and salt 
content of the SEC buffer can be screened to monitor any changes in the tetramer-to-dimer 
peak ratio. 
 
4.10.5. DISORDERED N-TERMINUS 
 
The first 60 residues of StSPL (see section 4.8.1. figure 4-30) possess a high content of 
prolines and is conformationally disordered in the electron density maps examined to date. 
Amphipathic proline-rich peptides are known to penetrate lipid bilayers (recently reviewed 
in (194)) and to be involved in protein binding events, especially to SH3 domains of proteins 
(195) (196). 
Intrinsically disordered regions, also called natively unfolded regions, are often involved in 
protein or lipid interactions (197). The N- and C-termini of the tumour suppressor p53 are 
intrinsically disordered (198). Its N-terminal disordered region contains a proline-rich repeat 
(PRR) which seems to be preferentially projected away from the core domain. Deletion of 
the PRR of the p53-related protein p63 abolishes its transactivation potential (199). 
Surprisingly, StSPL ΔNt-FLEX seems to be more active in vitro than WT StSPL (see part 3 
(manuscript) Fig. S6A). This might support the hypothesis that the N-terminal stretch 
interacts with the membrane, either to position the protein for cleavage of S1P still 
embedded within the membrane or to extract the substrate from the bilayer. Such a 
mechanism is not required in vitro, since the substrate is solubilised in detergent or in 
organic solvent. 
Additionally, Nt-FLEX might wrap onto Ct-EXT to close the active site (see part 3, Fig. S1D). 
The lack of the active gate might facilitate access to the active site and increase the cleavage 
turn-over compared to WT StSPL. Small-angle X-ray scattering (SAXS) might be of interest to 
unravel the behaviour of StSPL Nt-FLEX. 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  123 
4.10.6. SUBSTRATE ACCOMMODATION 
 
SPL might bind its substrate by interacting with the membrane similarly to peripheral 
membrane proteins (which do not span the membrane, unlike integral membrane proteins). 
Phospholipases, protein kinases C, lipid kinases and lipid phosphatases translocate to and 
interact with cellular membranes upon stimulation (191) (200) and their activity depends on 
their affinity to the membrane. E. coli pyruvate oxidase (EcPOX) undergoes conformational 
changes upon binding of pyuvate that trigger membrane association most presumably 
according to mode II on figure 4-43 (201). Recently, a report on the structure of Aquifex 
aeolicus sulphide:quinone oxidoreductase (SQR) and its putative membrane insertion 
mechanism was published (202). A helix-turn-helix motif penetrates into the membrane 
according to mode II to access the hydrophobic substrate quinone. Similarly, carnitine 
palmitoyltransferase 2 (CPT2) associates with the membrane (203) via a helix turn-helix 
motif composed of hydrophobic (tryptophan, phenylalanine, valine and leucine) and basic 
residues (lysine and arginine). In StSPL the first stretch of 60 residues (see section 4.8.1. 
figure 4-30) is indeed rich in proline and arginine, which might directly interact with S1P in 
the membrane while stabilizing the interaction by binding to the polar heads of 
phospholipids (mode III). Bacillus subtilis sphingomyelinase is assumed to interact with the 
membrane via a β-hairpin that might transport the substrate within the active site (mode II) 
(see section 1.5.1.). 
 
Figure 4-43. Various modes of protein-membrane interaction 
 
 
 
Once in contact with S1P still embedded into the membrane, SPL might cleave it or extract 
and accommodate it into the active site. This latter option might be possible since CERT (see 
section 1.5.3., ceramide transport protein) and GLTP (see section 1.5.4. glycolipid transfer 
protein) are able to extract sphingolipids from their natural environment. Alternatively, 
StSPL might interact with an S1P carrier similar to CERT and GLTP and able to deliver S1P to 
SPL. 
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5. RESULTS & DISCUSSION Saccharomyces cerevisiæ Dpl1p (Dpl1p) 
 
5.1. HOMOLOGY MODEL-BASED TRUNCATIONS DESIGN 
 
Unlike StSPL, Dpl1p possesses a predicted transmembrane helix spanning residues 58 to 81 
(figure 5-1). Compared to E. coli GadB, both SPLs have a C-terminal extension (the Ct-EXT 
domain) corresponding to residue 542-589 in Dpl1p (see part 3 (manuscript) Fig. S1A and B). 
 
Figure 5-1. GadB, Dpl1p, and StSPL topology 
 
 
 
A preliminary homology model of Dpl1p was generated based on the structure of GadB and 
sequence analysis of the 1-145 region of Dpl1p. The program COILS 
(http://www.ch.embnet.org/software/COILS_form.html) (204) predicted a coiled-coil region 
for residues 106-135. An open question about this initial model is that a hexameric 
arrangement like in GadB implies the presence of two coiled-coil regions, followed by 
transmembrane and lumenal domains, departing axially from the hexamer in opposite 
directions (figure 5-2 left): thus, the protein would have two transmembrane domains, one 
of which should be either unfolded or maybe binding to an unknown “shielding” protein 
with a hydrophobic surface. Such assumptions are of course not necessary for a dimeric 
arrangement (figure 5-2 right). 
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Figure 5-2. Dpl1p predicted homology-model based topologies 
 
 
 
This initial model of Dpl1p served to design soluble truncations to avoid using detergents in 
protein production and in crystallisation trials and to remove predicted floppy stretches that 
could hinder crystallisation. All truncations designed and expressed in pET28a+ are listed in 
table 5-1. The additional residues resulting from cloning are shown in figure 5-3. 
 
Table 5-1. Dpl1p truncations 
 
TRUNCATION STARTING / 
ENDING RESIDUE 
FEATURES 
Δ1-81 V82 / K589 Longest soluble construct 
Δ1-102 S103 / K589 Start in the linker / spacer region 
Δ1-116 V117 / K589  
Δ1-123 E124 / K589  
Δ1-133 N134 / K589  
Δ1-144 Q145 / K589 Core of the protein 
Δ1-116:ΔCt-EXT V117 / S541 Truncation of Ct-EXT 
Δ1-133:ΔCt-EXT N134 / S541  
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Figure 5-3. Additional residues of Dpl1p truncations cloned into pET28a+ 
 
 
 
Note: constructs Δ1-81 and Δ1-116 have no additional G at their N-terminus. 
 
5.2. EXPRESSION IN E. coli 
 
The expression conditions were optimized for construct Dpl1p Δ1-116 as described in 
Materials & Methods section 8.3.2. and in part 3 (manuscript) SI Text: the resulting 
optimized conditions are summarized in table 5-2. Noteworthy, adding 10 mM glucose in the 
culture medium is a prerequisite for protein expression. Bacteria grown in a medium lacking 
glucose did not express the protein at all (data not shown). Supplementing the medium with 
100 mM glucose reduced the protein expression level. Protein production was monitored by 
10 % SDS-PAGE and anti-His tag protein immuno-detection (Western blot). The constructs 
displayed various expression patterns. 
 
Table 5-2. Optimized expression conditions for Dpl1p truncations 
 
Expression system pET 
E. coli strain HMS174(DE3) 
Medium composition LB (10 g tryptone, 5 g yeast extract, 10 g NaCl) 
0.1 g/l pyridoxine 
10 mM glucose 
Appropriate antibiotics 
Starting OD600 nm (500 ml medium) 0.02 
OD600 nm at induction 0.8 
IPTG concentration 0.1 mM 
Chemicals added at induction 0.1 g/l pyridoxine 
Temperature 30°C 
Expression duration 24 hours 
 
Dpl1p Δ1-81 was not expressed in sufficient amounts to be visible on Coomassie-stained 
SDS-PAGE. N-terminal degradation was observed on anti-His tag immuno-blot 30 min after 
induction of expression in both HMS174(DE3) and BL-21(DE3), a protease-deficient strain 
(figure 5-4 lanes 3, 4 and 6). The overall expression level in BL-21 was significantly lower 
than in HMS174. Dpl1p Δ1-81 was IMAC-purified from 2 L culture harvested 30 min after 
induction, with the aim of determining the starting residue of the degradation products by 
N-terminal sequencing. Only band B (figure 5-4) provided unambiguous signals 
corresponding to truncations Δ1-132 and Δ1-133 (data not shown). The estimated purity of 
the sample after IMAC was lower than 5 % and the yield of the Dpl1p-derived bands (A, B, C) 
lower than 0.05 mg per litre culture. Interestingly, truncation Δ1-81 expressed in yeast also 
seemed to undergo degradation, suggesting that this protein variant is intrinsically instable 
(see section 5.3.1.). 
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Figure 5-4. Soluble expression of Dpl1p Δ1-81 in E. coli HMS174(DE3) and BL-21(DE3) 
 
 
 
Dpl1p Δ1-133 was likewise expressed in E. coli. No sharp band corresponding to this 
truncation was visible on Coomassie-stained SDS-PAGE, suggesting either a low expression 
level or some degradation after expression. Since the construct did not undergo visible 
degradation on immuno-blot (data not shown), the construct was purified and used for 
crystallisation trials (see section 5.3.3.). Truncation Δ1-116 was the first construct initially 
designed based on the homology model of Dpl1p (figure 5-2). It turned out to be highly 
expressed in E. coli (figure 5-5) and stable upon purification (see section 5.3.2.). 
 
Figure 5-5. Expression of Dpl1p Δ1-116 in E. coli 
 
 
 
Note: the expression test shown was carried out with BL-21(DE3), but similar results were 
obtained with HMS174(DE3). 
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Interestingly, Δ1-116:ΔCt-EXT and Δ1-133:ΔCt-EXT were both expressed to a similar amount 
as Δ1-116, indicating that the last 45 residues might destabilize the truncation Δ1-133 when 
containing the Ct-EXT domain. Dpl1p Δ1-123 was designed with the aim of working with a 
construct as highly expressed as Δ1-116 and lacking any floppy stretches that might prevent 
crystallisation. Unfortunately, this construct was expressed similarly to Δ1-133 (data not 
shown). Dpl1p Δ1-144 was designed to be free from flexible loops which could prevent 
crystallisation. Unfortunately, the construct did not yield any signal in the soluble fraction on 
immuno-blot and only a faint signal in the insoluble fraction (data not shown). Dpl1p Δ1-102 
was the last truncation designed based on the homology model and on the above presented 
results. The amount of Dpl1p Δ1-102 in the soluble fraction is similar to that of Δ1-116 (table 
5-3). Interestingly, a significantly lower amount of protein is found in the insoluble fraction 
of Δ1-102 compared to Δ1-116 (data not shown). 
 
Table 5-3. Overview of the expression in E. coli, purification and crystallisation outcome for 
Dpl1p truncations 
 
TRUNCATION SOLUBLE 
EXPRESSION(1) 
MAXIMAL YIELD 
[mg per L culture] 
CRYSTALS STRUCTURE 
Δ1-81 Low & 
Proteolysis 
< 0.05 
after IMAC 
  
Δ1-102 High 4 
after SEC 
Yes Yes(2) 
Δ1-116 High 5 
after SEC 
Spherulites No 
Δ1-123 Medium    
Δ1-133  0.3  
after SEC 
Tiny crystals &  
spherulites 
No 
Δ1-144 No    
Δ1-116:ΔCt-EXT High 1 
after SEC 
No  
Δ1-133:ΔCt-EXT   No  
 
(1) Low expression means that no signal was seen on SDS-PAGE (protein was detected only 
using immuno-detection); High expression means that a clear intense band was seen; 
Medium expression means that a faint band was seen. 
(2) The structure is presented in chapter 5.7. 
 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  129 
5.3. PURIFICATION AND CRYSTALLISATION 
 
5.3.1. Dpl1p FL AND Δ1-81 EXPRESSED IN S. cerevisiæ 
 
Full-length Dpl1p (called thereafter FL Dpl1p) and Δ1-81 fused to a C-terminal FLAG tag 
(figure 5-6) were expressed in S. cerevisiæ and purified using affinity chromatography or ion-
exchange chromatography by the laboratory of Prof. Howard Riezman in the University of 
Geneva (Switzerland). The elution fraction was then mailed to Zurich (on ice) and subjected 
to SEC prior to biophysical characterization and crystallisation trials. 
 
Figure 5-6. Dpl1p FL and Δ1-81 constructs expressed in yeast 
 
 
 
FL Dpl1p originated two close bands on Coomassie-stained SDS-PAGE in the range of the 
expected MW (67 kDa). The upper band disappeared after EndoH treatment, indicating that 
it corresponds to a glycosylated form of FL Dpl1p (data not shown). Several purification 
conditions were tested (table 5-4). 
 
Table 5-4. Dpl1p FL purification trials 
 
TRIAL CULTURE 
[L] 
DETERGENT PURIFICATION CONCENTRATION(1) SEC 
BUFFER 
YIELD(2) 
[mg] 
FURTHER 
EXPERIMENT 
1 15 DDM ION-
EXCHANGE 
(Tris buffer) 
NO KPi 0.025 MS & Nterm. 
sequencing 
2 5 Digitonin AFFINITY
(Tris buffer) 
No HEPES 0.025 MS 
3 15 DDM AFFINITY
(HEPES buffer) 
YES HEPES 0.05 Crystallisation
4 20 DDM AFFINITY
(HEPES buffer) 
YES HEPES 0.08 AUC 
 
(1) Performed in Zurich before SEC. 
(2) Of protein of the 9 ml-shoulder (see figure 5-7). 
 
SEC was performed under the same conditions as described for StSPL in Materials & 
Methods (section 8.3.1.) and in part 3 (manuscript) SI Text, using a Superdex-200 10/300 
column. Buffer composition was screened with the aim of increasing the yield of protein 
after SEC (table 5-5). 
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Table 5-5. Dpl1p FL and Δ1-81 SEC buffers composition 
 
FL Trial 1 FL Trial 2 FL Trial 3 FL Trial 4 Δ1-81 
50 mM KPi pH 7.2 50 mM HEPES pH 7.5    
100 mM NaCl   150 mM NaCl  
1 mM EDTA  0.25 mM EDTA 5 mM EDTA  
1 mM AET 1 mM TCEP  1 mM DTT  
10 μM PLP     
0.05 % (w/v) 
DDM(1) 
0.05 % (w/v) 
digitonin(2) 
0.05 % (w/v) 
DDM(1) 
  
 
(1) Corresponding to 5-fold CMC. 
(2) Corresponding to 2-fold CMC. 
 
The SEC elution profiles of trials 1 and 2 showed a main high MW peak eluting in the column 
void volume and a broad peak eluting at 9 ml (figure 5-7, grey and blue lines, respectively). 
The profile of the non-concentrated sample of trial 3 is similar to that of trial 1 (not shown). 
After concentration, an additional broad peak eluting at 11 ml appeared (figure 5-7, green 
line). The same behaviour was observed for trial 4 (not shown). When the 9-9.5 ml fraction 
of trial 2 was immediately reloaded onto the column without concentration, it produced a 
peak eluting also at 9 ml (data not shown), meaning that the higher-MW species was stable 
at 4°C without concentration, at least for a couple of hours. The fractions were analysed by 
SDS-PAGE (data not shown) and all peaks contained the characteristic pair of bands of FL 
Dpl1p. Based on a calibration run, the 9 ml and 11 ml peaks would correspond to species of 
350 and 200 kDa respectively. Since the constitutive unit of PLP-dependent enzymes is a 
dimer, it is unlikely that the 11 ml peak corresponds to a trimer: rather the two peaks may 
correspond to a tetramer and a dimer, respectively, assuming a significant detergent 
contribution to the apparent MW. The slight variations in the elution profiles observed in 
various detergents could also arise from expression level and sample manipulation. 
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Figure 5-7. SEC in DDM or digitonin of FL Dpl1p expressed in yeast 
 
 
 
Note: the profiles were normalized to 1 mAU at their highest peak. The intensity of the 9 ml-
peak of all trials was comprised between 5 and 50 mAU. 
 
The yield was in all attempts below 0.1 mg of pure protein after SEC for 20 L culture in 
fermentor and did not vary significantly upon changing the buffer composition of the first 
purification step, the detergent used and the composition of the SEC buffer. This indicates 
that expression level is the limiting factor or that the protein is not stable upon purification. 
FL Dpl1p was nevertheless further characterized. 
The identity of the protein from trial 2 was confirmed by mass spectrometry. Two peaks at 
67157 Da and at 68862 Da were visible, most likely corresponding to the FLAG tagged 
protein (expected MW of 67161 Da) and its glycosylated form, respectively. The sample 
before SEC and the SEC 9-ml peak fractions of attempt 3 were subjected to crystallisation 
trials using a nanodrop crystallisation robot at 20°C and a commercial screen (Clear Strategy 
screen I & II pH 7.5 & 8.5, Molecular Dimensions Limited). Protein-to-well solution ratios of 
3:1, 1:1, 1:3, for a total volume of 200 nl, were tested. Due to the low yield after SEC, the 
sample could not be concentrated to more than 0.5 mg/ml. No precipitate was visible on the 
plate (data not shown), even after plate equilibration (normally occurring after 
approximately two weeks). 
The SEC fractions of attempt 4 were subjected to AUC with the aim of determining the 
oligomeric state of the protein from each SEC peak. Unfortunately, no monodisperse species 
could be detected (data not shown). 
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Dpl1p Δ1-81 was similarly expressed in yeast, where the construct underwent degradation, 
as in E. coli (see chapter 5.2. figure 5-4). The first SEC peak eluting with the column void 
volume mainly contained the expected protein (MW of 57.6 Da) as seen on SDS-PAGE (band 
B) (figure 5-8). A second broad peak eluting at 11 ml was a mixture of a 75-80 kDa species 
(band A) and a 50-55 kDa species (band C). 
 
Figure 5-8. SEC of Dpl1p Δ1-81 expressed in yeast 
 
 
 
Note: the calibration curve was normalized to 140 mAU at its highest peak (230 kDa). 
 
The fractions of the two main peaks (figure 5-8 blue and green stars respectively) and the 
13-14 ml-shoulder (yellow stars) were pooled and analysed by N-terminal sequencing and 
MS. Unexpectedly, a single MS peak at 69580 Da was found in all samples (data not shown). 
This most likely arise from wrong sample manipulation, since N-terminal sequencing of the 
samples in solution clearly identified Dpl1p Δ1-81 in the void volume peak (blue code) while 
the other samples (green and yellow stars) were too heterogeneous to give a clear sequence 
(data not shown). When bands A, B and C were sequenced after transfer onto PVDF 
membrane, Dpl1p Δ1-81 was only detected in band B, while bands A and C were too 
heterogeneous to be sequenced (data not shown). 
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5.3.2. Dpl1p Δ1-116 EXPRESSED IN E. coli 
 
Like for StSPL, the purification of Dpl1p truncations expressed in E. coli was performed with 
IMAC and SEC (see Materials & Methods section 8.3.1. and part 3 (manuscript) SI Text). The 
protein eluted in SEC as a main sharp peak at 13 ml corresponding to an estimated MW of 
110 kDa (figure 5-9 solid line), based on column calibration with protein standards. Since the 
monomer of the construct has a MW of 53 kDa, this peak corresponded to a dimer. The 
average yield after SEC was in the range of 5 mg per L culture. 
 
Figure 5-9. SEC elution profile and Coomassie-stained SDS-PAGE of Dpl1p Δ1-116 
 
 
 
Note: the SEC buffer contained 50 mM HEPES-NaOH pH 7.5 instead of KPi. 
 
The identity of the main band was confirmed by protein immuno-detection (not shown). The 
oligomeric state was further analysed by AUC (not shown), which unambiguously confirmed 
that the construct is a dimer (measured MW of 100 kDa). N-terminal sequencing indicated 
that Met1 had been cleaved off. Pooled fractions stored for five days at 4°C without 
concentration were subjected again to SEC and displayed a single peak eluting at 13 ml 
(figure 5-9 dashed line) Since faint bands were still present on SDS-PAGE after SEC, the 
integrity of the protein stored one month at 4°C was checked using N-terminal sequencing 
and MS. The analysis provided similar results to those after SEC (data not shown), indicating 
that the protein is stable and not degraded when stored for up to one month at 4°C. The UV-
Vis spectrum was similar to that of Dpl1p Δ1-102 (see chapter 5.6.). 
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Despite extensive screening for crystallisation conditions, the construct only yielded 
spherulites (not shown). Importantly, when the SEC buffer contained HEPES instead of KPi, 
no changes were observed in the purification outcome, but the protein did not yield any 
spherulites. This suggests that phosphate ions might influence and perhaps stabilize the 
conformation of the protein. 
 
5.3.3. Dpl1p Δ1-133 EXPRESSED IN E. coli 
 
The MW of a monomer of Dpl1p Δ1-133 is 50.9 kDa. The protein eluted as a broad tailed 
peak at 13.2 ml (figure 5-10), also corresponding to a dimer. The prominent peak at 8 ml 
corresponded to high MW contaminants and did not show any signal on immuno-blot (figure 
5-10 inset, lower picture). The yield after SEC was in the range of 0.3 mg per L culture. 
 
Figure 5-10. SEC elution profile, Coomassie-stained SDS-PAGE and anti-His tag immuno-
detection of Dpl1p Δ1-133 
 
 
 
The pooled fractions after SEC were subjected to MS. Unlike Δ1-116, two peaks were found, 
one at the expected molecular mass and another at 25.1 kDa (data not shown), suggesting 
either that the sample was not pure or that Dpl1p Δ1-133 had undergone degradation. 
Indeed, compared to Δ1-116, the construct was prone to precipitation upon concentration, 
suggesting that this construct might expose hydrophobic patches that destabilize the 
protein. The UV-Vis spectrum was similar to that of Dpl1p Δ1-102 (see chapter 5.6.). 
Spherulites and tiny needle-like crystals were found in the crystallisation drops (not shown). 
Those crystals were tested at the SLS but exhibited no diffraction. 
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5.3.4. Dpl1p Δ1-116:ΔCt-EXT AND Δ1-133:ΔCt-EXT EXPRESSED IN E. coli 
 
Truncations of Ct-EXT (residues 542-589) combined with the two N-terminal truncations Δ1-
116 and Δ1-133 were expressed and purified under the same conditions as described. 
Surprisingly the construct Δ1-133:ΔCt-EXT, unlike Δ1-133, was expressed at a similar amount 
to Δ1-116:ΔCt-EXT and Δ1-116 (data not shown). The SEC elution profile of Dpl1p Δ1-
116:ΔCt-EXT was similar to that of Δ1-116 except that the main peak was broader (data not 
shown). The SEC elution profile of Dpl1p Δ1-133:ΔCt-EXT was similar to that of Δ1-133 (data 
not shown). The yield after SEC of both constructs amounted to 1 mg per L culture, i.e. about 
5-fold lower than Dpl1p Δ1-116. This is most likely due to an impaired protein stability upon 
purification. 
Neither crystals nor spherulites appeared in a preliminary crystallisation screen. 
 
5.3.5. Dpl1p Δ1-102 EXPRESSED IN E. coli 
 
Dpl1p Δ1-102 yielded the same amount of protein as Δ1-116 using IMAC and SEC as 
purification steps. The estimated protein purity after IMAC is around 95 % (figure 5-11, lane 
7). 
 
Figure 5-11. Dpl1p Δ1-102 IMAC purification 
 
 
 
The protein (MW of 54.5 kDa) elutes from SEC as a single peak at 13 ml with a faint shoulder 
on the right (figure 5-12). When a new SEC column was used and higher sample 
concentration was loaded, two defined peaks (called thereafter peak 1 and peak 2) eluted at 
12.9 and 13.1 ml, respectively (data not shown). The elution volumes corresponded to a MW 
of about 110 kDa. This value was confirmed by AUC (data not shown), indicating that Δ1-102 
was present as a dimer in solution at the concentration tested. Like Δ1-116, the pooled 
fractions of both peaks of Δ1-102 stored for one month at 4°C eluted as a single sharp peak 
at the same elution volume as just after IMAC (data not shown). This confirmed the stability 
of both SEC peaks of Δ1-102 upon storage at 4°C. Fractions corresponding to peak 1 and 
peak 2 were analysed by MS and N-terminal sequencing. The MWs and N-terminal 
sequences of both peaks were identical and were in good agreement with the expected 
mass and sequence. Like all constructs expressed and analysed so far, Δ1-102 lacked Met1. 
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Figure 5-12. Dpl1p Δ1-102 SEC purification 
 
 
 
Note: the concentration of the sample loaded was about 30 mg/ml. 
 
The yield after SEC was double in KPi than in HEPES buffer and less prone to precipitation 
upon concentration. This suggests a stabilizing role of the phosphate ion on Dpl1p Δ1-102. 
 
5.4. CRYSTALLISATION AND DATA COLLECTION OF Dpl1p Δ1-102 
 
See part 3 (manuscript) table S2. 
 
Crystallisation trials were carried out at 20°C and 4°C with protein exclusively in KPi buffer. 
The crystals presented here were obtained at 20°C. Both SEC peaks 1 and 2 were subjected 
to crystallisation and both gave crystals. When only one single peak eluted from SEC, the 
fractions were pooled according to the example displayed in section 5.3.5. (figure 5-12, 
yellow stars). The crystals were yellow due to the presence of PLP in the active site (figure 5-
13), as it was observed for native FL WT StSPL (see section 4.5.1.). Most of the crystals were 
found in conditions with a well solution containing Na-cacodylate at pH 6.1 to 6.7, 0.2 M 
Li2SO4 supplemented with various PEG lengths and concentrations. Some crystals of similar 
morphology were also obtained in NaOAc pH 5.5 or Na-cacodylate pH 6.5 and 40 % (v/v) 
MPD (hexylene glycol) or 35 % (v/v) isopropanol but they did not diffract to high resolution 
(data not shown). The crystal resulting in the Dpl1p structure was cryo-protected with 18 % 
EG. 
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Figure 5-13. Dpl1p Δ1-102 SEC peak 2 crystallisation resulting in STRUCTURE Dpl1p 
 
 
 
5.5. STRUCTURE DETERMINATION OF Dpl1p Δ1-102 
 
See part 3 (manuscript) Fig. 1B, S1 and table S2. 
 
Two point mutations, I308V and N469D are present in the sequence and presumably arise 
from the genome used for cloning (see part 3 SI Text). Residue 308 is found in a hydrophobic 
region outside the active site (figure 5-14) and a mutation to valine is unlikely to induce large 
conformational changes or to inactivate the protein. Residue 469 is located at about 20 Å 
from the disordered part of Ct-EXT (residues 542 to 563, shown with a dashed line), region 
which is not visible on the electron density map (see part 3 (manuscript) Fig. 1B). This stretch 
is presumably involved in substrate accommodation due to its flexibility and its location 
close to the active site entry (see part Fig. S1B and D). Residue K484 interacts 
electrostatically with D469: this surface salt bridge does not appear, however, to have 
altered the local conformation, as seen by superposition with structure St_1 (which actually 
sports a salt bridge exactly at the same positions but with swapped charges: D469 
corresponds to K399 and K484 corresponds to D413) (see part 3 Fig. 1B). 
 
Figure 5-14. Point mutations of Dpl1p Δ1-102 
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5.6. SPECTROPHOTOMETRIC ACTIVITY ASSAY OF Dpl1p Δ1-102 
 
The visible spectrum of Dpl1p Δ1-102 is characterized by a broad peak centred at 425-430 
nm (figure 5-15 dashed line) also exhibited by Dpl1p Δ1-116, Δ1-133, Δ1-116:ΔCt-EXT and 
Δ1-133:ΔCt-EXT (data not shown) and by FL WT StSPL (section 4.4.1.). FL Dpl1p expressed in 
yeast and purified in either digitonin or DDM displayed a similar spectrum, except that the 
peak was centred at 415 nm (data not shown). 
 
Figure 5-15. Dpl1p Δ1-102 visible spectrum and spectrophotometric activity assay with 
DHS1P 
 
 
 
Note: the test was carried out in KPi buffer with the pooled fractions from peak 2 of SEC. 
 
When DHS1P, S1P and PS1P were added to the protein, the characteristic peaks at 403 and 
420 nm (see part 3 (manuscript) Fig. 4A) were not observed (figure 5-15 full lines coloured 
grey to blue and part 3 (manuscript) Fig. S6J-L). Slight changes in the 380 nm region occurred 
over time but were interpreted as insignificant. The test was carried out with pooled 
fractions from either peak of SEC in KPi or HEPES buffer. The substrate was solubilised in 
either Triton X-100 or DDM or digitonin. 
This result might suggest that Dpl1p Δ1-102 is inactive. For the above-described reasons, this 
result must be confirmed by measuring the activity of WT Dpl1p (that is, Dpl1p carrying 
residues I308 and N469). Activity must be assayed using the spectrophotometric and MS 
assays, as well as with the use of the fluorogenic substrate (see 4.10.3. figure 4-42). 
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5.7. MUTAGENESIS STUDY: SYNTHETIC LETHALITY TEST 
 
5.7.1. STRUCTURE-BASED DESIGN OF MUTANTS 
 
As controls, the lumenal domain truncation Δ1-57 (figure 5-1) and the mutants K380A, 
K386A, C344A and Y554F studied in (112) were included in the assay. Since the active sites of 
StSPL and Dpl1p are indistinguishable (figure 5-16), Dpl1p mutants corresponding to the 
StSPL mutants tested in vitro were chosen (table 5-6). 
 
Figure 5-16. Dpl1p mutants assayed (stereo view) 
 
 
 
Note: Y554 sits on the disordered stretch of Ct-EXT spanning residues 542-563 and is 
therefore not visible in the structure. The location of StSPL Y482 might provide a hint 
on the position of Y554 in Dpl1p. For figure legend, see part 3 (manuscript) Fig. 3C. 
 
Table 5-6. Dpl1p mutagenesis study 
 
Dpl1 Activity(1) Conservation(2) Putative role(s) StSPL Activity(3) 
A172P Not tested No Active site loop conformation A103P Inactive 
Y174F Not tested Yes 
Catalysis /
Substrate polar head 
accommodation 
Y105F Presumably inactive 
H198A Not tested Yes 
Substrate polar head 
accommodation / 
Catalysis 
H129A Partly active 
C344A Partly active Yes Catalysis /PLP pyridinium ring stacking 
C276A Partly active 
K380A Inactive Yes Catalysis (internal aldimine) K311A Inactive 
K386A Inactive Yes 
Catalysis /
Substrate polar head 
accommodation 
K317A Inactive 
Y554F Partly active Yes 
Substrate accommodation / 
Regulation of activity and local 
conformation 
Y482F Partly active 
 
(1) See reference (112). 
(2) Compared to the bacterial and human counterparts. See table 4-11 section 4.9.1. 
(3) Of StSPL mutants using the spectrophotometric activity assay. 
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5.7.2. ASSAY PRINCIPLE 
 
The genes ura3, lcb3, leu2 and dpl1 were knocked-out in the genome of the yeast strain used 
for the test. The genes ura3 and lcb3 were carried on a separate plasmid (figure 5-17 upper 
left panel) and are both required for growth. The gene lcb3 encodes a long-chain base 
phosphate phosphatase and ura3 is involved in the synthesis of uracil. URA3 produces a 
toxic compound when 5-fluoroorotic acid (5-FOA) is used as a substrate (figure 5-17 upper 
right panel). 5-FOA is not toxic in itself. This strain is transformed with a plasmid carrying a 
gene encoding for a Dpl1p variant (pRS415-Dpl1p) and the selection marker gene leu2 which 
allows the strain to grow in the absence of leucine. The transformed strain is then grown on 
a medium containing uracil (figure 5-17 bottom panel) but not leucine. Growth on 5-FOA is 
only possible for a strain lacking ura3, thereby lcb3, and expressing an active Dpl1p to 
complement the loss of LCB3. Colony size is the criterion to estimate the activity of the 
Dpl1p variant. 
 
Figure 5-17. Principle of the synthetic lethality test 
 
 
 
5.7.3. RESULTS 
 
See part 3 (manuscript) Fig. 5B. 
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5.7.4. SUMMARY 
 
Table 5-7. Dpl1p activity: outcome and comparison with StSPL results of activity assay 
 
Dpl1p Mutation Truncation In vivo activity
 In vitro activity(1) StSPL In vitro activity(1) 
 Δ1-57 Partly active    
 Δ1-102  Inactive   
A172 A172P Inactive  A103P Inactive 
Y174 Y174F Partly active  Y105F Presumably inactive
H198 H198A Partly active  H129A Partly active 
C344 C344A Partly active  C276A Partly active 
K380 K380A Inactive  K311A Inactive 
K386 K386A Inactive  K317A Inactive 
Y554 Y554F Partly active  Y482F Partly active 
 
(1) Of Dpl1p Δ1-102 and StSPL mutants using the spectrophotometric activity assay. 
 
Part 5: Results & Discussion Saccharomyces cerevisiæ Dpl1p (Dpl1p) 
142 
5.8. DISCUSSION AND PERSPECTIVES 
 
5.8.1. PROPOSED MECHANISM 
 
Except for Y174F (StSPL Y105F), the results of the in vivo mutagenesis study of Dpl1p are in 
good agreement with those of the biochemical study on StSPL (table 5-7). As pointed out in 
section 4.7.1., the absence of the S1P-induced peaks in StSPL Y105F does not obligatorily 
correlate with enzyme inactivity. The enzyme activity of this mutant (and others) must be 
further investigated, for example with the use of a fluorogenic substrate (see 4.10.3. figure 
4-42). Hence, the mechanism proposed in figure 4-40 of section 4.10.3. for StSPL might be 
extended to Dpl1p. In case one assumes that StSPL Y105F is inactive, the discrepancies 
between yeast and bacterial SPL may be explained by their different biological context and 
role. Despite sharing more than 35 % sequence identity (see chapter 2.3. table 2-1), the two 
SPLs differ in cellular functions and, probably, in the regulation of activity. Given the 
importance of Dpl1p in yeast, one can assume that its activity must be fine-tuned. If the 
main role of StSPL is to degrade environmental sphingolipids as an energy source, the 
enzyme activity might have rather evolved towards a high turnover rate. In vivo activity 
studies of dpl1 P199, N195, H268, H379, Y381 and Y414 might provide further insights into 
the reaction mechanism (see figure 4-41), synergistically with the studies of the 
corresponding mutants of StSPL. 
Although the function of WT Dpl1p, i.e. that carries I308 and N469, has to be tested to draw 
further conclusions, the fact that Dpl1p Δ1-102 is in vitro inactive (chapter 5.6.) is not 
surprising given that Dpl1p Δ1-57 is only partly active in vivo (table 5-7). It nevertheless 
should be mentioned that the requirements for in vivo and in vitro activity might differ since 
cellular activity may be linked with protein targeting to membranes. Dpl1p lacking the 
transmembrane helix might theoretically be active in vitro (see section 1.4.3. figure 1-22), 
similarly to human SPL as reported in (61). Unfortunately, Dpl1p Δ1-81 is degraded in E. coli 
(chapter 5.2.) and possibly also in yeast (section 5.3.1.). Other truncations starting between 
residue 82 and 102 may be assayed for expression and stability and might provide new 
insights about the role and conformation of the spacer region. The available outcomes of 
expression (see chapter 5.2.) and purification (see sections 5.3.2. to 5.3.5.) attempts of 
Dpl1p truncations clearly indicate that the linker and spacer regions (figure 5-2) bear 
important features for protein stability and presumably activity. 
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5.8.2. DISORDERED REGIONS 
 
As for FL StSPL, some residues at the N-terminus are not or only faintly visible on the 
structure. It concerns Nt-EXT of FL StSPL (residues 1-57) and the first 26 residues of Dpl1p 
Δ1-102 (residues 103-128). Interestingly the first residue invariably visible in Dpl1p, D129, 
and in StSPL, K58, corresponds to the same residue in a pairwise alignment (figure 5-18). 
This indicates that the flexibility at the N-terminus is a conserved feature of both proteins 
and has probably a functional role. 
 
Figure 5-18. N-terminal disorder found in FL StSPL and Dpl1p Δ1-102 
 
 
 
Residues 541-565 of Ct-EXT are not visible in the structure and might also play a functional 
role (see part 3 (manuscript) Fig. S1E). One cannot exclude that this disorder is triggered by 
point mutation N469D (see chapter 5.5.), thus affecting substrate binding or correct 
positioning of residues required for activity, like Y554. 
Lithium ions are found in all crystallisation conditions of Dpl1p Δ1-102 and might also play a 
role in the conformation of the protein. Further screening for different conditions might be 
useful to determine the role of these ions in the disorder of Ct-EXT. 
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5.8.3. OLIGOMERIC STATE OF FL Dpl1p 
 
Dpl1p might be active in a higher oligomeric state, by analogy with GadB possibly a hexamer, 
and the oligomerization state might be modulated by a region missing (residues 1-102) in 
the truncated form. An alternative to working with FL Dpl1p might be to test the activity of a 
chimera of Dpl1p Δ1-102 fused to the N-terminal region of E. coli GadB or A. thaliana Gad1, 
also hexameric, as recently reported (205). This might provide hints about the requirement 
of oligomerization for Dpl1p activity. Similarly to StSPL, the SEC buffer composition might be 
screened with the aim of investigating the pH and salt-dependence of the oligomeric state of 
Dpl1p. The expression level of FL Dpl1p in yeast and its stability upon purification are not 
sufficient for biochemical and structural work (see section 5.3.1.). An alternative is the use of 
orthologues, like the recently described Legionella pneumoniæ LegS2 (117). Phylogenetic 
analysis attributes a protozoan that is, eukaryotic, origin to the Legionella protein. 
Interestingly, when expressed in COS7 mammalian cells, LegS2 targets to the mitochondrial 
membrane instead than to the ER as for yeast and human SPLs. Assuming that the protein 
expression level is higher than that of Dpl1p and that a suitable purification protocol is 
found, LegS2 might provide a useful tool to get insights into the structure and substrate 
accommodation mechanism of higher eukaryotic (like yeast and human) SPLs. 
The question of whether Dpl1p is active as a dimer, like human GAD65/67 (206) or as a 
multiple thereof, for example a hexamer by analogy with E. coli GadB (164), is then still 
open. The first hypothesis is preferable for two reasons. First, the functional roles of E. coli 
GadB and Dpl1p differ. GadB is involved in acid resistance, and a hexamer possessing six 
active sites allows a faster turnover, thereby a faster decrease of pH in response to 
environmental changes. Such a speed advantage might not be required for Dpl1p since the 
substrate is a powerful cell messenger present in low amounts. Second, assuming that Dpl1p 
is a hexamer, the location of the second triple-helical coiled-coil spanning the membrane is 
an enigma (see figure 5-2 left). For these reasons, we assume at present that Dpl1p is active 
as a dimer. 
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5.8.4. SUBSTRATE ACCOMMODATION 
 
The presence of a predicted transmembrane helix in Dpl1p adds a level of complexity to the 
mechanism of substrate accommodation of StSPL reported in section 4.10.6. Three different 
modes are suggested here. In mode I (figure 5-19 left panel), the transmembrane helices, 
presumably forming a double coiled-coil, would directly be involved in the accommodation 
of the substrate. Positively charged or polar residues (C65, K67, S70, N71) located in the 
predicted transmembrane helix (spanning residues 58 to 81) have recently been shown to be 
required for in vivo activity of Dpl1p (112). These residues might bind the polar head of the 
substrate and drive it into the active site through the spacer and the linker. This 
accommodation mode would be more likely in case that Dpl1p forms a higher oligomer, for 
example a hexamer implicating that the transmembrane domain is a triple-helical bundle, 
maybe allowing the building of a hydrophobic path from the membrane to the active site. 
The mechanism proposed in II (figure 5-19 middle panel) is similar to I, except that the 
substrate would be extracted from the membrane by positively charged residues of the 
spacer region. Alternatively, Dpl1p might start accommodating the substrate into the active 
site while still embedded within the membrane, as assumed for StSPL (figure 4-43 section 
4.6.10.) (but then the protein must be oriented differently from the way shown). The 
hypothesis of the existence of a yet unknown S1P carrier is illustrated in the mode III (figure 
5-19 right panel). The S1P importer CFTR (89) might be coupled to an S1P transport protein 
that would shuffle S1P into the active site of Dpl1p, as CERT transports ceramide from the ER 
to the Golgi (see section 1.5.3.). This last hypothesis is the most reasonable in terms of 
thermodynamics but requires the identification of the substrate carrier. 
 
Figure 5-19. Possible substrate accommodation mechanisms of FL Dpl1p 
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6. RESULTS & DISCUSSION HUMAN SPL (HsSPL) 
 
6.1. TRUNCATIONS DESIGN AND EXPRESSION VECTOR 
 
HsSPL truncations were designed based on a homology model (similar to that presented in 
chapter 5.1.) and on the behaviour of Dpl1p truncations upon expression (see chapter 5.2.). 
The constructs were first cloned into pQE60 for preliminary expression tests and the most 
promising among them were cloned into pET28a+, as described in Materials & Methods 
section 8.2.3. The additional residues resulting from the cloning are shown in figure 6-1 and 
the constructs tested are listed in figure 6-2. The numbering shows the corresponding 
residues of Dpl1p and StSPL. 
 
Figure 6-1. Additional residues of HsSPL truncations cloned into pQE60 and pET28a+ 
 
 
 
Figure 6-2. Residue correspondence in StSPL, Dpl1p and HsSPL and table of constructs 
designed and cloned (designed with a cross) 
 
 
 
HsSPL TRUNCATION pQE60 pET28a+ 
Δ1-63 X  
Δ1-80  X 
Δ1-94   
Δ1-103   
Δ1-111   
Δ1-122  X 
Δ1-94:Δ516-568   
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6.2. EXPRESSION IN E. coli AND SOLUBILITY ASSAY 
 
6.2.1. EXPRESSION 
 
The conditions for expression were screened and optimized as described in Materials & 
Methods section 8.3.3. Parameters such as medium, temperature, vector, addition of 
ethanol at induction and various OD600 nm were tested. All truncations were highly expressed 
but the protein was mainly found in the insoluble fraction of the cell, as shown in figure 6-3 
(lines 2' to 7') for HsSPL Δ1-80. Slight variations were observed in several expression 
conditions but the protein amount was invariably too low to be detected on Coomassie-
stained SDS-PAGE (see figure 6-3 lane 6, yellow star). 
 
Figure 6-3. Expression test of pQE60 HsSPL Δ1-80 in E. coli 
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6.2.2. SOLUBILITY 
 
The composition of the cell lysis buffer was screened to increase to amount of soluble 
protein. Addition of glycerol and NonidetTM P-40, a nonionic detergent, did not significantly 
increase the amount of protein in the soluble fraction, as opposite to NaCl (not shown) and 
Triton X-100 (see below). Lysing the cells at higher pH (see below) and heating the sample to 
40°C (not shown) increased the amount of protein in the soluble fraction. Heat treatment 
was not used due to uncertainty about the stability of the protein. NaCl was routinely added 
at 250 mM concentration to all buffers used. The pH of the buffer with and without 0.1 % 
(corresponding to 2- to 6-fold CMC) Triton X-100, was screened (figure 6-4). The best 
solubility was achieved in KPi pH 8.2, 250 mM NaCl and 0.1 % Triton X-100 (figure 6-4 lane 
3T). 
 
Figure 6-4. pQE60 HsSPL Δ1-80 cell lysis buffer screen: pH and Triton X-100 
 
 
 
6.3. PURIFICATION 
 
HsSPL Δ1-80 expressed in pQE60 was subjected to a purification attempt using IMAC and 
SEC. The same procedure as for StSPL (see part 3 (manuscript) SI Text) was used in a first trial 
(table 6-1, test 1), except that the buffers were supplemented with 250 mM NaCl. The 
sample eluted from IMAC was less that 1 % pure (data not shown) and SEC was not 
performed. The buffer composition was screened in a second trial (table 6-1, test 2). Since 
Dpl1p seemed more stable in the presence of phosphate than in HEPES (section 4.3.5.) 1 mM 
KPi was added when CHES was used as buffering agent (table 6-1, tests 3 and 4). The SEC 
buffer was supplemented with 250 mM NaCl and did not contain Triton X-100. In all 
conditions tested, the purity was estimated to be lower than 5 % (data not shown). 
 
Table 6-1. HsSPL Δ1-80 IMAC buffer composition 
 
 Test 1 Test 2 Test 3 Test 4 
50 mM KPi pH 8.2 X X   
1 mM KPi (pH 8.2)   X X 
50 mM CHES pH 9.5   X X 
0.1 % Triton X-100  X  X 
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6.4. DISCUSSION & PERSPECTIVES 
 
Truncations of eukaryotic Dpl1p can be efficiently expressed in E. coli (see chapter 5.2.) and 
its identity and similarity levels with HsSPL indicate a conserved fold. Interestingly, HsSPL 
seemed to behave differently than Dpl1p and StSPL upon expression in E. coli despite their 
sequence identity and similarity (see table 2-1 chapter 2.3.). HsSPL exhibits features that 
cannot be deduced from the study of its bacterial and yeast counterparts. For all truncations 
tested most of the protein (estimated to be more than 99 %) is found in the pellet after 
centrifugation, suggesting that it is either insoluble or misfolded. The insolubility of the 
truncated variants of HsSPL can originate from the genetic material (gene sequence and 
plasmid), from the expression system and the conditions of expression, from the biophysical 
properties of the protein and its truncations or from the cell lysis and protein purification 
procedure. 
The codons of HsSPL gene were optimized for expression in E. coli (see Material & Methods 
8.2.3.). Although a high level of expression is achieved, the protein is mainly found in the 
insoluble fraction of the cell (figure 6-3), suggesting that the bacterial translation machinery 
might be overloaded. A similar outcome was observed for truncations of human Gad65 (data 
not shown) and for SIVA1, a 17 kDa human protein involved in apoptosis (Dr. Peer Mittl, 
communication in a group seminar). Thus, coding sequence optimisation might promote 
protein aggregation or sequestration into inclusion bodies (this could be checked by 
comparison with a non-codon optimized gene). 
The type of plasmid and its promoter play a crucial role in protein overexpression. StSPL is 
significantly less expressed in the pET system than in pQE (data not shown). Both systems 
were used for HsSPL and yielded that same amount of protein in the soluble fraction, as 
opposite to StSPL. An auto-induction medium (207) (208) may provide a milder alternative 
and increase the amount of protein in the soluble fraction. Lactobacillus lactis and insect 
cells expression may provide an expression pattern different from that in E. coli. Cell-free (or 
in vitro) expression may be an interesting system to screen the solubility of HsSPL 
truncations if the properties of the protein are a bottle-neck for in vivo recombinant 
production. 
Compared to StSPL and Dpl1p, FL HsSPL and truncated variants have a significantly higher 
isoelectric point (see table 6-2) and this feature might not be properly dealt with by E. coli. 
The pH and ionic force of the cell lysis buffer may therefore be critical parameters 
influencing the stability and solubility of the protein and have to be screened. 
Other truncations may be designed based on more advanced bioinformatic methods. A 
truncation starting at V107 (Δ1-106) may improve the yield of soluble protein. HsSPL V107 
corresponds to the first residue visible in all FL StSPL and in Dpl1p Δ1-102 electron density 
maps (respectively corresponding to K58 and D129) (see figure 6-1). A recently developed 
method using GFP as a folding indicator might be of help to probe the folding of HsSPL 
truncations expressed in E. coli (209). 
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Table 6-2. Theoretical isoelectric points of FL WT StSPL, Dpl1p and HsSPL including the 
additional residues from cloning 
 
PROTEIN VECTOR pI(2)
FL WT StSPL pQE70 6.1 
StSPL ΔNt-FLEX (WT)  6.2 
StSPL ΔCt-EXT (WT)  6.25 
FL WT Dpl1p native sequence - 8.2 
Dpl1p Δ1-81(1) pET28a+ 7.4 
Dpl1p Δ1-102(1) 6.8 
Dpl1p Δ1-116 6.6 
Dpl1p Δ1-133 6.9 
Dpl1p Δ1-133:ΔCt-EXT 6.9 
FL WT HsSPL native sequence - 9.3 
HsSPL Δ1-63 pQE60 9.4 
HsSPL Δ1-80  9.3 
 pET28a+ 9.2 
HsSPL Δ1-94 pQE60 9.1 
HsSPL Δ1-94:ΔCt-EXT  9.2 
HsSPL Δ1-111  9.2 
 
(1) WT sequence, i.e. without point mutations I308V and N469V. 
(2) The pI was calculated with ProtParam (http://www.expasy.org/cgi-bin/protparam) (178). 
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7. CONCLUSIONS 
 
SPL exhibits structural similarity with serine-palmitoyl transferase (SPT) (see section 1.5.5.). 
Both SPL and SPT are PLP-dependent enzymes and share a similar fold: the rmsd between 
Dpl1p and the recently solved S. paucimobilis SPT is 2.5 Å over 296 aligned C atoms 
Interestingly, yeast and mammalian SPTs are presumably multimers of heterodimers. One 
subunit of the heterodimer, while strictly required for activity, lacks PLP and is therefore 
inactive. On the contrary, the above mentioned bacterial SPT is a homodimer with PLP 
bound in both active sites. Bacterial SPL exhibits, in one structure (St_2), conformational 
heterogeneity rather than the sequence heterogeneity observed in yeast and mammalian 
SPT. The conformational heterogeneity of St_2 affects cofactor binding, since one subunit 
does not contain PLP. Modulating the affinity of the protein towards the cofactor in one 
subunit might be a mechanism of regulation, as observed in human GAD65/67 (see section 
4.10.2). 
Similarly to SPT, the oligomeric state of SPL might not be conserved from prokaryotes to 
eukaryotes. Notably, FL WT SPL from Symbiobacterium thermophilum does not contain any 
predicted transmembrane helix, unlike its yeast and human counterparts. Eukaryotic SPL 
might be a homodimer, as observed in the crystal structure of Dpl1p Δ1-102, or a multiple 
thereof. If the oligomerization state is affected by the N-terminus of the protein, the in vitro 
inactivity of the Δ1-102 truncated variant could be related to its quaternary state. 
Noticeably, the lumenal domain of human SPL is about 20 residues shorter than that of 
Dpl1p, suggesting that the role of the very N-terminal part of the protein may vary across 
evolution. A truncated variant of Dpl1p (Δ1-57) lacking the lumenal domain is only partly 
active (see part 3 (manuscript) Fig. 5B), while the activity of StSPL truncated until the first 
visible residue on the structure (ΔNt-FLEX) is not affected (see part 3 Fig. S6A). Interestingly, 
the N-terminal regions of the bacterial and yeast enzymes are conformationally disordered 
until the same structurally aligned residue (see 5.8.2. figure 5-18), suggesting that this 
disorder or flexibility is a conserved feature from prokaryotes to eukaryotes even if its 
importance for activity varies across taxonomic domains. The conformational flexibility of 
the N-terminus of SPL might allow the region to interact with the membrane and help the 
accommodation of the substrate into the active site. In yeast and bacterial SPL, parts of the 
Ct-EXT domain are not visible in all structures, suggesting conformational flexibility in certain 
conditions. The Ct-EXT domains of both enzymes carry a conserved tyrosine involved in 
activity (482 in StSPL and 554 in Dpl1p). No autoinhibition via substituted aldamine was 
found in SPL and the structure of its C-terminal region does not allow for a GadB-like 
autoinhibition mode. Altogether, this indicates that the N- and C-termini are important to 
various extents for the activity of SPL from various organisms. 
Assuming that the results observed are not biased by the expression and purification 
procedures, one can conclude that SPLs from Symbiobacterium thermophilum, yeast and 
human do not exhibit the same biophysical properties. While StSPL is stable and allows 
extensive functional and structural studies (see table 7-1), truncated variants of Dpl1p 
behave very differently upon expression in E. coli (see table 7-2) and the corresponding 
truncations in human SPL are not found in the soluble fraction of the cell (see table 7-3). 
Unlike the established signalling role of eukaryotic SPLs (see section 1.4.3.), the enzyme has 
most probably a function in Symbiobacterium thermophilum metabolism. These various 
functions must be linked with different regulatory mechanisms. Since the active sites of 
bacterial and yeast SPLs are very similar, the less conserved N-terminal region might be the 
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"fingerprint" of each SPL ortholog and affect various features of the protein, including 
stability. For example, a yeast SPL truncation lacking both the lumenal and transmembrane 
domains (Δ1-81 see chapter 5.2.), undergoes N-terminal cleavage upon expression in 
bacteria and presumably also in yeast (see 5.3.1.). Specific proteolysis of the N-terminus 
might therefore represent a regulation mechanism specific to yeast SPL. The observation 
that the lumenal domain truncation of yeast SPL (Δ1-57 see part 3 Fig. 5B) is partially active 
in vivo may support this hypothesis. 
Except for one residue (Y105 in bacterial SPL and Y174 in yeast SPL), the roles in enzyme 
activity of the residues tested in this study appear to be conserved between bacterial and 
yeast SPLs. Assuming that the residue (or residues) carrying out the proton abstraction on C2 
(see section 4.10.3. figure 4-40) is strictly required for cleavage and that their mutation fully 
inactivates the protein, C276 in bacterial SPL and C344 in yeast SPL may not fulfil this 
function (see part 3 Fig. 4E and 5B). The mechanism proposed in 1993 assumed that a 
cysteine is the nucleophile (see section 1.4.3. figure 1-23) and was deduced from the 
sensitivity of rat SPL (from microsomes) to N-ethylmaleimide (NEM), a sulfhydryl reagent. 
This divergence with our experimental data may be explained in four ways. First, but not 
likely, mammalian SPLs might exhibit a different mechanism than yeast and bacterial SPLs. 
Second, NEM might indirectly affect the activity of SPL by altering the conformation of the 
active site, for instance by partly displacing the cofactor, that stacks against the side chain of 
C344. Third, partial activity, like in bacterial and yeast SPLs, might be retained after NEM 
treatment but might be below the detection threshold of the activity assay used for the 1993 
study. Last, our data are biased. This is very unlikely, since both in vitro and in vivo assays on 
bacterial and yeast SPLs provided similar results. 
Tyrosine 105 of bacterial SPL (Y174 for in the yeast enzyme) is located on a loop close to the 
S1P bond to be cleaved and forming part of the binding site of the phosphate moiety of the 
substrate. The Y105F mutant of bacterial SPL did not show activity bands when undergoing 
an in vitro spectrophotometric assay, while the Y174F mutant of yeast SPL was partly active 
in vivo. Assuming that these results are unbiased and their interpretation is correct, this 
would mean that the reaction mechanism (or regulation) is not completely conserved from 
bacteria to yeast. 
The best candidate for proton abstraction in bacterial and yeast SPLs is the highly conserved 
lysine 317 (386 in yeast). The neighbouring H129 (H198 in yeast), also plays an important 
role, likely in substrate binding, since its alanine mutant is only slightly active (see part 3 Fig. 
4E and 5B). Further analysis is required to decipher the precise role of all residues involved in 
the reaction mechanism of SPL. 
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Table 7-1. Summary of the main results obtained on StSPL 
 
Construc
t 
Vecto
r 
Soluble 
expressio
n (1) 
Oligomeri
c state 
Crystal
s 
Structur
e 
Activity
peaks(2) 
Relaxatio
n time 
Activit
y by 
MS 
FL WT pQE60 YES 4mer-2mer YES YES    
Δ1-22  NO       
Δ1-38         
FL WT pQE70 YES 4mer-2mer YES YES YES Reference Active 
ΔNt-FLEX   
Less 4mer 
than FL 
WT 
   Faster  
ΔCt-EXT       Slower  
S101A       Similar  
A103P  Lower than WT  No hits  
No 
peaks 
but 
spectral 
change
s 
 
 
Inactiv
e / 
partly 
active 
Y105F  YES Similar to FL WT   NO   
H129A      
Very 
small 
peaks & 
spectral 
change
s 
 
Faster  
Y249F      YES Similar  
C276A       Slower  
K311A   
Less 4mer 
than FL 
WT 
YES YES NO  
Inactiv
e / 
partly 
active 
K317A   Similar to FL WT   
No 
peaks 
but 
spectral 
change
s 
  
Y314F & 
Y324F      YES Similar  
Y482A / F       Slower  
 
Note (for all tables): 
(1) Corresponding to the amount of protein expressed in the soluble fraction of E. coli. A cross 
means that a band can be detected on Coomassie-stained SDS-PAGE. 
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(2) Corresponding to the appearance of the 403 nm- and 420 nm peaks using the 
spectrophotometric activity assay. 
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Table 7-2. Summary of the main results obtained on Dpl1p 
 
Truncation Point 
mutations 
Expression Soluble 
expression(1)
Yield 
after 
SEC(3) 
Crystals Structure Activity
peaks(2)
Δ1-81 I308V N469D 
Faint 
bands 
Proteolysis / 
degradation 
(immuno-
blot) 
< 
0.05    
Δ1-102  YES YES 4 YES YES NO 
Δ1-116 None   5 Spherulites Microcrystals NO  
Δ1-123   NO     
Δ1-134    0.3 Spherulites Microcrystals NO  
Δ1-145  Faint bands      
Δ1-116:Δ 
Ct-EXT  YES YES 1 NO   
Δ1-134:Δ 
Ct-EXT        
 
Note on Table 7-2: Except for Y174F, the in vivo activity assay on Dpl1p (not included) 
provided similar results to those of StSPL in vitro (see table 7-1). 
 
Table 7-3. Summary of the main results obtained on HsSPL 
 
Truncation Vector Expression Soluble expression(1) Yield after SEC(3) 
Δ1-63 pQE60 YES NO  
Δ1-80 pQE60   < 0.01 
 pET28a+    
Δ1-94 pQE60    
Δ1-103     
Δ1-111     
Δ1-122 pQE60    
 pET28a+    
Δ1-94:ΔCt-
EXT 
pQE60    
 
(3) Expressed in mg per L culture. 
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8. MATERIALS & METHODS 
 
8.1. CHEMICALS 
 
The plasmids and E. coli competent cells were purchased from Novagen (pET28a+ and 
HMS174(DE3)) and Qiagen (pQE60 and M15). The plasmid pQE70 was a kind gift from S. 
Savaresi (University of Zurich). The DNA polymerase was from Finnzymes. The restriction 
endonucleases and ligase were from New England Biolabs. The QuikChange site-directed 
mutagenesis kit was purchased from Stratagene. The oligonucleotide primers were from 
Microsynth. The Ni2+-nitriloacetic acid agarose (Ni-NTA) beads were from Qiagen. All 
chromatography columns and systems were from GE Healthcare. The sphingolipids were 
purchased from Avanti Polar Lipids, Acros and Alexis Biochemicals. Unless otherwise stated, 
all chemicals were of the highest commercially available grade. The Symbiobacterium 
thermophilum genome was a kind gift from Dr. Kenji Ueda, Nihon University, Fujisawa, 
Japan. Saccharomyces cerevisiæ (baker's yeast) was purchased from a local supermarket 
(Migros AG), product code 1150.027 (EAN number 7610.2011). 
 
8.2. CLONING FOR EXPRESSION IN E. coli 
 
8.2.1. StSPL WT AND VARIANTS 
 
See part 3 (manuscript) SI Text and table S1. 
 
The constructs Δ1-22 and Δ1-38 were cloned into pQE60, as described for FL StSPL. The 
primers used to clone these truncations as well as the mutants S101A, Y314F, Y324F and 
Y482A are listed in table 8-1. 
 
Table 8-1. Primers used for additional StSPL truncations and mutants 
 
CONSTRUCT NAME FORWARD (5') PRIMER 
 
REVERSE (3') PRIMER 
 
pQE60-StSPL Δ1-22 GGAAGATCTCCCTCCTCATTGCA
GGACTATT 
CCCAAGCTTACTAGTGATGGTGATGGTG
ATGCACCTCGTACAGCAGGTCG 
pQE60-StSPL Δ1-38 GGAAGATCTCCGCCTGCGAGGA
GGGA 
 
pQE70-StSPL FL S101A CTATGCCGCCGGCGCCG CGGCGCCGGCGGCATAG 
pQE70-StSPL FL Y314F GTACGGCTTCGGGGCCA TGGCCCCGAAGCCGTAC 
pQE70-StSPL FL Y324F GATCCTCTTCCGCAGAC GTCTGCGGAAGAGGATC 
pQE70-StSPL FL Y482A GCCCCGGTCGCCGGCATGGCC GGCCATGCCGGCGACCGGGGC 
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8.2.2. DPL1P TRUNCATIONS 
 
The cloning procedure is identical to that reported in part 3 (manuscript) SI Text and the 
primers are listed in table 8-2. 
 
Table 8-2. Primers used for Dpl1p truncations expressed in E. coli 
 
CONSTRUCT NAME FORWARD (5') PRIMER 
 
REVERSE (3') PRIMER 
 
POINT 
MUTATIONS 
pET28a+-Dpl1p 
Δ1-81 
CATGCCATGGTGAGGTT
AGCAGTGAGAAC 
CCGCTCGAGCTTGGTGG
CGGTATCCTCT 
I308 => V308 
N469 => D469 
pET28a+-Dpl1p 
Δ1-116 
CATGCCATGGTCAAACA
ATCGATCGAAGAC 
 None 
pET28a+-Dpl1p 
Δ1-123 
CATGCCATGGAACTAAT
TAGATCGGACTCT 
  
pET28a+-Dpl1p 
Δ1-133 
CATGCCATGGGAAATTT
CCCACAGTTGCCATCC 
  
pET28a+-Dpl1p 
Δ1-144 
CATGCCATGGGACAGGA
TGATGTTATTGAAGAGC 
  
pET28a+-Dpl1p 
Δ1-116:ΔCt-EXT 
Same as above CCGCTCGAGTGATTCGC
TCTTCAACTCTTG 
 
pET28a+-Dpl1p 
Δ1-133:ΔCt-EXT 
Same as above   
 
8.2.3. HsSPL TRUNCATIONS 
 
Various N-terminal and C-terminal truncations of the human spl gene were amplified by PCR 
using a synthetic sequence optimized for expression in E. coli (GenScript) based on the DNA 
sequence deposited by Van Veldhoven et al. (61) in the NCBI database under the accession 
number NP_003892. To clone the PCR products into pQE60 (Qiagen), NcoI and BglII 
restriction enzyme cleavage sites were incorporated into the forward (5') and reverse (3') 
primer, respectively (table 8-3). Some clones contained an additional G residue at the 5' (N-
terminal end of the protein) and all clones an additional RSHHHHHH at the 3' (C-terminal 
end) that resulted from cloning. Positive clones after ligation were sequenced to confirm the 
integrity of the construct. The pQE60-HsSPL plasmids were transformed into E. coli M15 
competent cells (Qiagen) and selected on LB agar containing 100 μg/ml of ampicillin and 50 
μg/ml of kanamycin. Single colonies were then used for protein expression. Similarly, some 
truncations of the spl gene were amplified by PCR and inserted into pET28a+ (Novagen) 
using the restriction enzymes NcoI and XhoI. The protein transcribed from pET28a+ contains 
the same additional residues as from pQE60 at the N-terminus and an additional LEHHHHHH 
stretch of residues at the C-terminus. The primers used are listed in table 8-3. 
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Table 8-3. Primers used for HsSPL truncations 
 
CONSTRUCT NAME FORWARD (5') PRIMER 
 
REVERSE (3') PRIMER 
 
ADDITIONAL 
N-TERMINAL 
RESIDUE 
pQE60-HsSPL 
Δ1-63 
CATGCCATGGAGTCGCTGT
GGTCTCGCT 
GGAAGATCTATGCGGCTTC
GGCGAACCG 
None 
pQE60-HsSPL 
Δ1-80 
CATGCCATGGGAAGCCCAA
TTATTGGACGTAAGATC 
 GS 
pQE60-HsSPL 
Δ1-94 
CATGCCATGGGAACTAAAG
ACGATATCAGCAAAAAT 
 G 
pQE60-HsSPL 
Δ1-103 
CATGCCATGGGATCTTTCCT
GAAAGTAGATAAAGA 
 G 
pQE60-HsSPL 
Δ1-111 
CATGCCATGGGATATGTGA
AAGCGCTGCCTTCT 
 G 
pQE60-HsSPL 
Δ1-122 
CATGCCATGGGAAGCTCGG
CAGTACTGGAAAAA 
 G 
pQE60-HsSPL 
Δ1-94:ΔCt-EXT 
(516-568) 
Same as above GGAAGATCTAGGATTTTTC
ATAATTTGAGTAACG 
G 
pET28a+-HsSPL 
Δ1-80 
Same as above CCGCTCGAGATGCGGCTTC
GGCGAACCG 
GS 
pET28a+-HsSPL 
Δ1-122 
Same as above  G 
 
8.3. EXPRESSION AND PURIFICATION 
 
8.3.1. StSPL 
 
The total and soluble expression levels of StSPL variants in E. coli were assessed using 4 ml-
cultures. Various cell culture parameters, like medium, temperature, cell density at 
induction, amount of inducer, harvesting time, as well as composition of the cell lysis buffer 
were optimized to obtain the highest amount of soluble protein. The cells from culture 
samples measured at regular intervals were spun for 5 min at 12000 g at room temperature 
and suspended in 50 μl buffer (buffer 1_St (table 8-4) or another one) per 1 OD600 nm unit. 
The suspension was frozen and thawed twice at -20°C. An equal amount of buffer 2_St 
(table 8-4) was then added. The samples were incubated 1 h at room temperature. Care was 
taken to protect them from light, due to the light sensitivity of the enzyme cofactor, PLP. A 
second incubation for 1 h at 60°C followed. The cells were then spun 30 min at 12000 g at 
room temperature. The supernatant, representing the soluble fraction of the lysed cells, was 
separated. The pellet, representing the insoluble fraction and unlysed cells, was 
resuspended in the same amount of buffer as the supernatant, and both fractions were 
mixed with SDS-PAGE loading dye and applied on 10 % SDS-PAGE for analysis. Anti-6x His tag 
immunoblot was performed according to standard procedure to confirm the identity of the 
protein (210). 
The expression conditions used for protein production are described in part 3 (manuscript) 
SI Text. 
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Table 8-4. Buffers used for the purification of StSPL and Dpl1p 
 
CHEMICAL BUFFER 1_St 
BUFFER 
1_Sc 
BUFFER 
2_St 
BUFFER 
3 
BUFFER 
4 
BUFFER 
5 
BUFFER 
6 
KPi pH 7.2 (KOH, 
20°C) [mM] 
50       
NaCl [mM] -      100 
IMIDAZOLE 
[mM] -    10 100  
EDTA-NaOH 
[mM] -   1  5 1 
DTT [mM] - 1 2 1    
PLP [μM] - 200 400 200   10 
PROTEASE 
INHIBITOR 
COCKTAIL 
WITHOUT EDTA 
- 1x 2x 0.5x 0.5x 1x  
CHICKEN EGG 
WHITE 
LYSOZYME 
- 100 000 U/ml 
200 000 
U/ml     
DNase I - 10 μg/ml 20 μg/ml     
 
8.3.2. Dpl1p 
 
To assess the total and soluble expression of each Dpl1p variant, the same procedure as for 
StSPL was followed with minor variations. The cell pellets were frozen and thawed and then 
suspended in 100 μl buffer (buffer 1_St (table 8-4) or another one) per 1 OD600 nm unit. The 
samples, protected from light, were incubated for 1 h on ice and subjected to two 
freezing/thawing cycles before separating the soluble and insoluble fractions by 
centrifugation as previously described. 
The expression conditions used for protein production are described in part 3 (manuscript) 
SI Text. 
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8.3.3. HsSPL 
 
To assess the total and soluble expression of each human SPL variant, the same procedure as 
for Dpl1p was employed except that the various cell lysis buffers were tested for their ability 
to efficiently lyse the cells and solubilise the protein. 
Human SPL Δ1-80 carried by pQE60 was expressed in E. coli M15 in TB (12 g/l bacto-
tryptone, 24 g/l bacto-yeast extract, 0.4 % v/v glycerol, pH brought to 7.3 (20°C) with H3PO4) 
supplemented with the appropriate antibiotics. The procedure was the same as for Dpl1p 
with the following modifications: the 100 ml-preculture was grown at 30°C, the culture 
grown at 37°C before and at 18°C after induction. 
The cell pellet of 1 L culture (≈ 7.5 g wet cells) was resuspended in twice its volume of buffer 
1_Sc supplemented with 250 mM NaCl (table 8-4). The following steps were similar to the 
purification of Dpl1p except that the beads were washed twice in buffer 3 containing 250 
mM NaCl, before elution with buffer 4 containing the same amount of NaCl. Other buffers 
were also tested for their ability to increase the yield of soluble protein. SEC was performed 
with buffer 6 supplemented with 250 mM NaCl. 
 
8.4. SPECTROPHOTOMETRIC MEASUREMENTS 
 
8.4.1. StSPL AND DPL1P NATIVE SPECTRA 
 
This part is described in part 3 (manuscript) SI Text. 
 
8.4.2. SPECTROPHOTOMETRIC ACTIVITY ASSAY 
 
This part is described in part 3 (manuscript) SI Text. 
 
For solubility screening, the phosphosphingolipids were solubilised in 1 or 0.16 % (w/v) 
Triton X-100, 0.1 % (w/v) dodecylmaltoside (DDM), 0.25 % digitonin (Sigma), 100 % dimethyl-
sulfoxide (DMSO), 100 % ethanol, 50 % (v/v) ethanol in water, and 4 mg/ml bovine serum 
albumin (BSA) (Fluka) in water. The solution or solvent was added to the phospholipid 
powder to reach a maximal concentration of 0.05, 0.5, 1 or 2 mg/ml (≈ 0.125, 1.3, 2.6 and 5 
mM respectively). It must be mentioned that insoluble material was invariably observed in 
all conditions and concentrations tested. In addition, variations in the amount of soluble 
material after solubilisation in one given solution or solvent were frequently observed, 
presumably due to discrepancies in the properties of the lipid batch and to the inherently 
difficult reproducibility of the solubilisation procedure. 
 
8.4.3. FL WT StSPL INHIBITED WITH SEMICARBAZIDE AND IODOACETAMIDE 
 
The procedure for inhibition of StSPL by semicarbazide is described in part 3 (manuscript) SI 
Text. 
 
Similarly the inhibition ability of iodoacetamide (Fluka) has been tested at 100-fold molar 
excess iodoacetamide over protein monomer after 15 min incubation at room temperature. 
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8.4.4. FL WT StSPL INCUBATED WITH HUMAN SPL INHIBITORS 
 
2-acetyl-4-tetrahydroxybutyl-imidazole (THI) (Matreya) was solubilised to a maximal 
concentration of 10 mM in 100 % ethanol or water using the same procedure as for the 
phosphosphingolipids (see section 8.4.2.) except that the incubation step at 37°C was 
omitted and that also the compound was protected from light, because of the light-sensitive 
imidazole ring. THI was only partly soluble under the conditions tested. The test set up was 
similar to semicarbazide, except that the precise concentration of THI was unknown. THI was 
added to a 14 μM protein solution and the mix was incubated for time spans ranging from 0 
to 3 h at room temperature before addition of substrate. 
P-FTY720 was a kind gift from Dr Volker Brinkmann, Novartis Pharma AG, Basel, Switzerland. 
Various solubilisation methods were employed. In a first attempt, the compound was 
solubilised to 1 mM (same protocol as described for the phosphosphigolipids) in 100 % 
ethanol, 50 % ethanol in water, 100 % DMSO, and 1 or 0.16 % (w/v) Triton X-100. In another 
attempt, P-FTY720 was solubilised to 50 mM in DMSO containing 2 M HCl, vortexed and 
spun down as described for the phospholipids. No insoluble material was observed. This 
stock solution was then diluted to 1 mM in 100 % ethanol, 50 % ethanol in water, 100 % 
methanol, 100 % DMSO, 1 or 0.16 % (w/v) Triton X-100 and various amounts of these 
solutions were added to the protein. In a third trial, the compound was first dissolved to 1 
mM in 100 % methanol and incubated for 30 min at 60°C including 1 min vortex every 4 min. 
The solution was then sonicated for 10 min, extensively vortexed and spun down as 
described. Aliquots were dried at 60°C and a 4 mg/ml BSA solution was added to reach 
either 1 mM or 2 mM P-FTY720. The sample was then solubilised as described for the 
phospholipids. 
FTY720 was either a kind gift from Dr Volker Brinkmann or purchased from Cayman 
Chemical. The compound was solubilised to 20 mg/ml in 1 or 0.16 % (w/v) Triton X-100, 100 
% ethanol, 100 % DMSO, vortexed and spun down 10 min at 14000 g at room temperature. 
The supernatant was kept for further analysis. 
 
8.4.5. EFFECT OF DIVALENT CATIONS AND LDAO ON FL WT StSPL ACTIVITY 
 
The test was carried out similarly to the previous inhibition tests. Briefly, an EDTA-free 16 
μM protein solution was mixed with various amounts of Mg-, Sr-, Ba-, Ca- and ZnCl2 and then 
mixed with the substrate under spectrophotometric monitoring. Ca- and ZnOAc have also 
been used. The spectra of the mix were directly recorded, without incubation. 
Similarly, spectra were recorded in presence of a final concentration of 10 mM 
lauryldimethylamine-oxide (LDAO) (Fluka). 
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8.5. ANALYTICAL ULTRACENTRIFUGATION 
 
A sedimentation velocity experiment was performed on an analytical ultracentrifuge 
ProteomeLab XL-I (Beckman-Coulter). The first peak (elution around 11 ml) of the SEC 
chromatogram of pQE60 FL WT StSPL was concentrated and set at 15 and 0.4 mg/ml 
whereas the second peak (elution around 13 ml) was set at 33 and 0.4 mg/ml. Dpl1p Δ1-102 
was concentrated to 44 mg/ml and diluted to 2 mg/ml. The samples were sedimented at 
30000 rpm (rotor An-50 Ti) at 4°C. The samples at 0.4 mg/ml were detected using UV-visible 
absorbance at 320 nm and those at 2, 15 and 33 mg/ml using interference. The spectra were 
analysed with the program SedFit (National Institutes of Health) with refinement of the 
frictional coefficient (179). 
 
8.6. MASS SPECTROMETRY 
 
The mass of proteins after SEC was confirmed by MS. The samples in solution were desalted 
with C4 ZipTip® pipettes tips (Millipore) and diluted first in water and further with 50 % 
acetonitrile, 0.2 % formic acid pH 2 before injection. Protein masses were measured in the 
positive mode on a quadrupole mass spectrometer equipped with an electrospray ionization 
(ESI) source and a time of flight (TOF) ion separation device (Q-TOF Ultima API, Waters 
Corporation). Multiple-charged protein ion signals were deconvoluted to produce zero-
charge spectra using the Maximum EntropyTM 1 (MaxEnt1) algorithm in the Micromass 
MassLynx software package (Thermo Scientific). 
 
8.7. N-TERMINAL AMINO ACID SEQUENCE DETERMINATION 
 
SDS-PAGE protein bands corresponding to the protein after SEC were transferred to a 
polyvinylidene fluoride (PVDF) membrane (Immobilon-P, Millipore) by means of a Mini-Trans 
Blot® electrophoretic transfer cell (Bio-Rad) according to the manufacturer's instructions. 
After transfer, the membrane was stained with 0.1 % Coomassie in water/ethanol/acetic 
acid (60/39/1) to identify the proteins of interest and allowed to dry at room temperature. 
The 55 kDa bands were excised to have their 6 to 10 N-terminal residues sequenced by the 
Edman degradation method (211) with a Procise® 492cLC protein sequencer (Applied 
Biosystems). 
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8.8. CRYSTALLISATION 
 
In all cases, suitable crystallisation conditions were screened for using a nanodrop 
crystallisation robot (Honeybee 963, Digilab Genomic Solutions) starting from commercially 
available (Molecular Dimensions Limited, Clear Strategy Screens I & II) and hand-made 
crystallisation screens, using the sitting-drop vapour diffusion method in 96 well plates 
(Crystalquick, Greiner bio-one) at 4 and 20°C. Various ratios of protein sample to well 
solution and various protein concentrations were tested. Conditions where the largest 
crystals had grown were scaled-up in 24 well plates (Cryschem, Hampton Research). The 
crystals from either 96 or 24 well plates were mounted in a cryo loop (Hampton Research) 
and transferred into a mixture of well solution and ethylene glycol (EG) for cryo-protection 
(see part 3 (manuscript) table S2 and section 4.5.5. table 4-6). In the case of soaking and co-
crystallisation experiments, the cryo-protection solution was supplemented with the 
corresponding compound at the appropriate concentration. Crystals were then flash-frozen 
by rapid immersion in liquid propane and stored in liquid nitrogen until data collection. 
 
8.8.1. NATIVE FL WT StSPL 
 
Initial crystals were found in various conditions at 20°C incubation by diluting a 21-32 mg/ml 
protein sample with either an equal (1:1 drop) or half a volume (2:1 drop) of well solution. 
They usually appeared after two to fifteen days. 
 
8.8.2. FL WT StSPL IN COMPLEX WITH DIVALENT CATIONS 
 
SOAKING 
Native protein crystals obtained as described above were transferred to a mixture of well 
solution supplemented with 10, 50 and 100 mM final concentration of MgCl2. The crystals 
were incubated for 1 h 10, 1 h 15 to 1 h 20 min, respectively, before cryo-protection and 
freezing. 
 
CO-CRYSTALLISATION 
A molar excess of 100-fold of MgCl2, BaCl2 and SrCl2 over protein subunit was added to the 
protein (set at 9 mg/ml). The samples were centrifuged for 10 min at 14000 g at room 
temperature and crystallised as described. 
 
8.8.3. FL WT StSPL IN COMPLEX WITH SEMICARBAZIDE (CO-CRYSTALLISATION) 
 
This part is described in part 3 (manuscript) SI Text and table S2 (structure St_4). 
 
8.8.4. StSPL K311A IN COMPLEX WITH PE (CO-CRYSTALLISATION) 
 
This part is described in part 3 (manuscript) SI Text and table S2 (structure St_3). 
 
SOAKING TRIALS WITH A LONG-CHAIN ALDEHYDE 
Similarly to the S1P soaking procedure, crystals resulting from co-crystallisation of the K311A 
mutant with PE were soaked in a 5 mM solution of cis-11-hexadecenal (Fluka) in 1 % Triton 
X-100. 
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8.8.5. StSPL K311A IN COMPLEX WITH S1P 
 
SOAKING 
Crystals of the inactive mutant K311A were obtained as described for the WT enzyme. 
Several soaking methods were tried. In a first trial, no solvent or detergent was added to the 
sample. Powder of S1P (Acros) was suspended in the corresponding well solution and 
intensively vortexed. 2 μl of the suspension were added to the well (0.8 μl). The well was 
closed and incubated for 6 h at 20°C before cryo-protection and freezing. In a second trial, 
crystals were incubated in S1P solubilised in the well solution (supplemented with 1 % Triton 
X-100). The mixture was incubated from 6 h to 6 weeks at 20°C before being transferred into 
a cryo-protection solution. 
 
CO-CRYSTALLISATION 
In a first trial, a 5 mg/ml protein solution was mixed with 1 mg of S1P powder and incubated 
for 17 h under orbital shaking, either at room temperature or at 4°C in either 10 or 100 μM 
PLP. The sample was concentrated five times before crystallisation. 
In a second trial, 0.5 ml of 2 mg/ml S1P in 1 % Triton X-100 and 0.5 ml of a protein solution 
at 5 mg/ml were mixed and incubated for 2 h at room temperature, followed by a 18 h-long 
step of orbital shaking at 4°C. The sample was subjected to a SEC purification step aiming at 
removing the detergent from the sample, as described in 8.3. The protein was then 
concentrated to 15 mg/ml and crystallised as described. 
In a third trial, 1 ml S1P solubilised in 1 % Triton X-100 was added to 0.7 ml protein solution 
concentrated to 20 mg/ml. The final concentration of detergent amounted to 0.6 %, that is 
approximately 3.6 times its critical micelle concentration (CMC) and the protein 
concentration was 8 mg/ml. The plates were set up with a sample-to-well solution ratio of 
2:1, without incubation. A similar experiment was carried out using S1P solubilised in 0.16 % 
and 0.08 % Triton X-100 instead of 1 % that corresponds respectively to its CMC and half its 
CMC. The samples were incubated for 17 h at 4°C under orbital shaking and concentrated 
2.5 times before crystallisation. 
S1P solubilised in 50 % ethanol in water (v/v) was similarly diluted with respect to the 
protein until a final ethanol concentration of 15 % (v/v). The mixture was then incubated for 
30 min without stirring either at room temperature within a closed tube or at 60°C in an 
open tube to allow for evaporation of ethanol. The mixtures were centrifuged, concentrated 
to reach 10 mg/ml and crystallised as already described. This procedure was repeated at 4°C. 
 
8.8.6. OTHER MUTANTS OF StSPL 
 
The A103P mutant was subject to crystallisation trials according to the same protocol as 
described for native FL WT StSPL. 
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8.8.7. Dpl1p Δ1-102 
 
This part is described in part 3 (manuscript) SI Text and table S2 (structure Dpl1p). 
 
8.8.8. OTHER TRUNCATIONS OF Dpl1p 
 
The truncated variants Δ1-116, Δ1-133, Δ1-116:ΔCt-EXT, Δ1-133:ΔCt-EXT were subjected to 
crystallisation trials under the same conditions as Dpl1p Δ1-102. The truncation Δ1-116 
yielded only spherulites and Δ1-133 thin needles, which didn't diffract. The truncations Δ1-
116:ΔCt-EXT and Δ1-133:ΔCt-EXT did not yield any crystals. 
 
8.9. DATA COLLECTION 
 
Datasets were collected at 100K at the X06SA beamline of the Swiss Light Source (SLS), 
Villigen, Switzerland. Care was taken to limit radiation damage to the crystals by using 
appropriate beam filtering. All datasets were collected on the high-resolution diffractometer 
of the beamline, using a PILATUS 6M detector, with the exception of datasets St_1 and St_2, 
collected on a MD2 micro-diffractometer using a MAR225 CCD detector. 
 
8.9.1. Sr, Mg, Ba ANOMALOUS SIGNALS (CO-CRYSTALLISATION) 
 
These datasets were collected with the aim of detecting the small anomalous scattering 
signal deriving from divalent cations (Sr2+, Mg2+, Ba2+) bound to the protein. To this end, care 
was taken to collect redundant datasets with heavy beam filtering, in order to increase the 
accuracy of the anomalous differences and to reduce the effects of radiation damage. 
Processing with XDS (see also chapter 8.10) was carried out with the option 
STRICT_ABSORPTION_CORRECTION= TRUE, treating the Bijvoet pairs as distinct symmetry-
related reflections in the calculation of the absorption correction coefficients. 
 
8.10. STRUCTURE DETERMINATION, REFINEMENT AND MODEL VALIDATION 
 
The models used for molecular replacement are listed in table 8-5. 
 
8.10.1. StSPL STRUCTURES St_1-4 
 
The refinement statistics of St_1-4 are found in part 3 (manuscript) SI Text and table S3. 
 
8.10.2. OTHER StSPL STRUCTURES 
 
The refinement statistics of St_5-10 are found in section 4.6.8. table 4-9. 
 
8.10.3. Dpl1p STRUCTURE 
 
This part is described in part 3 (manuscript) SI Text and table S3. 
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Table 8-5. Structure determination of the high-resolution datasets 
 
STRUCTURE 
CODE SAMPLE 
RESOLUTION 
[Å] 
NUMBER OF 
POLYPEPTIDE 
CHAINS PER a.u. 
MOLECULAR 
REPLACEMENT 
SEARCH MODEL 
NCS(1) 
St_2 pQE60 FL WT StSPL native 3.0 2 polyS GadB YES 
St_5 pQE60 FL WT StSPL native 3.4 4 
St_2 
(subunits A & B) YES 
St_1 pQE60 FL WT StSPL native 2.0 2 
St_10 
(subunits A & B) NO 
St_6 
pQE70 FL WT 
StSPL 
soaking in 
10 mM Mg2+ 
2.4 4 St_10 (subunits A & B) NO 
St_7 
pQE70 FL WT 
StSPL 
soaking in 
50 mM Mg2+ 
2.7 4 St_10 (subunits A & B) NO 
St_8 
pQE70 FL WT 
StSPL 
soaking in 
100 mM Mg2+ 
3.4 4 St_2 (subunits A & B) YES 
St_9 
pQE70 FL WT 
StSPL 
co-cryst. with 
Sr2+ 
2.6 2 St_10 (subunits A & B) NO 
St_3 
pQE70 StSPL 
K311A co-
cryst. with PE 
2.9 4 St_10 (subunits A & B) YES 
St_4 
pQE70 StSPL 
K311A co-
cryst. with 
SEMIC 
2.0(5) 2 St_10 (subunits A & B) NO 
St_10 
pQE70 StSPL 
K311A soaked 
with S1P 
1.9 4 St_2 (subunits A & B) NO 
Dpl1p pET28a+ Dpl1p Δ1-102 native 3.1(5) 4 
St_10 
(subunits A & B) YES 
 
(1) NCS applied (using Phenix): note that St_5, 6, 7, 8, 9 and 10 were not refined to  
completion. Application of NCS may change in a complete refinement protocol for datasets 
St_6,7 and 9. 
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8.11. S1P CLEAVAGE ASSAYS 
 
8.11.1. DETECTION OF SUBSTRATE AND REACTION PRODUCT BY MS 
 
This experiment is described in part 3 (manuscript) SI Text. 
 
8.11.2. LONG-CHAIN ALDEHYDE DERIVATIZATION TRIALS 
 
The long-chain aldehyde end product of the SPL reaction was subjected to derivatization 
with dinitrophenylhydrazine (DNPH) after lipid extraction, carried out using two different 
protocols described in (212) and in (113), (131), respectively. Chloroform was replaced by 
dichloromethane in the lipid extraction attempt based on (212). Dried material from the 
organic phase was resuspended in 20 μl 100 % methanol and derivatized with DNPH as 
described in (131) and (143). The internal and external standards used were trans-2-hexenal 
(Acros) and trans-2-tridecenal (Sigma-Aldrich). The corresponding 2,4-
dinitrophenylhydrazone derivatives were detected spectrophotometrically by monitoring 
the absorbance increase at 378 nm and not on HPLC as performed in (131). A DNPH 
derivatization test omitting the lipid extraction was also tried. For this, 20 μl of reaction 
mixture was used instead of 20 μl of organic phase resuspended in methanol. 
 
8.11.3. S1P DERIVATIZATION AND HPLC SEPARATION 
 
Derivatization of the primary amine of S1P and PE with naphthalene-2,3-dicarboxaldehyde 
(NDA) (Invitrogen) was carried out as described in (213) with some modifications. Instead of 
the lipid extraction step, S1P solubilised in either 100 % ethanol or 0.16 % Triton X-100 was 
separated from the enzyme in a Vivaspin-500 50000 MWCO concentrator (Sartorius Stedim) 
according to the manufacturer's instructions. The same test omitting the separation step 
was also tried. The flow-through was used in the same way as the lipid extract as explained 
in (213) except that 10 mM NDA and sodium cyanate (NaCN) solutions were used instead of 
5 mM. 20 μl of derivatization mixture were separated using a C18 reverse-phase HPLC 
column (Macherey-Nagel) calibrated with S1P and PE standards. Mobile phase A was 50 mM 
KPi pH 6.5, while mobile phase B was acetonitrile. The gradient program was 0-25 min 100-
40 % A, 0-60 % B; 25-35 min 100 % A. The separation was carried out at 40°C at a flow rate of 
1 ml/min. The derivatives were detected at 420 and 443 nm. The HPLC system was from 
Agilent and the chromatograms were analysed using the software ChemStation (Agilent). 
 
8.12. YEAST SYNTHETIC LETHALITY TEST 
 
This experiment is described in part 3 (manuscript) SI Text. 
 
The plasmid pRS415- Dpl1p fl wt as well as pRS415 plasmids carrying Dpl1p mutants were a 
kind gift from Prof. Howard Riezman (University of Geneva, Switzerland). 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  169 
9. REFERENCES 
 
1. van Meer G, Voelker DR, & Feigenson GW (2008) Membrane lipids: where they are 
and how they behave. Nat Rev Mol Cell Biol 9:112-124. 
2. Marsch M & Helenius A (2006) Virus entry:open sesame. Cell 124:729-740. 
3. Marsh D (2007) Lateral pressure profile, spontaneous curvature frustration, and the 
incorporation and conformation of proteins in membranes. Biophys J. 93:3884-3899. 
4. Hla T, Lee MJ, Ancellin N, Paik JH, & Kluk MJ (2001) Lysophospholipids--receptor 
revelations. Science 294:1875-1878. 
5. Daum G (1985) Lipids of mitochondria. Biochim Biophys Acta 822:1-42. 
6. Strauss JFr, Kishida T, Christenson LK, Fujimoto T, & Hiroi H (2003) START domain 
proteins and the intracellular trafficking of cholesterol in steroidogenic cells. Mol Cell 
Endocrinol. 202:59-65. 
7. Devaux PF & Morris R (2004) Transmembrane asymmetry and lateral domains in 
biological membranes. Traffic. 5:241-246. 
8. Pomorski T & Menon AK (2006) Lipid flippases and their biological functions. Cell Mol 
Life Sci. 63:2908-2921. 
9. Anglin TC, Liu J, & Conboy JC (2007) Facile lipid flip-flop in a phospholipid bilayer 
induced by gramicidin A measured by sum-frequency vibrational spectroscopy. 
Biophys J. 92:L01-03. 
10. López-Montero I, et al. (2005) Rapid transbilayer movement of ceramides in 
phospholipid vesicles and in human erythrocytes. J Biol Chem. 280:25811-25819. 
11. Daleke DL (2007) Phospholipid flippases. J Biol Chem. 282:821-825. 
12. Aye IL, Singh AT, & Keelan JA (2009) Transport of lipids by ABC proteins: interactions 
and implications for cellular toxicity, viability and function. Chem Biol Interact 
180:327-339. 
13. Baumann NA, et al. (2005) Transport of newly synthesized sterol to the sterol-
enriched plasma membrane occurs via nonvesicular equilibration. Biochemistry 
44:5816-5826. 
14. Sleight RG & Pagano RE (1983) Rapid appearance of newly synthesized 
phosphatidylethanolamine at the plasma membrane. J Biol Chem 258:9050-9058. 
15. Kaplan MR & Simoni RD (1985) Intracellular transport of phosphatidylcholine to the 
plasma membrane. J Cell Biol 101:441-445. 
16. Voelker DR (1990) Characterization of phosphatidylserine synthesis and translocation 
in permeabilized animal cells. J Biol Chem 265:14340-14346. 
17. Warnock DE, Lutz MS, Blackburn WA, Young WWJ, & Baenziger JU (1994) Transport 
of newly synthesized glucosylceramide to the plasma membrane by a non-Golgi 
pathway. Proc Natl Acad Sci U S A 91:2708-2712. 
18. Hanada K, et al. (2003) Molecular machinery for non-vesicular trafficking of 
ceramide. Nature 426:803-809. 
19. Hanada K, Kumagai K, Tomishige N, & Kawano M (2007) CERT and intracellular 
trafficking of ceramide. Biochim Biophys Acta 1771:644-653. 
20. Kudo N, et al. (2008) Structural basis for specific lipid recognition by CERT responsible 
for nonvesicular trafficking of ceramide. Proc Natl Acad Sci U S A 105:488-493. 
21. van Veldhoven PP & Mannaerts GP (1993) Sphingosine-phosphate lyase. Adv Lipid 
Res 26:69-98. 
Part 9: References 
170 
22. Merrill AHJ, Wang MD, Park M, & Sullards MC (2007) (Glyco)sphingolipidology: an 
amazing challenge and opportunity for systems biology. Trends Biochem Sci. 32:457-
468. 
23. Bartke N & Hannun YA (2009) Bioactive sphingolipids: metabolism and function. J 
Lipid Res 50 91-96. 
24. Linn SC, et al. (2001) Regulation of de novo sphingolipid biosynthesis and the toxic 
consequences of its disruption. Biochem Soc Trans 29:831-835. 
25. Pewzner-Jung Y, Ben-Dor S, & Futerman AH (2006) When do Lasses (longevity 
assurance genes) become CerS (ceramide synthases)?: Insights into the regulation of 
ceramide synthesis. J Biol Chem 281:25001-25005. 
26. Causeret C, Geeraert L, Van der Hoeven G, Mannaerts GP, & Van Veldhoven PP 
(2000) Further characterization of rat dihydroceramide desaturase: tissue 
distribution, subcellular localization, and substrate specificity. Lipids 35:1117-1125. 
27. Raas-Rothschild A, Pankova-Kholmyansky I, Kacher Y, & Futerman AH (2004) 
Glycosphingolipidoses: beyond the enzymatic defect. Glycoconj J 21:295-304. 
28. Wijesinghe DS, et al. (2005) Substrate specificity of human ceramide kinase. J Lipid 
Res 46:2706-2716. 
29. Tafesse FG, Ternes P, & Holthuis JC (2006) The multigenic sphingomyelin synthase 
family. J Biol Chem 281:29421-29425. 
30. Marchesini N & Hannun YA (2004) Acid and neutral sphingomyelinases: roles and 
mechanisms of regulation. Biochem Cell Biol 82:27-44. 
31. Xu R, et al. (2006) Golgi alkaline ceramidase regulates cell proliferation and survival 
by controlling levels of sphingosine and S1P. FASEB J 20:1813-1825. 
32. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, & Spiegel S (2006) Sphingosine 
kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 
1758:2016-2026. 
33. Johnson KR, et al. (2003) Role of human sphingosine-1-phosphate phosphatase 1 in 
the regulation of intra- and extracellular sphingosine-1-phosphate levels and cell 
viability. J Biol Chem 278:34541-34547. 
34. Bandhuvula P & Saba JD (2007) Sphingosine-1-phosphate lyase in immunity and 
cancer: silencing the siren. Trends Mol Med 13:210-217. 
35. Horibata Y & Hirabayashi Y (2007) Identification and characterization of human 
ethanolaminephosphotransferase1. J Lipid Res. 48:503-508. 
36. Dobrosotskaya IY, Seegmiller AC, Brown MS, Goldstein JL, & Rawson RB (2002) 
Regulation of SREBP processing and membrane lipid production by phospholipids in 
Drosophila. Science 296:879-883. 
37. Hakomori S (2000) Traveling for the glycosphingolipid path. Glycoconj J 17:627-647. 
38. Tani M, Ito M, & Igarashi Y (2007) Ceramide/sphingosine/sphingosine 1-phosphate 
metabolism on the cell surface and in the extracellular space. Cell Signal 19:229-237. 
39. Romiti E, et al. (2000) Characterization of sphingomyelinase activity released by 
thrombin-stimulated platelets. Mol Cell Biochem 205:75-81. 
40. Duan RD, et al. (2003) Identification of human intestinal alkaline sphingomyelinase as 
a novel ecto-enzyme related to the nucleotide phosphodiesterase family. J Biol Chem 
278:38528-38536. 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  171 
41. Johnson KR, Becker KP, Facchinetti MM, Hannun YA, & Obeid LM (2002) PKC-
dependent activation of sphingosine kinase 1 and translocation to the plasma 
membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-
myristate 13-acetate (PMA). J Biol Chem 277:35257-35262. 
42. Don AS & Rosen H (2009) A lipid binding domain in sphingosine kinase 2. Biochem 
Biophys Res Commun 380:87-92. 
43. Spiegel S & Milstien S (2003) Sphingosine-1-phosphate: an enigmatic signalling lipid. 
Nat Rev Mol Cell Biol 4:397-407. 
44. Yatomi Y, et al. (1997) Sphingosine 1-phosphate, a bioactive sphingolipid abundantly 
stored in platelets, is a normal constituent of human plasma and serum. J Biochem 
121:969-973. 
45. Hänel P, Andréani P, & Gräler MH (2007) Erythrocytes store and release sphingosine 
1-phosphate in blood. FASEB J 21:1202-1209. 
46. Mitra P, et al. (2006) Role of ABCC1 in export of sphingosine-1-phosphate from mast 
cells. Proc Natl Acad Sci U S A 103:16394-16399. 
47. Boujaoude LC, et al. (2001) Cystic fibrosis transmembrane regulator regulates uptake 
of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular 
activity of sphingosine 1-phosphate. J Biol Chem 276:35258-35264. 
48. Goñi FM & Alonso A (2002) Sphingomyelinases: enzymology and membrane activity. 
FEBS Lett 531:38-46. 
49. Tani M & Kuge O (2009) Sphingomyelin synthase 2 is palmitoylated at the COOH-
terminal tail, which is involved in its localization in plasma membranes. Biochem 
Biophys Res Commun 381:328-332. 
50. Vacaru AM, et al. (2009) Sphingomyelin synthase-related protein SMSr controls 
ceramide homeostasis in the ER. J Cell Biol 185:1013-1027. 
51. Monick MM, et al. (2004) Cooperative prosurvival activity by ERK and Akt in human 
alveolar macrophages is dependent on high levels of acid ceramidase activity. J 
Immunol 173:123-135. 
52. Ferlinz K, et al. (2001) Human acid ceramidase: processing, glycosylation, and 
lysosomal targeting. J Biol Chem 276:35352-35360. 
53. Ohlsson L, et al. (2007) Purification and characterization of human intestinal neutral 
ceramidase. Biochimie 89:950-960. 
54. Bose R, et al. (1995) Ceramide synthase mediates daunorubicin-induced apoptosis: 
an alternative mechanism for generating death signals. Cell 82:405-414. 
55. Hornemann T, Wei Y, & von Eckardstein A (2007) Is the mammalian serine 
palmitoyltransferase a high-molecular-mass complex? Biochem J 405:157-164. 
56. Han G, et al. (2009) Identification of small subunits of mammalian serine 
palmitoyltransferase that confer distinct acyl-CoA substrate specificities. Proc Natl 
Acad Sci U S A 106:8186-8191. 
57. Hanada K, et al. (1997) A mammalian homolog of the yeast LCB1 encodes a 
component of serine palmitoyltransferase, the enzyme catalyzing the first step in 
sphingolipid synthesis. J Biol Chem 272:32108-32114. 
58. Giussani P, et al. (2006) Sphingosine-1-phosphate phosphohydrolase regulates 
endoplasmic reticulum-to-golgi trafficking of ceramide. Mol Cell Biol 26:5055-5069. 
59. Sutherland CM, et al. (2006) The calmodulin-binding site of sphingosine kinase and its 
role in agonist-dependent translocation of sphingosine kinase 1 to the plasma 
membrane. J Biol Chem 281:11693-11701. 
Part 9: References 
172 
60. Stahelin RV, et al. (2005) The mechanism of membrane targeting of human 
sphingosine kinase 1. J Biol Chem 280:43030-43038. 
61. Van Veldhoven PP, Gijsbers S, Mannaerts GP, Vermeesch JR, & Brys V (2000) Human 
sphingosine-1-phosphate lyase: cDNA cloning, functional expression studies and 
mapping to chromosome 10q22(1). Biochim Biophys Acta 1487:128-134. 
62. Toledo MS, Suzuki E, Handa K, & Hakomori S (2005) Effect of ganglioside and 
tetraspanins in microdomains on interaction of integrins with fibroblast growth 
factor receptor. J Biol Chem 280:16227-16234. 
63. Bollinger CR, Teichgräber V, & Gulbins E (2005) Ceramide-enriched membrane 
domains. Biochim Biophys Acta 1746:284-294. 
64. Ray PE (2009) Shiga-like toxins and HIV-1 'go through' glycosphingolipids and lipid 
rafts in renal cells. Kidney Int 75:1135-1137. 
65. Hannun YA & Obeid LM (2008) Principles of bioactive lipid signalling: lessons from 
sphingolipids. Nat Rev Mol Cell Biol 9:139-150. 
66. Spiegel S & Milstien S (2002) Sphingosine 1-phosphate, a key cell signaling molecule. J 
Biol Chem 277:25851-25854. 
67. Gouaze-Andersson V & Cabot MC (2006) Glycosphingolipids and drug resistance. 
Biochim Biophys Acta 1758:2096-2103. 
68. Smith ER, Merrill AHJ, Obeid LM, & Hannun YA (2000) Effects of sphingosine and 
other sphingolipids on protein kinase C. Methods Enzymol 312:361-373. 
69. Venable ME, Lee JY, Smyth MJ, Bielawska A, & Obeid LM (1995) Role of ceramide in 
cellular senescence. J Biol Chem 270:30701-30708. 
70. Obeid LM, Linardic CM, Karolak LA, & Hannun YA (1993) Programmed cell death 
induced by ceramide. Science 259:1769-1771. 
71. Chalfant CE & Spiegel S (2005) Sphingosine 1-phosphate and ceramide 1-phosphate: 
expanding roles in cell signaling. J Cell Sci 118:4605-4612. 
72. Hinkovska-Galcheva V, et al. (2005) Ceramide 1-phosphate, a mediator of 
phagocytosis. J Biol Chem 280:26612-26621. 
73. Hla T (2004) Physiological and pathological actions of sphingosine 1-phosphate. 
Semin Cell Dev Biol. 15:513-520. 
74. Johnson KR, et al. (2005) Immunohistochemical distribution of sphingosine kinase 1 
in normal and tumor lung tissue. J Histochem Cytochem 53:1159-1166. 
75. Shida D, Takabe K, Kapitonov D, Milstien S, & Spiegel S (2008) Targeting SphK1 as a 
new strategy against cancer. Curr Drug Targets 9:662-673. 
76. French KJ, et al. (2006) Antitumor activity of sphingosine kinase inhibitors. J 
Pharmacol Exp Ther 318:596-603. 
77. Taha TA, Argraves KM, & Obeid LM (2004) Sphingosine-1-phosphate receptors: 
receptor specificity versus functional redundancy. Biochim Biophys Acta 1682:48-55. 
78. Schwab SR, et al. (2005) Lymphocyte sequestration through S1P lyase inhibition and 
disruption of S1P gradients. Science 309:1735-1739. 
79. Liu H, Chakravarty D, Maceyka M, Milstien S, & Spiegel S (2002) Sphingosine kinases: 
a novel family of lipid kinases. Prog Nucleic Acid Res Mol Biol 71:493-511. 
80. Hobson JP, et al. (2001) Role of the sphingosine-1-phosphate receptor EDG-1 in 
PDGF-induced cell motility. Science 291:1800-1803. 
81. Shu X, Wu W, Mosteller RD, & Broek D (2002) Sphingosine kinase mediates vascular 
endothelial growth factor-induced activation of ras and mitogen-activated protein 
kinases. Mol Cell Biol 22:7758-7768. 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  173 
82. Young KW, et al. (2003) Ca2+/calmodulin-dependent translocation of sphingosine 
kinase: role in plasma membrane relocation but not activation. Cell Calcium 33:119-
128. 
83. Xia P, et al. (2002) Sphingosine kinase interacts with TRAF2 and dissects tumor 
necrosis factor-alpha signaling. J Biol Chem 277:7996-8003. 
84. Edsall LC, Cuvillier O, Twitty S, Spiegel S, & Milstien S (2001) Sphingosine kinase 
expression regulates apoptosis and caspase activation in PC12 cells. J Neurochem 
76:1573-1584. 
85. Birchwood CJ, Saba JD, Dickson RC, & Cunningham KW (2001) Calcium influx and 
signaling in yeast stimulated by intracellular sphingosine 1-phosphate accumulation. J 
Biol Chem 276:11712-11718. 
86. Rivera J, Proia RL, & Olivera A (2008) The alliance of sphingosine-1-phosphate and its 
receptors in immunity. Nat Rev Immunol 8:753-763. 
87. Kobayashi N, et al. (2006) Sphingosine 1-phosphate is released from the cytosol of rat 
platelets in a carrier-mediated manner. J Lipid Res 47:614-621. 
88. Sato K, et al. (2007) Critical role of ABCA1 transporter in sphingosine 1-phosphate 
release from astrocytes. J Neurochem 103:2610–2619. 
89. van Meer G & Lisman Q (2002) Sphingolipid transport: rafts and translocators. J Biol 
Chem 277:25855-25858. 
90. Kim RH, Takabe K, Milstien S, & Spiegel S (2009) Export and functions of sphingosine-
1-phosphate. Biochim Biophys Acta 1791:7692-7696. 
91. Lee MJ, et al. (1998) Sphingosine-1-phosphate as a ligand for the G protein-coupled 
receptor EDG-1. Science 279:1552-1555. 
92. Liu Y, et al. (2000) Edg-1, the G protein-coupled receptor for sphingosine-1-
phosphate, is essential for vascular maturation. J Clin Invest 106:951-961. 
93. Kupperman E, An S, Osborne N, Waldron S, & Stainier DY (2000) A sphingosine-1-
phosphate receptor regulates cell migration during vertebrate heart development. 
Nature 406:192-195. 
94. Brinkmann V, et al. (2002) The immune modulator FTY720 targets sphingosine 1-
phosphate receptors. J Biol Chem 277:21453-21457. 
95. Mandala SM, et al. (2002) Alteration of lymphocyte trafficking by sphingosine-1-
phosphate receptor agonists. Science 296:346-349. 
96. Graeler M, Shankar G, & Goetzl EJ (2002) Cutting edge: suppression of T cell 
chemotaxis by sphingosine 1-phosphate. J Immunol 169:4084-4087. 
97. Pappu R, et al. (2007) Promotion of lymphocyte egress into blood and lymph by 
distinct sources of sphingosine-1-phosphate. Science 316:295-298. 
98. Venkataraman K, et al. (2008) Vascular endothelium as a contributor of plasma 
sphingosine 1-phosphate. Circ Res 102:669-676. 
99. Yatomi Y (2008) Plasma sphingosine 1-phosphate metabolism and analysis. Biochim 
Biophys Acta 1780:606-611. 
100. Schwab SR & Cyster JG (2007) Finding a way out: lymphocyte egress from lymphoid 
organs. Nat Immunol 8:1295-1301. 
101. Ledgerwood LG, et al. (2008) The sphingosine 1-phosphate receptor 1 causes tissue 
retention by inhibiting the entry of peripheral tissue T lymphocytes into afferent 
lymphatics. Nat Immunol 9:42-53. 
102. Matloubian M, et al. (2004) Lymphocyte egress from thymus and peripheral 
lymphoid organs is dependent on S1P receptor 1. Nature 427:355-360. 
Part 9: References 
174 
103. Mao C, Wadleigh M, Jenkins GM, Hannun YA, & Obeid LM (1997) Identification and 
characterization of Saccharomyces cerevisiae dihydrosphingosine-1-phosphate 
phosphatase. J Biol Chem 272:28690-28694. 
104. Mandala SM, et al. (1998) Sphingoid base 1-phosphate phosphatase: a key regulator 
of sphingolipid metabolism and stress response. Proc Natl Acad Sci U S A 95:150-155. 
105. Mao C, Saba JD, & Obeid LM (1999) The dihydrosphingosine-1-phosphate 
phosphatases of Saccharomyces cerevisiae are important regulators of cell 
proliferation and heat stress responses. Biochem J 342 Pt 3:667-675. 
106. Mandala SM, et al. (2000) Molecular cloning and characterization of a lipid 
phosphohydrolase that degrades sphingosine-1- phosphate and induces cell death. 
Proc Natl Acad Sci U S A 97:7859-7864. 
107. Ogawa C, Kihara A, Gokoh M, & Igarashi Y (2003) Identification and characterization 
of a novel human sphingosine-1-phosphate phosphohydrolase, hSPP2. J Biol Chem 
278:1268-1272. 
108. Le Stunff H, et al. (2002) Characterization of murine sphingosine-1-phosphate 
phosphohydrolase. J Biol Chem 277:8920-8927. 
109. Le Stunff H, Milstien S, & Spiegel S (2004) Generation and metabolism of bioactive 
sphingosine-1-phosphate. J Cell Biochem 92:882-899. 
110. Saba JD, Nara F, Bielawska A, Garrett S, & Hannun YA (1997) The BST1 gene of 
Saccharomyces cerevisiae is the sphingosine-1-phosphate lyase. J Biol Chem 
272:26087-26090. 
111. Fyrst H & Saba JD (2008) Sphingosine-1-phosphate lyase in development and disease: 
sphingolipid metabolism takes flight. Biochim Biophys Acta 1781:448-458. 
112. Mukhopadhyay D, Howell KS, Riezman H, & Capitani G (2008) Identifying key residues 
of sphinganine-1-phosphate lyase for function in vivo and in vitro. J Biol Chem 
283:20159-20169. 
113. Van Veldhoven PP & Mannaerts GP (1991) Subcellular localization and membrane 
topology of sphingosine-1-phosphate lyase in rat liver. J Biol Chem 266:12502-12507. 
114. Reiss U, et al. (2004) Sphingosine-phosphate lyase enhances stress-induced ceramide 
generation and apoptosis. J Biol Chem 279:1281-1290. 
115. Ikeda M, Kihara A, & Igarashi Y (2004) Sphingosine-1-phosphate lyase SPL is an 
endoplasmic reticulum-resident, integral membrane protein with the pyridoxal 5'-
phosphate binding domain exposed to the cytosol. Biochem Biophys Res Commun 
325:338-343. 
116. Zhou J & Saba JD (1998) Identification of the first mammalian sphingosine phosphate 
lyase gene and its functional expression in yeast. Biochem Biophys Res Commun 
242:502-507. 
117. Degtyar E, Zusman T, Ehrlich M, & Segal G (2009) A Legionella effector acquired from 
protozoa is involved in sphingolipids metabolism and is targeted to the host cell 
mitochondria. Cell Microbiol 11:1219-1235. 
118. Skrzypek MS, Nagiec MM, Lester RL, & Dickson RC (1999) Analysis of phosphorylated 
sphingolipid long-chain bases reveals potential roles in heat stress and growth 
control in Saccharomyces. J Bacteriol 181:1134-1140. 
119. Gottlieb D, Heideman W, & Saba JD (1999) The DPL1 gene is involved in mediating 
the response to nutrient deprivation in Saccharomyces cerevisiae. Mol Cell Biol Res 
Commun 1:66-71. 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  175 
120. Grote E, Vlacich G, Pypaert M, & Novick PJ (2000) A snc1 endocytosis mutant: 
phenotypic analysis and suppression by overproduction of dihydrosphingosine 
phosphate lyase. Mol Biol Cell 11:4051-4065. 
121. Chen WV, Delrow J, Corrin PD, Frazier JP, & Soriano P (2004) Identification and 
validation of PDGF transcriptional targets by microarray-coupled gene-trap 
mutagenesis. Nat Genet 36:304-312. 
122. Alvarez RH, Kantarjian HM, & Cortes JE (2006) Biology of platelet-derived growth 
factor and its involvement in disease. Mayo Clin Proc 81:1241-1257. 
123. Ito K, et al. (2007) Lack of sphingosine 1-phosphate-degrading enzymes in 
erythrocytes. Biochem Biophys Res Commun 357:212-217. 
124. Oskouian B, et al. (2006) Sphingosine-1-phosphate lyase potentiates apoptosis via 
p53- and p38-dependent pathways and is down-regulated in colon cancer. Proc Natl 
Acad Sci U S A 103:17384-17389. 
125. Oskouian B & Saba J (2007) Sphingosine-1-phosphate metabolism and intestinal 
tumorigenesis: lipid signaling strikes again. Cell Cycle 6:522-527. 
126. Hibbs K, et al. (2004) Differential gene expression in ovarian carcinoma: identification 
of potential biomarkers. Am J Pathol 165:397-414. 
127. Seo EY, et al. (2006) Identification of the target genes of atopic dermatitis by real-
time PCR. J Invest Dermatol 126:1187-1189. 
128. Zhan X & Desiderio DM (2006) Nitroproteins from a human pituitary adenoma tissue 
discovered with a nitrotyrosine affinity column and tandem mass spectrometry. Anal 
Biochem 354:279-289. 
129. Kariya Y, et al. (2005) Products by the sphingosine kinase/sphingosine 1-phosphate 
(S1P) lyase pathway but not S1P stimulate mitogenesis. Genes Cells 10:605-615. 
130. Zhang K, et al. (2007) Redirection of sphingolipid metabolism toward de novo 
synthesis of ethanolamine in Leishmania. Embo J 26:1094-1104. 
131. Bandhuvula P, Fyrst H, & Saba JD (2007) A rapid fluorescence assay for sphingosine-1-
phosphate lyase enzyme activity. J Lipid Res 48:2769-2778. 
132. Van Veldhoven PP (2000) Sphingosine-1-phosphate lyase. Methods Enzymol 311:244-
254. 
133. Stoffel W, LeKim D, & Sticht G (1969) Distribution and properties of 
dihydrosphingosine-1-phosphate aldolase (sphinganine-1-phosphate alkanal-lyase). 
Hoppe Seylers Z Physiol Chem 350:1233-1241. 
134. Stoffel W & Grol M (1974) Chemistry and biochemistry of 1-desoxysphinganine 1-
phosphonate (dihydrosphingosine-1-phosphonate). Chem Phys Lipids 13:372-388. 
135. Boumendjel A & Miller SP (1994) Synthesis of sphingosine-1-phosphate and 
dihydrosphingosine-1-phosphate. J Lipid Res 35:2305-2311. 
136. Stoffel W, Bauer E, & Stahl J (1974) The metabolism of sphingosine bases in 
Tetrahymena pyriformis. Sphingosine kinase and sphingosine-1-phosphate lyase. 
Hoppe Seylers Z Physiol Chem 355:61-74. 
137. Billich A, et al. (2003) Phosphorylation of the immunomodulatory drug FTY720 by 
sphingosine kinases. J Biol Chem 278:47408-47415. 
138. Paugh SW, Payne SG, Barbour SE, Milstien S, & Spiegel S (2003) The 
immunosuppressant FTY720 is phosphorylated by sphingosine kinase type 2. FEBS 
Lett 554:189-193. 
139. Mullershausen F, et al. (2009) Persistent signaling induced by FTY720-phosphate is 
mediated by internalized S1P1 receptors. Nat Chem Biol 5:428-434. 
Part 9: References 
176 
140. Bandhuvula P, Tam YY, Oskouian B, & Saba JD (2005) The immune modulator FTY720 
inhibits sphingosine-1-phosphate lyase activity. J Biol Chem 280:33697-33700. 
141. Sasaki H, Arai H, Cocco MJ, & White SH (2009) pH dependence of sphingosine 
aggregation. Biophys J 96:72727-72733. 
142. Bedia C, et al. (2009) Synthesis of a fluorogenic analogue of sphingosine-1-phosphate 
and its use to determine sphingosine-1-phosphate lyase activity. Chembiochem 
10:820-822. 
143. Bandhuvula P, Li Z, Bittman R, & Saba JD (2009) Sphingosine 1-phosphate lyase 
enzyme assay using a BODIPY-labeled substrate. Biochem Biophys Res Commun 
380:366-370. 
144. Shimojo T, Akino T, Miura Y, & Schroepfer GJJ (1976) Sphingolipid base metabolism. 
Stereospecific uptake of proton in the enzymatic conversion of sphinganine 1-
phosphate to ethanolamine 1-phosphate. J Biol Chem 251:4448-4447. 
145. Openshaw AE, Race PR, Monzó HJ, Vázquez-Boland JA, & Banfield MJ (2005) Crystal 
structure of SmcL, a bacterial neutral sphingomyelinase C from Listeria. J Biol Chem 
280:35011-35017. 
146. Obama T, et al. (2003) His151 and His296 are the acid-base catalytic residues of 
Bacillus cereus sphingomyelinase in sphingomyelin hydrolysis. Biol Pharm Bull 
26:920-926. 
147. Ago H, et al. (2006) Structural basis of the sphingomyelin phosphodiesterase activity 
in neutral sphingomyelinase from Bacillus cereus. J Biol Chem 281:16157-16167. 
148. Murakami MT, et al. (2006) Structural insights into the catalytic mechanism of 
sphingomyelinases D and evolutionary relationship to glycerophosphodiester 
phosphodiesterases. Biochem Biophys Res Commun 342:323-329. 
149. Murakami MT, Fernandes-Pedrosa MF, Tambourgi DV, & Arni RK (2005) Structural 
basis for metal ion coordination and the catalytic mechanism of sphingomyelinases 
D. J Biol Chem 280:13658-13664. 
150. Inoue T, et al. (2009) Mechanistic insights into the hydrolysis and synthesis of 
ceramide by neutral ceramidase. J Biol Chem 284:9566-9577. 
151. Tani M, Iida H, & Ito M (2003) O-glycosylation of mucin-like domain retains the 
neutral ceramidase on the plasma membranes as a type II integral membrane 
protein. J Biol Chem 278:10523-10530. 
152. Malinina L, Malakhova ML, Teplov A, Brown RE, & Patel DJ (2004) Structural basis for 
glycosphingolipid transfer specificity. Nature 430:1048-1053. 
153. Malinina L, et al. (2006) The liganding of glycolipid transfer protein is controlled by 
glycolipid acyl structure. PLoS Biol 4:e362. 
154. Airenne TT, et al. (2006) Structural evidence for adaptive ligand binding of glycolipid 
transfer protein. J Mol Biol 355:224-236. 
155. Hornemann T, et al. (2009) The SPTLC3 subunit of serine-palmitoyltransferase 
generates short chain sphingoid bases. J Biol Chem 284:26322-26330. 
156. Ikushiro H, Hayashi H, & Kagamiyama H (2003) Bacterial serine palmitoyltransferase: 
a water-soluble homodimeric prototype of the eukaryotic enzyme. Biochim Biophys 
Acta 1647:116-120. 
157. Ikushiro H, Islam MM, Tojo H, & Hayashi H (2007) Molecular characterization of 
membrane-associated soluble serine palmitoyltransferases from Sphingobacterium 
multivorum and Bdellovibrio stolpii. J Bacteriol 189:5749-5761. 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  177 
158. Yard BA, et al. (2007) The structure of serine palmitoyltransferase; gateway to 
sphingolipid biosynthesis. J Mol Biol 370:870-886. 
159. Shiraiwa Y, Ikushiro H, & Hayashi H (2009) Multifunctional role of his159in the 
catalytic reaction of serine palmitoyltransferase. J Biol Chem 284:15487-15495. 
160. Raman MC, et al. (2009) The External Aldimine Form of Serine Palmitoyltransferase: 
STRUCTURAL, KINETIC, AND SPECTROSCOPIC ANALYSIS OF THE WILD-TYPE ENZYME 
AND HSAN1 MUTANT MIMICS. J Biol Chem 284:17328-17339. 
161. Ikushiro H, Fujii S, Shiraiwa Y, & Hayashi H (2008) Acceleration of the substrate 
Calpha deprotonation by an analogue of the second substrate palmitoyl-CoA in 
Serine Palmitoyltransferase. J Biol Chem 283:7542-7553. 
162. Ikushiro H, et al. (2009) Structural Insights into the Enzymatic Mechanism of Serine 
Palmitoyltransferase from Sphingobacterium multivorum. J Biochem 146:549-562. 
163. De Biase D, Tramonti A, Bossa F, & Visca P (1999) The response to stationary-phase 
stress conditions in Escherichia coli: role and regulation of the glutamic acid 
decarboxylase system. Mol Microbiol 32:1198-1211. 
164. Capitani G, et al. (2003) Crystal structure and functional analysis of Escherichia coli 
glutamate decarboxylase. Embo J 22:4027-4037. 
165. Gut H, et al. (2006) Escherichia coli acid resistance: pH-sensing, activation by chloride 
and autoinhibition in GadB. Embo J 25:2643-2651. 
166. Altschul SF, et al. (1997) Gapped BLAST and PSI-BLAST: a new generation of protein 
database search programs. Nucleic Acids Res 25:3389-3402. 
167. Boutet E, Lieberherr D, Tognolli M, Schneider M, & Bairoch A (2007) 
UniProtKB/Swiss-Prot. Methods Mol Biol 406:89-112. 
168. Ohno M, et al. (2000) Symbiobacterium thermophilum gen. nov., sp. nov., a 
symbiotic thermophile that depends on co-culture with a Bacillus strain for growth. 
Int J Syst Evol Microbiol 50:1829-1832. 
169. Nishida H, Beppu T, & Ueda K (2009) Symbiobacterium lost carbonic anhydrase in the 
course of evolution. J Mol Evol 68:90-96. 
170. Ueda K, et al. (2001) Distribution and diversity of symbiotic thermophiles, 
Symbiobacterium thermophilum and related bacteria, in natural environments. Appl 
Environ Microbiol 67:3779-3784. 
171. Sugihara T, et al. (2008) Distribution of Symbiobacterium thermophilum and related 
bacteria in the marine environment. Biosci Biotechnol Biochem 72:204-211. 
172. Ueda K, et al. (2004) Genome sequence of Symbiobacterium thermophilum, an 
uncultivable bacterium that depends on microbial commensalism. Nucleic Acids Res 
32:4937-4944. 
173. Sahu SK, Rajasekharan A, & Gummadi SN (2009) GroES and GroEL are essential 
chaperones for refolding of recombinant human phospholipid scramblase 1 in E. coli. 
Biotechnol Lett 31:1745-1752. 
174. Eliot AC & Kirsch JF (2004) Pyridoxal phosphate enzymes: mechanistic, structural, and 
evolutionary considerations. Annu Rev Biochem 73:383-415. 
175. Toney MD (2005) Reaction specificity in pyridoxal phosphate enzymes. Arch Biochem 
Biophys 433:279-287. 
176. Cook PD, Thoden JB, & Holden HM (2006) The structure of GDP-4-keto-6-deoxy-D-
mannose-3-dehydratase: a unique coenzyme B6-dependent enzyme. Protein Sci 
15:2093-2106. 
Part 9: References 
178 
177. Sharif S, et al. (2007) 15N nuclear magnetic resonance studies of acid-base properties 
of pyridoxal-5'-phosphate aldimines in aqueous solution. J Phys Chem B 111:3869-
3876. 
178. Gasteiger E, et al. (2005) Protein Identification and Analysis Tools on the ExPASy 
Server. John M. Walker (ed): The Proteomics Protocols Handbook, Humana Press 571-
607. 
179. Lebowitz J, Lewis MS, & Schuck P (2002) Modern analytical ultracentrifugation in 
protein science: a tutorial review. Protein Sci 11:2067-2079. 
180. Webster SP, et al. (2000) Mechanism of 8-amino-7-oxononanoate synthase: 
spectroscopic, kinetic, and crystallographic studies. Biochemistry 39:516-528. 
181. Ikushiro H, Hayashi H, Kawata Y, & Kagamiyama H (1998) Analysis of the pH- and 
ligand-induced spectral transitions of tryptophanase: activation of the coenzyme at 
the early steps of the catalytic cycle. Biochemistry 37:3043-3052. 
182. Krissinel E & Henrick K (2007) Inference of macromolecular assemblies from 
crystalline state. J Mol Biol 372:774-797. 
183. Huheey JE, Keiter EA, & Keiter RL eds. (1993) Inorganic Chemistry : Principles of 
Structure and Reactivity (HarperCollins, New York, USA). 
184. Cordes EH & Jencks WP (1962) Semicarbazone formation from pyridoxal, pyridoxal 
phosphate, and their Schiff bases. Biochemistry 1: 
185. Srivastava SK & Beutler E (1973) A new fluorometric method for the determination of 
pyridoxal 5'-phosphate. Biochim Biophys Acta 304:765-773. 
186. Bagdanoff JT, et al. (2009) Inhibition of sphingosine-1-phosphate lyase for the 
treatment of autoimmune disorders. J Med Chem 52:3941-3953. 
187. Jones DT (1999) Protein secondary structure prediction based on position-specific 
scoring matrices. J Mol Biol 292:195-202. 
188. Bryson K, et al. (2005) Protein structure prediction servers at University College 
London. Nucleic Acids Res 33:W36-38. 
189. Kaufman DL, Houser CR, & Tobin AJ (1991) Two forms of the gamma-aminobutyric 
acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal 
distributions and cofactor interactions. J Neurochem 56:720-723. 
190. Dunathan HC (1966) Conformation and reaction specificity in pyridoxal phosphate 
enzymes. Proc Natl Acad Sci U S A 55:712-716. 
191. Cho W, Bittova L, & Stahelin RV (2001) Membrane binding assays for peripheral 
proteins. Anal Biochem 296:153-161. 
192. de Andrade SA, et al. (2005) Conformational changes of Loxosceles venom 
sphingomyelinases monitored by circular dichroism. Biochem Biophys Res Commun 
327:117-123. 
193. Watanabe N, et al. (2008) Mechanism of substrate recognition and PLP-induced 
conformational changes in LL-diaminopimelate aminotransferase from Arabidopsis 
thaliana. J Mol Biol 384:1314-1329. 
194. Pujals S & Giralt E (2008) Proline-rich, amphipathic cell-penetrating peptides. Adv 
Drug Deliv Rev 60:473-484. 
195. Williamson MP (1994) The structure and function of proline-rich regions in proteins. 
Biochem J 297:249-260. 
196. Yu H, et al. (1994) Structural basis for the binding of proline-rich peptides to SH3 
domains. Cell 76:933-945. 
197. Fink AL (2005) Natively unfolded proteins. Curr Opin Struct Biol 15:35-41. 
Questioning the Sphinx: Structural and functional studies of sphingosine-1-phosphate lyase 
  179 
198. Wells M, et al. (2008) Structure of tumor suppressor p53 and its intrinsically 
disordered N-terminal transactivation domain. Proc Natl Acad Sci U S A 105:5762-
5767. 
199. Helton ES, Zhang J, & Chen X (2008) The proline-rich domain in p63 is necessary for 
the transcriptional and apoptosis-inducing activities of TAp63. Oncogene 27:2843-
2850. 
200. Lomize AL, Pogozheva ID, Lomize MA, & Mosberg HI (2007) The role of hydrophobic 
interactions in positioning of peripheral proteins in membranes. BMC Struct Biol 
7:pages not indicated. 
201. Neumann P, Weidner A, Pech A, Stubbs MT, & Tittmann K (2009) Structural basis for 
membrane binding and catalytic activation of the peripheral membrane enzyme 
pyruvate oxidase from Escherichia coli. Proc Natl Acad Sci U S A 105:17390-17395. 
202. Marcia M, Ermler U, Peng G, & Michel H (2009) The structure of Aquifex aeolicus 
sulfide:quinone oxidoreductase, a basis to understand sulfide detoxification and 
respiration. Proc Natl Acad Sci U S A 106:9625-9630. 
203. Rufer AC, et al. (2007) Carnitine palmitoyltransferase 2: analysis of membrane 
association and complex structure with a substrate analog. FEBS Lett 581:3247-3252. 
204. Lupas A, Van Dyke M, & Stock J (1991) Predicting coiled coils from protein sequences. 
Science 252:1162-1164. 
205. Gut H, et al. (2009) A Common Structural Basis for pH- and Calmodulin-mediated 
Regulation in Plant Glutamate Decarboxylase. J Mol Biol 392:334-351. 
206. Fenalti G, et al. (2007) GABA production by glutamic acid decarboxylase is regulated 
by a dynamic catalytic loop. Nat Struct Mol Biol 14:280-286. 
207. Sivashanmugam A, et al. (2009) Practical protocols for production of very high yields 
of recombinant proteins using Escherichia coli. Protein Sci 18:936-948. 
208. Fox BG & Blommel PG (2009) Autoinduction of protein expression. Curr Protoc 
Protein Sci Chapter 5:Unit 5.23. 
209. Geertsma ER, Groeneveld M, Slotboom DJ, & Poolman B (2008) Quality control of 
overexpressed membrane proteins. Proc Natl Acad Sci U S A 105:5722-5727. 
210. Lindner P, et al. (1997) Specific detection of his-tagged proteins with recombinant 
anti-His tag scFv-phosphatase or scFv-phage fusions. Biotechniques 22:140-149. 
211. Edman P & Begg G (1967) A protein sequenator. Eur J Biochem 1:80-91. 
212. Andréani P & Gräler MH (2006) Comparative quantification of sphingolipids and 
analogs in biological samples by high-performance liquid chromatography after 
chloroform extraction. Anal Biochem 358:239-246. 
213. He X, Huang CL, & Schuchman EH (2009) Quantitative analysis of sphingosine-1-
phosphate by HPLC after napthalene-2,3-dicarboxaldehyde (NDA) derivatization. J 
Chromatogr B Analyt Technol Biomed Life Sci 877:983-990. 
  
    181
10. ACKNOWLEDGMENTS 
 
First of all, I would like to thank Markus Grütter for making this project possible and for all 
his support during the entire thesis. The scientific advices and state-of-the-art lab 
infrastructure he provided me were invaluable. 
 
I am indebted to Guido Capitani. He initiated the project and followed it throughout its 
course. I appreciated so much his expertise, advices, support and patience. He guided me 
and taught me so many things (especially in crystallography) that he would actually deserve 
much more than four lines of acknowledgments! 
 
Special thanks go to Prof. Howard Riezman, for the very nice collaboration, his help, and for 
expertise in functional assays and data analysis. 
 
I thank Prof. Antonio Baici and Prof. Raimund Dutzler to be in my thesis committee. 
 
I thank Prof. Daniela De Biase to share her expertise in spectroscopy. Her help was 
invaluable. 
 
I'm very grateful to Christophe Briand, Beat Blattmann, Céline Stutz-Ducommun, Serge 
Chesnov and Bernd Roschitzki for their expertise, flexibility, motivation and enthusiasm. I 
thank my colleagues from the "L70 office", Heinz Gut, Christian Stirnimann, and our "guest" 
Oliv Eidam, for the excellent professional working atmosphere, advices and help. I extend 
these acknowledgments to all my colleagues from the Grütter group, as well as the Dutzler 
group. 
 
I don't forget Prof. Peter Schürmann. I thank him for having accompanied my first steps into 
research and my (rapidly) growing interest for research. I enjoyed so much the wonderful 
master thesis project he offered me! I also thank my lab- and study mate Dominique Glauser 
for the fantastic five years of studies and practical work in Neuchâtel and especially for the 
collaboration during the last year. 
 
My colleagues at PSI were fantastic: Daniela (thank you so much for your help and support!) 
and Antonietta, Remo, and Yannick. 
 
Special thanks go to my friends the crazy Doucette and Guillaume, for opening my horizons 
and taking care of me, and to Céline (again!), Beatrice, Carine and Patrick for the great (too 
scarce!) time together. 
 
I would like to deeply thank my family for their love, support and patience. They could cope 
with my (very frequent) mood fluctuations linked to research. I am so lucky to have you! 
 
Last but not least, I thank Steve, the biggest and the most beautiful surprise of my life. He 
has shared my time for more than two years, heard, helped and supported me so well. Part 
of this thesis goes to you. You are simply brilliant! 
 
  
  
11. CURRICULUM VITÆ 
 
Personal data 
 
Name    Bourquin 
First names   Florence Evelyne 
Date of birth   December 10th, 1979 
Place of birth   La Chaux-de-Fonds (NE), Switzerland 
Citizenship   Buttes, Les Verrières, La Côte-aux-Fées (NE), Switzerland 
 
 
Education 
 
1995-1998 High school (scientific section) in La Chaux-de-Fonds (NE), Switzerland 
1998-2002 Undergraduate studies in biology, specialisation in biochemistry and plant 
physiology, at the University of Neuchâtel (NE), Switzerland 
2002-2003 Diploma thesis at the Plant Biochemistry Laboratory, University of Neuchâtel 
 Supervisor: Prof. Peter Schürmann 
Title: "Mutagenèse dirigée de la ferrédoxine:thiorédoxine réductase de 
Synechocystis: Aspects fonctionnels et interaction avec la ferrédoxine 
et les thiorédoxines f et m" 
2003 Degree: Dipl. Biol. 
2003-2005 Research associate at Paul Scherrer Institute (PSI), Villigen (AG), Switzerland 
  Supervisors: Prof. Fritz K. Winkler, Dr. XiaoDan Li 
 Subject: Structural studies of i-CLiPs (intra-membrane cleaving proteases) 
2005-2009 PhD studies at the Department of Biochemistry, University of Zürich (ZH), 
Switzerland within the framework of the NCCR Structural Biology program 
 Supervisors: Prof. Markus G. Grütter, Dr. Guido Capitani 
 Collaboration: Prof. Howard Riezman, University of Geneva (GE), Switzerland 
2009 Dissertation 
Title: "Questioning the Sphinx: Structural and functional studies of 
sphingosine-1-phosphate lyase" 
 
 
 
  184
Publications 
 
Characterization of ferredoxin:thioredoxin reductase modified by site-directed 
mutagenesis. Glauser DA*, Bourquin F*, Manieri W, Schürmann P (2004). 
J Biol Chem. 279(16): 16662-9. 
* equal contribution 
 
Spectroscopic characterization of site-specific [Fe(4)S(4)] cluster chemistry in 
ferredoxin:thioredoxin reductase: implications for the catalytic mechanism. Walters EM, 
Garcia-Serres R, Jameson GN, Glauser DA, Bourquin F, Manieri W, Schürmann P, Johnson 
MK, Huynh BH. (2005). 
J Am Chem Soc. 127(26): 9612-24. 
 
Structural snapshots along the reaction pathway of ferredoxin-thioredoxin reductase. Dai 
S, Friemann R, Glauser DA, Bourquin F, Manieri W, Schürmann P, Eklund H. (2007). 
Nature. 448(7149): 92-6. 
 
Role of histidine-86 in the catalytic mechanism of ferredoxin:thioredoxin reductase. 
Walters EM, Garcia-Serres R, Naik SG, Bourquin F, Glauser DA, Schürmann P, Huynh BH, 
Johnson MK. (2009). 
Biochemistry. 48(5): 1016-24. 
 
Structural basis for activity of eukaryotic and prokaryotic sphingosine-1-phosphate lyase, a 
key enzyme of sphingolipid metabolism 
Bourquin F et al. (2009) 
Manuscript submitted. 
 
 
Courses and meeting contributions 
 
2003  NCCR Practical course "Characterization and Crystallization of Soluble and 
Membrane Proteins", 13-17.10.2003, University of Zürich, Switzerland 
2009  7th NCCR Symposium on New Trends in Structural Biology, 07-08-09.2009, 
Zürich, Switzerland (poster contribution: Structural studies of sphingosine-1-
phosphate lyase) 
 
 
 
  
 
